{"taxa": [{"scientific_name": "stevia connata", "compounds": ["longipinane-7\u03b1,8\u03b2,9\u03b2-triol-1-one-7,9-diangelate", "stigmasterol", "longipin-2-ene-7\u03b2,8\u03b1,9\u03b1-triol-1-one-7-angelate-8-methylbutyrate", "longipin-2-ene-7\u03b2,8\u03b1,9\u03b1-triol-1-one 8-angelate-9-methylbutyrate", "longipinane-7\u03b2,8\u03b1,9\u03b1-triol-1-one 8,9-diangelate", "longipinane-7\u03b2,8\u03b1,9\u03b1-triol-1-one 7,8-diangelate", "longipinane-7\u03b2,8\u03b1,9\u03b1-triol-1-one-7-angelate-8-methylbutyrate", "longipin-2-ene-7\u03b2,8\u03b1,9\u03b1-triol-1-one-7,8-diangelate", "longipin-2-ene-7\u03b2,8\u03b1,9\u03b1-triol-1-one-8,9-di-angelate"], "accepted_name": "Stevia connata", "accepted_species": "Stevia connata", "accepted_genus": "Stevia", "inchi_keys": {"stigmasterol": "HCXVJBMSMIARIN-PHZDYDNGSA-N"}, "inchi_key_simps": {"stigmasterol": "HCXVJBMSMIARIN"}}, {"scientific_name": "stevia subpubescens", "compounds": ["3,4\u03b2-epoxy-5\u03b2,10\u03b2-cis-17\u03b1,20\u03b1-clerod-13(14)-en-15,16-olide", "9r,13r-epoxylabdane diterpenes"], "accepted_name": "Stevia subpubescens", "accepted_species": "Stevia subpubescens", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia viscida", "compounds": ["8,14-seco-oleana-8(26),13-dien-3\u03b2-ol"], "accepted_name": "Stevia viscida", "accepted_species": "Stevia viscida", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia eupatoria", "compounds": ["8,14-seco-oleana-8(26),13-dien-3\u03b2-ol acetate"], "accepted_name": "Stevia eupatoria", "accepted_species": "Stevia eupatoria", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia pilosa", "compounds": ["longipinenes", "(4r,5s,7s,8s,9s,10r,11r,2\u02b9\u02b9s)-7-angeloyloxy-9-hydroxy-8-(a-methyl-butyryloxy)-longipin-2-en-l-one", "(4r,5s,7s,8r,10r,11r,2\u02b9\u02b9s)-7-angeloyloxy -8-(a-methylbutyryloxy)-longipin-2-en-l-one"], "accepted_name": "Stevia pilosa", "accepted_species": "Stevia pilosa", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia monardifolia", "compounds": ["7\u03b2-angeloyloxy-8\u03b1-isovaleroyloxylongipin-2-en-1-one", "7\u03b2,8\u03b1-diangeloyloxylongipin-2-en-1-one", "7\u03b2,8\u03b1-diangeloyloxylongipinan-1-one"], "accepted_name": "Stevia monardifolia", "accepted_species": "Stevia monardifolia", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia tomentosa", "compounds": ["1,5:3,4-diepoxyguaia-10(14)-en-12,8-olide"], "accepted_name": "Stevia tomentosa", "accepted_species": "Stevia tomentosa", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia phlebophylla", "compounds": ["16\u03b2-hydroxy-17-acetoxy-ent-kauran-19-oic acid- (6-o-\u03b2-d-xylopyranosyl-\u03b2-d-glucopyranosyl) ester"], "accepted_name": "Stevia phlebophylla", "accepted_species": "Stevia phlebophylla", "accepted_genus": "Stevia", "inchi_keys": {}, "inchi_key_simps": {}}, {"scientific_name": "stevia satureiifolia var. satureiifolia", "compounds": ["cirsimaritin", "5-desmethylsinensetin", "eupatorin"], "accepted_name": "Stevia satureiifolia", "accepted_species": "Stevia satureiifolia", "accepted_genus": "Stevia", "inchi_keys": {"cirsimaritin": "ZIIAJIWLQUVGHB-UHFFFAOYSA-N", "5-desmethylsinensetin": "QEWSAPKRFOFQIU-UHFFFAOYSA-N", "eupatorin": "KLAOKWJLUQKWIF-UHFFFAOYSA-N"}, "inchi_key_simps": {"cirsimaritin": "ZIIAJIWLQUVGHB", "5-desmethylsinensetin": "QEWSAPKRFOFQIU", "eupatorin": "KLAOKWJLUQKWIF"}}, {"scientific_name": "stevia serrata", "compounds": ["chamazulene", "(e)-nerolidol", "germacrene d", "caryophyllene oxide"], "accepted_name": "Stevia serrata", "accepted_species": "Stevia serrata", "accepted_genus": "Stevia", "inchi_keys": {"chamazulene": "GXGJIOMUZAGVEH-UHFFFAOYSA-N", "(e)-nerolidol": "FQTLCLSUCSAZDY-SDNWHVSQSA-N", "germacrene d": "GAIBLDCXCZKKJE-RXJOXMPGSA-N", "caryophyllene oxide": "NVEQFIOZRFFVFW-RGCMKSIDSA-N"}, "inchi_key_simps": {"chamazulene": "GXGJIOMUZAGVEH", "(e)-nerolidol": "FQTLCLSUCSAZDY", "germacrene d": "GAIBLDCXCZKKJE", "caryophyllene oxide": "NVEQFIOZRFFVFW"}}, {"scientific_name": "stevia urticifolia", "compounds": ["hispidulin", "nepetin", "quercetin", "quercetin-3-o-\u03b1-l-arabinofuranoside"], "accepted_name": "Stevia urticifolia", "accepted_species": "Stevia urticifolia", "accepted_genus": "Stevia", "inchi_keys": {"hispidulin": "IHFBPDAQLQOCBX-UHFFFAOYSA-N", "nepetin": "FHHSEFRSDKWJKJ-UHFFFAOYSA-N", "quercetin": "REFJWTPEDVJJIY-UHFFFAOYSA-N"}, "inchi_key_simps": {"hispidulin": "IHFBPDAQLQOCBX", "nepetin": "FHHSEFRSDKWJKJ", "quercetin": "REFJWTPEDVJJIY"}}, {"scientific_name": "stevia subpubescens var. subpubescens", "compounds": ["ermanin", "cistenolic acid", "ayanin", "stigmasterol", "sakuranetin", "4\u2032-o-methylsakuranetin", "scoparone", "3,7,4\u2032-o-trimethylkaempferol", "labdanolic acid", "l-chiro inositol", "melilotoside", "hyperin"], "accepted_name": "Stevia subpubescens var. subpubescens", "accepted_species": "Stevia subpubescens", "accepted_genus": "Stevia", "inchi_keys": {"ermanin": "RJCJVIFSIXKSAH-UHFFFAOYSA-N", "ayanin": "KPCRYSMUMBNTCK-UHFFFAOYSA-N", "stigmasterol": "HCXVJBMSMIARIN-PHZDYDNGSA-N", "sakuranetin": "DJOJDHGQRNZXQQ-AWEZNQCLSA-N", "scoparone": "GUAFOGOEJLSQBT-UHFFFAOYSA-N", "labdanolic acid": "KHCCSRVJJDOANA-ZOSGAXDSSA-N", "melilotoside": "GVRIYIMNJGULCZ-ZMKUSUEASA-N", "hyperin": "OVSQVDMCBVZWGM-DTGCRPNFSA-N"}, "inchi_key_simps": {"ermanin": "RJCJVIFSIXKSAH", "ayanin": "KPCRYSMUMBNTCK", "stigmasterol": "HCXVJBMSMIARIN", "sakuranetin": "DJOJDHGQRNZXQQ", "scoparone": "GUAFOGOEJLSQBT", "labdanolic acid": "KHCCSRVJJDOANA", "melilotoside": "GVRIYIMNJGULCZ", "hyperin": "OVSQVDMCBVZWGM"}}, {"scientific_name": "stevia jorullensis", "compounds": ["stigmasterol", "11,13-dihydroreynosin", "stigmasteryl glucopyranoside", "\u03b2-sitosteryl glucopyranoside", "1\u03b2-hydroxycolartin", "chlorogenic acid", "11\u03b2,13-dihydrocostunolide", "\u03b2-sitosterol"], "accepted_name": "Stevia jorullensis", "accepted_species": "Stevia jorullensis", "accepted_genus": "Stevia", "inchi_keys": {"stigmasterol": "HCXVJBMSMIARIN-PHZDYDNGSA-N", "chlorogenic acid": "CWVRJTMFETXNAD-JUHZACGLSA-N", "11\u03b2,13-dihydrocostunolide": "NVKPIHNJIZGFRA-GAFUQQFSSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N"}, "inchi_key_simps": {"stigmasterol": "HCXVJBMSMIARIN", "chlorogenic acid": "CWVRJTMFETXNAD", "11\u03b2,13-dihydrocostunolide": "NVKPIHNJIZGFRA", "\u03b2-sitosterol": "KZJWDPNRJALLNS"}}, {"scientific_name": "stevia lucida", "compounds": ["alantolactone", "isoalantolactone"], "accepted_name": "Stevia lucida", "accepted_species": "Stevia lucida", "accepted_genus": "Stevia", "inchi_keys": {"alantolactone": "PXOYOCNNSUAQNS-AGNJHWRGSA-N", "isoalantolactone": "CVUANYCQTOGILD-QVHKTLOISA-N"}, "inchi_key_simps": {"alantolactone": "PXOYOCNNSUAQNS", "isoalantolactone": "CVUANYCQTOGILD"}}], "text": "Molecules 2021, 26, 2733. https://doi.org/10.3390/molecules26092733 www.mdpi.com/journal/molecules Review Stevia Genus: Phytochemistry and Biological Activities Update Jimena Borgo 1,2,3, Laura C. Laurella 1,2, Florencia Martini 1,3, Cesar A. N. Catal\u00e1n 4 and Valeria P. S\u00fclsen 1,2,3,* 1 Instituto de Qu\u00edmica y Metabolismo del F\u00e1rmaco (IQUIMEFA), CONICET\u2014Universidad de Buenos Aires, Buenos Aires 1113, Argentina; jimeborgo@gmail.com (J.B.); lclposdoc@gmail.com (L.C.L.); flormartini1@gmail.com (F.M.) 2 C\u00e1tedra de Farmacognosia, Facultad de Farmacia y Bioqu\u00edmica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina 3 C\u00e1tedra de Qu\u00edmica Medicinal, Facultad de Farmacia y Bioqu\u00edmica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina 4 Instituto de Qu\u00edmica Org\u00e1nica, Facultad de Bioqu\u00edmica Qu\u00edmica y Farmacia, Universidad Nacional de Tucum\u00e1n, Ayacucho 471 (T4000INI), San Miguel de Tucum\u00e1n, Argentina; ccatalan@fbqf.unt.edu.ar * Correspondence: vsulsen@ffyb.uba.ar Abstract: The Stevia genus (Asteraceae) comprises around 230 species, distributed from the southern United States to the South American Andean region. Stevia rebaudiana, a Paraguayan herb that pro\u2010duces an intensely sweet diterpene glycoside called stevioside, is the most relevant member of this genus. Apart from S. rebaudiana, many other species belonging to the Stevia genus are considered medicinal and have been popularly used to treat different ailments. The members from this genus produce sesquiterpene lactones, diterpenes, longipinanes, and flavonoids as the main types of phy\u2010tochemicals. Many pharmacological activities have been described for Stevia extracts and isolated compounds, antioxidant, antiparasitic, antiviral, anti\u2010inflammatory, and antiproliferative activities being the most frequently mentioned. This review aims to present an update of the Stevia genus covering ethnobotanical aspects and traditional uses, phytochemistry, and biological activities of the extracts and isolated compounds. Keywords: Stevia; sesquiterpene lactones; diterpenes; flavonoids; biological activity 1. Introduction The genus Stevia represents one of the most diverse and characteristic of the tribe Eupatoriae, subfamily Asteroidae, family Asteraceae. Its distribution area ranges from the southern United States to the Andean region of South America, to northern Chile and northern Patagonia in Argentina [1,2]. Members of Stevia comprise herbs and shrubs that are found mainly 500\u20133500 m above sea level. They grow in a wide range of environments including grasslands, scrublands, forested mountain slopes, conifer forests, and subalpine vegetation, although they most often inhabit semi\u2010dry mountainous terrains [3]. The number of species within the genus is estimated to be 230. Mexico and South America are characterized by highlands where Stevia species grow. Most species are found in South America, within Peru, Bolivia, southern Brazil, Paraguay, and northern Argentina, where approximately 120 species are found [3,4]. There are more than 80 spe\u2010cies known to be in North America, and at least 70 are native to Mexico. Records show that the genus is not present in the Bahamas, the Antilles, or Amazonia [2,3]. The genus is known worldwide for the species Stevia rebaudiana (Bertoni) Bertoni (Asteraceae), popularly named \u201cstevia\u201d, which produces large amounts of stevioside, a powerful non\u2010nutritive natural sweetener. Stevioside is composed of a mixture of several closely related ent\u2010kaurene glycosides, among which stevioside, rebaudioside A, and dulcoside A and B are the most important. Stevioside is the most abundant sweetener that, together with the other diterpene glycosides, accumulates in the leaves. The aqueous extracts of S. rebaudiana are used commercially to sweeten different products and also for Citation: Borgo, J.; Laurella, L.C.; Martini, F.; Catal\u00e1n, C.A.N.; S\u00fclsen, V.P. Stevia Genus: Phytochemistry and Biological Activities Update. Molecules 2021, 26, 2733. https:// doi.org/10.3390/molecules26092733 Academic Editor: Natalizia Miceli Received: 7 April 2021 Accepted: 30 April 2021 Published: 6 May 2021 Publisher\u2019s Note: MDPI stays neu\u2010tral with regard to jurisdictional claims in published maps and institu\u2010tional affiliations. Copyright: \u00a9 2021 by the authors. Li\u2010censee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and con\u2010ditions of the Creative Commons At\u2010tribution (CC BY) license (http://crea\u2010tivecommons.org/licenses/by/4.0/). Molecules 2021, 26, 2733 2 of 45 the extraction of sweet principles. Stevia rebaudiana has also demonstrated several biolog\u2010ical activities in preclinical and clinical studies including antidiabetic, anticariogenic, an\u2010tioxidant, antihypertensive, antimicrobial, anti\u2010inflammatory, and antitumor activities, among others [5]. Revisions on the genus covering ethnobotany and phytochemistry data have been published previously [1,6,7]. However, in the last years, most of the scientific papers and reviews were dedicated almost exclusively to S. rebaudiana and its constituents. The aim of this review is to provide an update on the Stevia genus focusing on ethnobotanical, phytochemical, and pharmacological data published in the last decades. Articles covering the biological activities of extracts and isolated compounds of this genus will be analyzed and discussed. 2. Ethnobotany Ethnobotanical data on Stevia species have been described since the 18th century. The latest revision covering ethnobotanical and ethnopharmacological aspects of the Stevia species was published in 2002 [6]. A literature survey covering the period January 2002\u2013February 2021 was carried out here in order to update the information related to these topics. The traditional uses of 29 species from Central and South America are available. Some of the most common popular uses of Stevia species are related to antidiarrheal, anti\u2010inflammatory, antimalarial uses, as a febrifuge, a diuretic, a diaphoretic, to treat heart dis\u2010eases, stomachaches, and skin conditions (Table 1). Table 1. Ethnobotanical uses of Stevia species. Species Common Name Ethnobotanical Use Location Refs. S. achalensis Comadre Ornamental. Argentina [8,9] S. balansae Hieron. \u2010 Antidiarrheal. Paraguay [10] S. bogotensis Tr. ex Cort\u00e9s Jarilla, Clavito, eupatoria Febrifugue. Diaphoretic. Colombia [6,10] S. cardiatica Perkins \u2010 Heart diseases. Bolivia [6,10] S. collina Gardn. Ca\u00e1\u2010eh\u00e9 Sweetener. As stomachic. Brazil [6] S. connata Lag. Peric\u00f3n de monte Stomachache treatment. Guatemala [6,10] S. elatior HBK. A\u2010c\u00ed To soothe burns and scratches Mexico [6,10] S. eupatoria (Spreng.) Wild Hierba del borrego, yerba del bo\u2010rrego, cola del borrego, estevia Diuretic. Antimalarial. For stomach\u2010ache. Hypoglycemiant. Analgesic. Anti\u2010inflammatory. Antihyperten\u2010sive. Cuba [6,10,11] S. fiebrigii Hieron. var. vattuo\u2010nei (Hicken) Cabrera \u2010 Ornamental. Argentina [8] S. glandulosa Hook. et Arn. Hierba de la pulga Antipyretic. Mexico [6,10] S. linoides Sch. Bip. \u2010 Astringent. \u2010 [12] S. lucida Lag. Yerba del aire, hierba de la ara\u00f1a, ma\u2010li\u2010too, kebuj, mariposa, chirca, chilca, javillo, golondrina de la saba\u2010nera To cure wounds. To soothe pains. Rheumatism treatment. Anti\u2010in\u2010flammatory. Mexico, Guate\u2010mala, Colombia, Venezuela [6,10] S. macbridei B. L. Robins var. anomala B. L. Robins Jauja\u2010huancayo Used as a bath by women. Peru [6,10] S. mercedensis Hieron. var. mer\u2010cedensis Comadre Ornamental. Bolivia, Argen\u2010tina [9,13] S. nepetifolia HBK Zazal, anis de rat\u00f3n, perac\u00f3n Dysmenorrhea treatment. Mexico, Guate\u2010mala [6,10] S. palmeri Gray Raniweri, raniwori Odoriferous. Mexico [6] S. petiolata (Cass) Sch. Bip. Guarme\u2010guarmi To give flavor to meat. Peru [6,10] S. pilosa Lag. Flor de Mar\u00eda Antimalarial. Antipyretic. Cathartic. Diuretic. Mexico [6,10] Molecules 2021, 26, 2733 3 of 45 S. plummerae Gray Ronino To make washes and poultices for open wounds. Mexico [6] S. puberula Hook. Lima\u2010lima Used as tea substitute and stomach medicine. Peru [6,10] S. rebaudiana Bertoni Hierba dulce del Paraguay, estevia, stevia Sweetener. Food additive. Contra\u2010ceptive. Antidiabetic. Used to regu\u2010late arterial pressure. Paraguay, Brazil [6,10] S. rhombifolia HKB var. step\u2010phanocoma Sch. Bip. Manka pak\u2019I, pirq\u2019a Stomachache treatment. As an emetic. Used for mate. Peru [6] S. salicifolia Cav. Hierba del aire, hierba de la mula, la envidia, zazale de olor, yerba de la mula. Hierba de la Santa Rita Rheumatism treatment. Cathartic. For intestinal upset due to parasites. Purgative. For fevers and colds. Mexico, USA [6,10] S. sanguinea Hieron. Malvisco Ornamental. Argentina [8] S. satureiifolia (Lam.) Sch. Bip. ex Klotzsch var. satureiifolia Romerillo Ornamental. Argentina, Brazil, Uruguay [8] S. serrata Cav. Ronino, Uriki, Otoninawa, Chapo, yerba picante, hiperic\u00f3n, Q\u2019ang\u2019aj, anis silvestre, hipericon arrie To make washes and poultices for open wounds. Applied to cuts on feet and on snake bites. As cough remedy. For gastrointestinal disor\u2010ders. Guatemala, Mexico [6,10,14] S. subpubescens Lag. Hierba de la mula, Zazal As a bath after parturition. Stom\u2010achache treatment. To treat joint pains. Mexico [6,10] S. trifida Lag. Manzanilla de agua Dysentery treatment. Mexico [6,10] S. yalae Cabrera \u2010 Ornamental. Argentina [8] Many plants such as S. connata, S. eupatoria, S. puberula, S. serrata, and S. subpubescens have been used for gastrointestinal disorders. Other species have been used as therapy for infectious diseases. In this sense, S. bogotensis, S. eupatoria, S. glandulosa, S. pilosa, and S. salicifolia have been employed as antipyrectic and antiparasitic. The anti\u2010inflammatory use of Stevia plants has also been described in the literature; for instance, S. eupatoria, S. lucida, and S. salicifolia have been described as useful for the treatmet of inflammatory processes. Stevia eupatoria, S. lucida, S. salicifolia, S. serrata, and S. subpubescens have been used in the United States, Mexico, and Central America and northern South America. These Stevia species have many associated medicinal properties and have been popularly used to treat a wide range of diseases. Stevia eupatoria, known as \u201chierba del borrego\u201d, \u201cyerba del borrego\u201d, and \u201ccola del Borrego\u201d has been described as antimalarial and has been used for its diuretic properties. Mexican folk medicine has used this species as an herbal remedy for stomach pain and for its hipoglycemic, analgesic, anti\u2010inflammatory, and antihypertensive properties. This spe\u2010cies is known as \u201cestevia\u201d (synonym of S. purpurea) [6,10,11]. Stevia lucida is widespread from Mexico to Venezuela. This plant is popularly known in Mexico as \u201cyerba del aire\u201d and \u201chierba de la ara\u00f1a\u201d. In Guatemala, it is called \u201ckebuj\u201d and in Colombia, it is known as \u201cchilca\u201d and \u201cgolondrina de la sabanera\u201d. In Venezuela, it is named \u201cchilca\u201d and \u201cchirca\u201d. Stevia glutinosa, a synonym of S. lucida, is called \u201cjavillo\u201d, \u201cjavilla\u201d, and \u201cmariposa\u201d. Several uses have been described for this species, including external use to relieve pain and treat wounds. In Colombia, a decoction of the aerial parts of S. lucida has been used to alleviate inflammatory processes. In Guatemala, it has been used to treat rheumatism. With the same purpose, in Maracaibo (Venezuela), a decoction of the leafy stems of S. lucida has been used. In Mexican folk medicine, \u201cyerba del aire\u201d has been used to treat chilly cramps [6,10]. S. salicifolia constitutes another species known with different common names and is distributed from southern United States to Mexico. In traditional medicine, it is known as \u201chierba del aire\u201d, \u201chierba de la mula\u201d, \u201czazal\u201d, \u201czazale de olor, \u201cyerba de la mula\u201d, and \u201cla envidia\u201d in Mexico. This species, synonym of S. stenophylla, is also known as \u201chierba de la Santa Rita\u201d. In Mercado Juarez (Toluca, Mexico), the dried aerial parts of S. salicifolia Molecules 2021, 26, 2733 4 of 45 are marketed to prepare decoctions or alcoholic infusions that can be used \u201cas a rub\u201d to treat rheumatism. In Mexico, the decoction of the dried roots has been used as a cathartic, and the infusion of the roots has been recommended for intestinal upset due to parasites. The roots, mashed and placed in warm water, are used to prepare a drink employed as a purgative. The leaves are used to prepare tea (infusion) for colds and fevers [6,10]. Stevia serrata is known in traditional medicine as \u201cronino\u201d, \u201curiki\u201d, \u201cotoninawa\u201d, \u201cchapo\u201d, \u201cyerba picante\u201d, \u201chiperic\u00f3n\u201d, \u201cQ\u2019ang\u2019aj\u201d, \u201canis silvestre\u201d, and \u201chipericon arrie\u201d. The external use of crushed roots of S. serrata for washes and poultices applied directly to open wounds has been reported. The whole plant crushed and rubbed has been employed in snake bites. This species has been described as a cough remedy and to treat gastroin\u2010testinal disorders [6,10,14]. In Mexico, S. subpubescens (synonym of S. subpubescens var. subpubescens) is com\u2010monly known as \u201czazal\u201d and also as \u201chierba de la mula\u201d. The aerial parts of this species have been recommended as a decoction to be used as a bath by women after parturition. The leaves are used for stomachaches and the whole fried plant can be rubbed on affected parts to treat joint pain [6,10]. Other species have also been described as medicinal. The decoction of S. macbridei has been used externally by women as a bath. The infusion or tea of S. nepetifolia has been suggested to alleviate dysmenorrhea symptoms. A drink prepared with the roots of S. balansae has been employed in Paraguay to treat diarrhea. The infusion of roots and flow\u2010ers of S. trifida has been orally administrated to treat dysentery. In the last years, several Argentinean Stevia species have been employed with an or\u2010namental purpose. In this sense, S. achalensis, S. fiebrigii var. vattuonei, S. mercedensis var. mercedensis, S. sanguinea, S. satureiifolia var. satureiifolia and S. yalae can be mentioned. In particular, the species S. fiebrigii var. vattuonei and S. mercedensis var. mercedensis are com\u2010monly used in northern Argentina as ornamentation in religious festivities. 3. Phytochemistry 3.1. General Aspects Being one of the largest and most easily recognizable from the tribe Eupatoriae, the genus Stevia is surprisingly diverse in its chemical composition. The phytochemistry of the Stevia genus was reviewed by Hernandez et al. [1] and by Cerda\u2010Garc\u00eda\u2010Rojas and Pereda\u2010Miranda [7]. Sesquiterpenoids are by far the major and most typical secondary metabolites found in the aerial parts and roots of Stevia species. To our knowledge, phytochemical information is available to date on 61 Stevia spe\u2010cies, sesquiterpene lactones (STLs), diterpenes, longipinanes, and flavonoids being the main types of compounds reported. Other phytochemical groups include triterpenes and sterols. Sesquiterpene lactones are frequently found and isolated from different Stevia species [1]. This phytochemical group is the subject of numerous studies due to the extensive bi\u2010ological activities presented. It has shown anti\u2010inflammatory, cytotoxic, antiviral, antima\u2010larial, antileishmanial, and trypanocidal activities, among others [15,16]. The STLs most commonly reported in Stevia are germacranolides and guainolides, whose skeletons are considered to be of the first and second degree of biogenetic com\u2010plexity, respectively. However, other skeletal types corresponding to the third degree of complexity such as xanthanolides, pseudoguaianolides, and eremophilanolides were also found. Both trans\u2010fused lactones toward C\u20106 and cis\u2010fused lactones toward C\u20108 were iso\u2010lated from Stevia species [1]. A common characteristic of the STLs of this genus is the \u03b2\u2010orientation of substituents at C\u20108. Among germacranolides, germacrolides, heliangolides, and melampolides have been described, the latter type being found exclusively in South American species [1,7]. In guaianolides, oxidation is frequently observed at the C\u20103, C\u20108, and C\u201014 positions and also at C\u20102. Pseudoguaianolides have been isolated only from Molecules 2021, 26, 2733 5 of 45 Mexican species. A unique and specific structural type of STL found in Stevia is jujuyen\u2010solide, isolated from Stevia jujuyensis [1]. In Stevia, diterpenoids of the labdane, ent\u2010labdane, ent\u2010kaurane, and clerodane type have been described. Among them, the diterpenoids with kaurane skeleton predominate. The production of glycosidic diterpenes was also reported in species of this genus. In this sense, the most relevant compound is the sweetener stevioside, an ent\u2010kaurane diterpene glycoside isolated from S. rebaudiana, as mentioned above. Longipinanes are the other phytochemical group commonly found in Stevia. They are tricyclic sesquiterpenes that are frequently poliesterified. The positions C\u20107, C\u20108, C\u20109, and C\u201013 are usually oxidazed with acyloxy and/or hydroxyl groups and a keto function is present at C\u20101 which is \u03b1,\u03b2\u2010unsaturated in most compounds [1]. Longipinenes are highly oxygenated tricyclic structures with a spatial configuration susceptible to different types of rearrangements [17]. The absolute configuration of most longipinanes isolated from Stevia spp. has been determined by chemical correlation with (+)\u2010longipinene and by circular dichroism. The most common ester residues present in the structure are angelate, tiglate, senecioate, methacrylate, and acetate; however, other groups have also been de\u2010scribed (epoxyangelate, isovalerate, isobutyrate) [7]. In Stevia, flavonoids are less frequently reported than sesquiterpene lactones and diterpenes. However, flavonoids are a group with well\u2010known biological activities such as anti\u2010inflammatory, antioxidant, antiarrhythmic, antihypertensive, antiviral, and anti\u2010protozoal, among others. Most of the flavonoids reported in Stevia are flavones and flavo\u2010nols and their glycosides, the flavonols being the most commonly produced as in other Eupatoriae genera. Flavonols and flavones have similar substitution patterns. Hydroxyla\u2010tion may occur at positions 5, 7, 3\u2032, or 4\u2032 for flavones and flavonols. This is the case, for example, for the flavones apigenin and luteolin and the flavonols kaempferol and querce\u2010tin, respectively. Polyhydroxylated and methoxylated flavones and flavonols in the A\u2010ring are also found. Glycosylation can occur at positions 3, 7, or 4\u2032, with glucose and ga\u2010lactose being the sugars most frequently found. It is worth mentioning the differences found between the North and Central Ameri\u2010can species and the South American ones. The former have a higher amount of methox\u2010ylated aglycones and flavonoids glycosides of luteolin and quercetin than the Stevia spe\u2010cies from South America. 3.2. Advances in the Chemistry of Stevia As mentioned above, the chemistry of the Stevia genus was reviewed in 1998 and in 2002 [1,7]. Consequently, in this review, a survey of all the published literature on the chemistry, biological activity, and pharmacology of extracts and isolated compounds of this genus was carried out, covering the period from January 1998 to February 2021. Ac\u2010cording to the literature, in this period, 14 Stevia species were studied regarding their chemical composition (Table S1). From the air\u2010dried roots of S. connata, collected in Mexico, eight longipinenes (1\u20138) and stigmasterol (9) were isolated. The isolated compounds were longipinane\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one\u20107\u2010angelate\u20108\u2010methylbutyrate (1), longipin\u20102\u2010ene\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one\u20108,9\u2010di\u2010angelate (2), longipinane\u20107\u03b1,8\u03b2,9\u03b2\u2010triol\u20101\u2010one\u20107,9\u2010diangelate (3), longipinane\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one 7,8\u2010diangelate (4), longipin\u20102\u2010ene\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one\u20107,8\u2010diangelate (5), long\u2010ipinane\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one 8,9\u2010diangelate (6), longipin\u20102\u2010ene\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one 8\u2010an\u2010gelate\u20109\u2010methylbutyrate (7), and longipin\u20102\u2010ene\u20107\u03b2,8\u03b1,9\u03b1\u2010triol\u20101\u2010one\u20107\u2010angelate\u20108\u2010methylbutyrate (8); (1), (2), and (7) being new natural compounds [18]. In 2000, Roman et al. [19] reported the isolation of grindelane diterpenoids from the leaves of Mexican Stevia subpubescens. Four new 9R,13R\u2010epoxylabdane diterpenes (10\u201313) and a known clerodane derivative, 3,4\u03b2\u2010epoxy\u20105\u03b2,10\u03b2\u2010cis\u201017\u03b1,20\u03b1\u2010clerod\u201013(14)\u2010en\u201015,16\u2010olide (14), were reported. Molecules 2021, 26, 2733 6 of 45 Two triterpenes, 8,14\u2010seco\u2010oleana\u20108(26),13\u2010dien\u20103\u03b2\u2010ol (15) and its acetyl derivative, 8,14\u2010seco\u2010oleana\u20108(26),13\u2010dien\u20103\u03b2\u2010ol acetate (16), were isolated from Stevia viscida and Ste\u2010via eupatoria, respectively [20]. The phytochemical study of S. pilosa, led to the isolation of longipinenes. The com\u2010pounds (4R,5S,7S,8S,9S,10R,11R,2\u02b9\u02b9S)\u20107\u2010angeloyloxy\u20109\u2010hydroxy\u20108\u2010(a\u2010methyl\u2010butyryloxy)\u2010longipin\u20102\u2010en\u2010l\u2010one (17) and (4R,5S,7S,8R,10R,11R,2\u02b9\u02b9S)\u20107\u2010angeloyloxy \u20108\u2010(a\u2010methylbutyr\u2010yloxy)\u2010longipin\u20102\u2010en\u2010l\u2010one (18), and other four logipinenes (19\u201322) were isolated from the roots of a Mexican collection of S. pilosa [21]. The presence of flavonoid glycosides of lute\u2010olin and quercetin, chromenes derivatives, longipinenes with angelate and methylbutyr\u2010ate ester residues, polysaccharides (mainly glucose), and fatty acids was demonstrated in the methanol extracts of this species and in S. eupatoria [11]. In 2009, three longipinenes were isolated from S. monardifolia methanol extract: 7\u03b2,8\u03b1\u2010diangeloyloxylongipin\u20102\u2010en\u20101\u2010one (23), 7\u03b2,8\u03b1\u2010diangeloyloxylongipinan\u20101\u2010one (24), and 7\u03b2\u2010angeloyloxy\u20108\u03b1\u2010isovaleroyloxylongipin\u20102\u2010en\u20101\u2010one (25) [22]. The new sesquiterpene lactone 1,5:3,4\u2010diepoxyguaia\u201010(14)\u2010en\u201012,8\u2010olide (26) was described by Valdez\u2010Calder\u00f3n et al. [23]. This diepoxyguaianolide, isolated from the aerial parts of S. tomentosa, contains two \u03b2\u2010oriented epoxide groups in the five\u2010membered car\u2010bocyclic ring. A chemical study of the Mexican S. phlebophylla was carried out by Ceunan et al. [24]. The phytochemical study of this plant led to the isolation of a new diterpene glycoside, 16\u03b2\u2010hydroxy\u201017\u2010acetoxy\u2010ent\u2010kauran\u201019\u2010oic acid\u2010 (6\u2010O\u2010\u03b2\u2010D\u2010xylopyranosyl\u2010\u03b2\u2010D\u2010glucopyra\u2010nosyl) ester (27). A bioguided fractionation of the dichloromethane extract of the Argentinean species S. satureiifolia var. satureiifolia, led to the isolation of three methoxylated flavones: eupa\u2010torin (28), cirsimaritin (29), and 5\u2010desmethylsinensetin (30) [25]. Reis Simas et al. [26] reported the chemical composition of the essential oil of S. serrata collected in the highlands of Guatemala. The analysis of the essential oil, obtained by hy\u2010drodistillation, showed a high content of sesquiterpenes, chamazulene (31) (60.1%) being the major component. Other compounds identified were (E)\u2010nerolidol (32), caryophyllene oxide (33), and germacrene D (34). From the aerial parts of S. urticifolia, four flavonoids were described [27]. The phyto\u2010chemical investigation led to the isolation of hispidulin (5,7,4\u2010trihydroxy\u20106\u2010methoxyfla\u2010vone) (35), nepetin (6\u2010methoxyluteolin; 5,7,3,4\u2010tetrahydroxy\u20106\u2010methoxyflavone) (36), quercetin (3,5,7,3,4\u2010pentahydroxyflavone) (37), and quercetin\u20103\u2010O\u2010\u03b1\u2010L\u2010arabinofuranoside (38). Aerial parts of S. subpubescens var. subpubescens, collected in Mexico, were extracted consecutively with hexane, EtOAc, and MeOH to obtain the corresponding extracts. The purification of the extracts by chromatographic techniques led to the isolation of stigmas\u2010terol (9), the flavonoids 4\u2032\u2010O\u2010methylsakuranetin (39), sakuranetin (40), 3,7,4\u2032\u2010O\u2010trime\u2010thylkaempferol (41), ayanin (42), ermanin (43), hyperin (44), the labdanes cistenolic (45) and labdanolic (46) acids, the coumarins scoparone (47), melilotoside (48), L\u2010chiro inositol (49), and mixtures of stigmasteryl and \u03b2\u2010sitosteryl glucosides [28]. From the aerial parts of Stevia jorullensis, three sesquiterpene lactones, a germa\u2010cranolide, 11\u03b2,13\u2010dihydrocostunolide (50) and two eudesmanolides, 11,13\u2010dihydroreyno\u2010sin (51), and 1\u03b2\u2010hydroxycolartin (52) were described. These sesquiterpene lactones were reported for the first time in the Stevia genus. Additionally, chlorogenic acid (53), \u03b2\u2010sitos\u2010terol (54), stigmasterol (9), \u03b2\u2010sitosteryl glucopyranoside (55), and stigmasteryl glucopyra\u2010noside (56) were also isolated [29]. The isolation of helenin from the aerial parts of S. lucida was reported by Chac\u00f3n\u2010Morales et al. [30]. The authors described the isolation and identification of helenin, a nat\u2010ural mixture of the isomeric eudesmanolides alantolactone (57) and isoalantolactone (58). This was the first report of this natural eudesmanolide mixture in Stevia and in the Eupa\u2010torieae tribe. Molecules 2021, 26, 2733 7 of 45 4. Biological Activity Various biological activities of extracts and isolated compounds from the Stevia spe\u2010cies have been reported. Some details of the pharmacological properties of Stevia extracts published up to February 2021 are presented. The activity of the compounds reported by Hernandez et al. [1], and of those published in the period January 1998\u2013February 2021, is also described here. As evidenced by the literature, research on biological properties is primarily oriented by chemotaxonomic and ethnopharmacological aspects, among others. 4.1. Biological Activity of Stevia Extracts Most of the pharmacological activities of extracts of Stevia species are related to anti\u2010oxidant, antiparasitic, antiviral, anti\u2010inflammatory, and antiproliferative activities. There are numerous publications on the biological activities of Stevia rebaudiana Ber\u2010toni extracts. Taking into account all of the information available, the number of publica\u2010tions, and the potential of this species, a review dedicated exclusively to its pharmacolog\u2010ical properties should be recommended. For this reason, only a few representative and thorough papers on S. rebaudiana were included in this update. The oldest report about the biological activity of Stevia extracts corresponds to Four\u2010net et al. [31]. In this study, the authors evaluated the antiprotozoal activity of Bolivian medicinal plants. The ethanol, ethyl acetate, and petroleum ether extracts of Stevia yaconensis were tested on Leishmania brasiliensis, L. donovanni, L. amazonensis, and Trypano\u2010soma cruzi. The extracts were active in the range 50\u2013100 \u03bcg/mL against the parasites. The antimutagenic effect of the methanolic extracts obtained from the leaves, roots, and flowers of S. pilosa and S. eupatoria were evaluated by Cari\u00f1o\u2010Cortes et al. [11]. The authors found an inhibitory effect of both species on the mutagenicity induced by 2\u2010ami\u2010noanthracene in the strain TA98. The best effect was observed with leaves of both species and the flowers of S. eupatoria. The mutations induced with N\u2010ethyl\u2010N\u02b9\u2010nitro\u2010N\u2010nitro\u2010soguanidine in the strain TA100 were also reduced. Extracts from flowers and roots of S. pilosa and S. eupatoria, respectively, showed an inhibition of about 93%. Using mitomycin\u2010C on the strain TA102, a reduction of 87% with the extract of the leaves of S. eupatoria was obtained. The antioxidant potential of the extracts has also been demonstrated (>90%). The antiviral properties of a dried extract of the leaves of S. rebaudiana were assessed by Kedik et al. [32]. At a concentration of 2000 \u03bcg/mL, the extract inhibited the reproduc\u2010tion of RNA\u2010containing Teschen disease virus (porcine teschovirus) by 0.5 lg tissue cyto\u2010pathic dose (TCD50), the DNA\u2010containing infectious rhinotracheitis (IRT) virus (bovine herpesvirus 1) by 0.25 lg TCD50, and RNA\u2010containing human coronavirus (Hco V\u2010229E) by 0.33 lg TCD50. At a dose of 4000 \u03bcg/mL, the extract inactivated Teschen disease virus by 0.75 lg TCD50, IRT virus by 0.5 lg TCD50, and coronavirus by 0.66 lg TCD50. Another investigation carried out with the aqueous leaf extract of S. rebaudiana demonstrated its antioxidant activity. The IC50 value of the aqueous extract in DPPH rad\u2010ical scavenging assay was 83.45 \u03bcg/mL. The total phenolic content of the aqueous leaf extract was 56.73 mg/g. The extract also inhibited the hydroxyl radical, nitric oxide, and superoxide anions with IC50 values of 100.86, 98.73, and 100.86 \u03bcg/mL, respectively [33]. The acetone extract of S. rebaudiana was evaluated for its hepato\u2010protective efficacy on rats treated with CCl4 (carbon tetrachloride) as hepatotoxic. The extract showed the ability to suppress the elevation of serum ALT (p < 0.05) and AST (p < 0.001) activities. The administration of the extract allows the prevention of deleterious effects caused by CCl4, lowering lipid peroxidation, and the enhancement of antioxidant activities as SOD and CAT [34]. The trypanocidal activity of four Argentinean Stevia species was evaluated by Beer et al. [25]. The dichloromethane extracts of Stevia satureiifolia var satureiifolia, S. aristata, S. multiaristata, and S. entreriensis were assessed on T. cruzi epimastigotes. All the extracts showed antiprotozal activity at concentrations of 100 and 10 \u03bcg/mL. S. aristata and S. Molecules 2021, 26, 2733 8 of 45 satureiifolia var. satureiifolia extracts were the most active with growth inhibition percent\u2010ages of 87.3 \u00b1 0.3% and 90.9 \u00b1 1.2% at a concentration of 10 \u03bcg/mL. Machado et. al. [27] evaluated the antioxidant capacity of the hexane, ethanol, and ethyl acetate extracts of S. urticifolia, using the DPPH assay. Crude extracts were consid\u2010ered active when IC50 < 500 g/mL. The ethanol and ethyl acetate extracts showed antioxi\u2010dant capacity. To determine the influence of the extraction solvent in the phenolic content, Medina Medrano et al. [35] macerated leaves of S. ovata, S. origanoides, and S. viscida with water, ethanol 50%, and ethanol 100%. The total phenolic content of each extract was determined by the colorimetric method and the antioxidant activity of the leaves extracts was evalu\u2010ated using ABTS+ radical scavenging assay and DPPH free radical scavenging assay. The authors concluded that the samples with the highest phenolic content were those ex\u2010tracted with the solvent combination (ethanol\u2013water). These same extracts showed greater antioxidant activity. A three\u2010arm single\u2010blinded randomized crossover trial was developed by Farhat et al. in 2019 [36] to investigate the effect of the Stevia sweetener on postprandial glucose levels, appetite, and food intake, as a strategy for type 2 diabetes treatment. Participants received preloads of water, sugar (60 g), and Stevia (1 g) on three different days, followed by an ad libitum pizza lunch. The results showed that Stevia lowers appetite sensation and did not increase food intake or postprandial glucose levels. The aerial parts of S. subpubescens var. subpubecens were extracted by Perez Castorena et al. in 2019 [28] for phytochemical analysis and evaluation of anti\u2010inflammatory activity. Hexane, acetyl acetate, and methanol extracts were obtained. Anti\u2010inflammatory activity was tested on the TPA model of induced acute ear edema. The different extracts at 1 mg/ear dose presented mild anti\u2010inflammatory activity. The anticancer activity of S. pilosa and S. eupatoria methanolic root extracts on prostate cancer cells was studied by Martinez\u2010Rojo et al. [37]. The study was conducted on a hu\u2010man fibroblast cell line, and on androgen\u2010dependent (LNCaP) and androgen\u2010independent (PC\u20103) prostate cancer cell lines. The cell viability was evaluated using a Trypan Blue ex\u2010clusion test for 48 h and the migration by a wound\u2010healing assay. Both extracts signifi\u2010cantly reduced the viability and migration of prostate cancer cells in all concentrations evaluated. The antiproliferative effect of the Stevia extracts was higher in cancer cells than in normal cells. The essential oil of S. serrata demonstrated antinociceptive and anti\u2010inflammatory ac\u2010tivity in an in vivo experiment conducted by Cordeiro [14]. The essential oil was tested in chemical (capsaicin\u2010 and glutamate\u2010induced licking response) or thermal (hot plate) mod\u2010els of nociception. The mechanism of action was evaluated using two receptor antagonists (naloxone, atropine) and an enzyme inhibitor (L\u2010NAME). The antihyperalgesic effect was evaluated using carrageenan\u2010induced nociception and evaluated in the hot plate. The data obtained suggested that the essential oil of S. serrata presents an antinociceptive effect me\u2010diated, at least in part, through activation of opioid, cholinergic, and nitrergic pathways. Finally, the antioxidant activity of the aqueous extracts of seven wild plants collected from Peru was evaluated in 2021 by Gonzales et al. [38]. Among them, S. macbridei was tested. An in vitro DPPH assay was conducted along with the in vivo assay on the sensi\u2010bility towards hydrogen peroxide of the yeast sod1 mutant. Both assays determined that S. macbridei aqueous extracts possess antioxidant activity. 4.2. Biological Activity of Compounds Isolated from Stevia Species Biological activities regarding compounds isolated from Stevia species can be found in the literature, most of them being dedicated to the sweetener diterpene glycosides from Stevia rebaudiana. Taking into consideration that sesquiterpene lactones, together with diterpenoids and flavonoids, are phytochemical groups of interest due to their pharmacological Molecules 2021, 26, 2733 9 of 45 potential, details of these types of compounds strictly, isolated from Stevia spp., will be analyzed. In this review we have focused on the activity of compounds isolated from Stevia species. However, it should be considered that many of these compounds can also be found in plant species of other genera and families. 4.2.1. Biological Activity of Sesquiterpene Lactones Sesquiterpene lactones (STLs) are one of the major phytochemical groups of com\u2010pounds present in Stevia. Many of the biological activities attributed to medicinal plants and extracts can be related to the presence of this type of compound. Sesquiterpene lac\u2010tones have a wide range of biological activities reported: antitumoral, antiparasitic, tryp\u2010anocidal, leishmanicidal, antioxidant, neuroprotective, antiallergic, antidiabetic, anti\u2010in\u2010flammatory, etc. [15,16]. The bioactive sesquiterpene lactones isolated from Stevia species are detailed in Table 2 and Figure 1. The STL achalensolide (59) has been isolated from S. achalensis, S. polyphylla, and S. satureifolia [1]. The cytotoxic activity of this guaianolide has been tested in human tumor cell lines: U251 (glioblastoma), MCF\u20107 (breast), and SKLU\u20101 (lung). The IC50 values ob\u2010tained were 9.5 \u00b1 0.8, 9.5 \u00b1 0.8, and 7.6 \u00b1 0.3 \u03bcM, respectively. The anti\u2010inflammatory ac\u2010tivity was assessed in a mouse ear model of edema induced by TPA. Achalensolide pre\u2010sented an inhibition of 12.40% at 1 \u03bcM [39]. The isolation of the STL inuviscolide (60) from S. achalensis, S. isomeca, and S. ovata has been reported in the literature [1]. This compound showed inhibition of proinflamma\u2010tory enzymes: elastase, cyclooxygenase 1, and secretory phospholipase A2. It was able to reduce the skin leukocyte infiltration in a murine model of dermatitis [40]. Iniviscolide has also shown anti\u2010inflammatory in vivo activity in the ear and paw edema tests. The guaianoline\u2010type sesquiterpene lactone inuviscolide reduced phospholipase A2\u2010induced edema with an ID50 of 98 \u03bcmol/kg. In intact cells, it decreased the generation of leukotriene B4 (IC50 = 94 \u03bcM) [41]. This compound demonstrated cytotoxic activity against human melanoma cell lines, inhibiting the proliferation of the cell lines: SK\u201028, 624 mel, and 1363 mel in a dose\u2010dependent manner. The compound also caused cell\u2010cycle arrest at G2/M and induced apoptotic cell death [42]. Costunolide (61) is a germacranolide\u2010type sesquiterpene lactone that has been found in the genus Stevia only from S. amambayensis. However, this compound has been obtained from many other Asteraceae species [41]. This STL exhibited antitumor activity against cancer cells. Its mode of action is related to the induction of apoptosis, regulation of the cell cycle, and inhibition of angiogenesis and metastasis. It also reversed the drug re\u2010sistance mechanism [41]. Compound 61 was active against osteosarcoma and adenocarcinoma in xenografted mice. This STL has also shown potent anti\u2010inflammatory activity, as well as antidiabetic, antihelminth, antimicrobial, antimycobacterial, antiulcer, and antioxidant effects [41,43]. Recent studies demonstrated the antiosteoarthritic and antiasthmatic effects of this ses\u2010quiterpene lactone. The evaluation of costunolide as an inducer of hair growth in mice was also proven [41]. Costunolide exhibited in vitro activity against the epimastigotes of T. cruzi with a minimum lethal concentration of 7 \u03bcM [44]. Costunolide was also active against amastigotes of Leishmania mexicana (IC50 = 9.4 \u03bcM). When testing against Trypanosoma cruzi amastigotes, it did not show significant activity. Cytotoxicity was assessed on Monkey Vero cells [45]. The antitrypanosomal activity of costunolide was also evaluated by Julianti et al. [46]. This sesquiterpene lactone was active against Trypanosoma brucei rhodesiense with an IC50 of 1.3 \u00b1 0.4 \u03bcM and with a CC50 of 7.7 \u00b1 1.3 \u03bcM in L6 cell, showing a selectivity index (SI) of 5.9. Lee et al. [47] demonstrated the antiallergic effect of costunolide using in vitro and in vivo models. This STL was able to reduce the number of immune cells, mainly eosinophils, Molecules 2021, 26, 2733 10 of 45 and diminished the expression and secretion of Th2 cytokines (IL\u20104 and IL\u201013) in the bron\u2010choalveolar lavage fluid and lung tissues of mice with allergic asthma. Compound 61 produced a hypolipidemic effect in streptozotocin\u2010induced diabetic rats and would prevent osteoporosis by the enhancement of osteoblastic function [48,49]. Studies conducted by Ham et al. [50] demonstrated that costunolide produces a neuro\u2010protective effect and inhibits dopamine\u2010induced apoptosis. Thus, this sesquiterpene lac\u2010tone has been considered a promising candidate for the treatment of neurodegenerative diseases such as Parkinson\u2019s. Stevia grisebachiana was one of the sources of the germacranolide hanphyllin (3\u03b2\u2010hy\u2010droxycostunolide) (62). The cytotoxic activity of this compound was evaluated in cervical adenocarcinoma HeLa, breast adenocarcinoma MCF7, and skin epidermoid carcinoma A431 cells using the MTT assay. Hanphyllin showed moderate tumor cell\u2010growth inhibi\u2010tory activity with an IC50 of 14.95 \u00b1 2.21, 12.67 \u00b1 1.25, and 13.98 \u00b1 1.38 \u03bcM, respectively [51]. Hanphyllin was also able to activate the antioxidant response element (related to neurodegenerative diseases) on primary mouse cortical cultures. The cytotoxycity of this STL was also evaluated. The viability of the cells was nearly 100% at concentrations of 12.5 and 25 \u03bcM [52]. Eupatoriopicrin (63) is a germacranolide\u2010type sesquiterpene lactone that has been isolated from S. alpina var. glutinosa, S. maimarensis, S. procumbens, and S. sarensis [1]. This compound has been tested for its trypanocidal activity on epimastigotes, trypomastigotes, and amastigotes of Trypanosoma cruzi [53,54]. Eupatoriopicrin was active against the forms of the parasite with IC50 values of 4.39, 19.9, and 6.3 \u03bcM, respectively. On Vero cells, this STL presented a CC50 of 257.7 \u03bcM. Selectivity indexes were 12.9 and 40.6 for trypo\u2010mastigotes and amastigotes, respectively. The administration of 1 mg/kg/day of eupatori\u2010opicrin to infected mice produced a significant reduction in the parasitemia levels. Skele\u2010tal muscular tissues from eupatopicrin\u2010treated mice displayed only focal and interstitial lymphocyte inflammatory infiltrates and small necrotic areas [54]. This sesquiterpene lac\u2010tone has also demonstrated activity against Trypanosoma brucei rhodesiense with IC50 values of 1.2 and 1.4 \u03bcM and SI of 1.3 and 11.1, respectively [46,55]. Eupatoriopicrin also inhibited pro\u2010inflammatory functions of neutrophils via sup\u2010pression of IL\u20108 and TNF\u2010\u03b1 production (IC50 < 1 \u03bcM) and p38 and ERK 1/2 MAP Kinases. In an in vivo assay, it suppressed neutrophil migration in a thioglycolate\u2010induced inflam\u2010mation model [56]. Furthermore, it produced inhibition of the MurA enzyme of Escherichia coli and Pseudomona aeruginosa [57]. Eupatoriopicrin was also active on tumor cell lines [58,59]. Together with the activity reported for eupatoriopicrin, 5\u2010deoxyeupatoriopicrin (64) from S. chamaedrys also demonstrated the capacity to suppress the production of inflam\u2010matory cytokines. [56]. Eupatolide (65) is a sesquiterpene lactone (germacranolide) isolated from S. alpina var. glutinosa [1]. This compound exhibited cytotoxicity against HL60 (IC50 = 2.91 \u03bcM), SMMC\u20107721 (IC50 = 2.46 \u03bcM), A\u2010549 (IC50 = 2.86 \u03bcM), MCF\u20107 (IC50 = 2.91 \u03bcM), and SW\u2010480 (IC50 = 3.01 \u03bcM) cancer cell lines. This sesquiterpene lactone also showed significant inhib\u2010itory activity against LPS\u2010induced NO production in RAW264.7 macrophages with an IC50 of 2.00 \u03bcM [60]. Later, Boldbaatar et al. [61] demonstrated that eupatolide inhibited the proliferation, migration, and invasion of breast cancer cells and explained the possible molecular mechanism by which it exerted its activity. The presence of the STL eucannabinolide (66) has been reported in S. origanoides and S. sarensis [1]. Eucannabinolide was active on T. cruzi with IC50 = 18 \u00b1 3 \u03bcM (7.6 \u03bcg/mL). On Leishmania infantum, this compound was less active (IC50 > 25 \u03bcM) [62]. Eucannabino\u2010lide has also demonstrated activity against Trypanosoma brucei rhodesiense trypomastigotes (IC50 = 1.1 \u00b1 0.1 \u03bcM). The cytotoxicity on mammalian cells (CC50) on the L6\u2010cell line from rat\u2010skeletal myoblasts was 7.8 \u00b1 0.8 \u03bcM [55]. Eucannabinolide was also active on the par\u2010asite when it was loaded onto nanoparticles with a free drug equivalent IC50 value of 3.32 \u03bcM [63]. Eucannabinolide has also shown cytotoxic activity against tumor cell lines [64] Molecules 2021, 26, 2733 11 of 45 and anti\u2010inflammatory activity [65]. Recently, Zhu et al. [66] reported that this STL sup\u2010pressed the growth and metastasis of triple negative breast cancer (TNBC) via inactivation of signal transducer and activator of transcription 3 (STAT3). The guaianolide achillin (67) has been isolated from Stevia alpina var. alpina [1]. This guaianolide\u2010type sesquiterpene lactone has shown anti\u2010inflammatory, antiallergic (IC50 = 100 \u03bcM) and cytotoxic activity on SMMC\u20107721 cell lines [67]. Sanchez\u2010Carranza et al. [68] demonstrated that achillin enhances the cytotoxic effect of paclitaxel and the induction of G2/M phase cell cycle arrest and apoptosis when associating both drugs. This guainolide also reduced P\u2010gp levels and increased the intracellular retention of doxorubicin in Hep3B/PTX cells. This compound was moderately active and selective on Trypanosoma cruzi epimastigotes with an IC50 of 41.24 \u03bcM and a SI of 3.52 [53]. Leukodin or desacetoxymatricarin (68) is a sesquiterpene lactone that has been ob\u2010tained from S. pilosa [1]. This compound has shown antiallergic effects [67] and has inhib\u2010ited melanin pigment synthesis and tyrosinase activity in B16F10 melanoma cells [69]. This sesquiterpenelactone also inhibited meiosis in oocytes of amphibians [70]. From S. yaconensis var. subeglandulosa, the guaianolide ludartin (69) has been isolated [1]. Ludartin inhibited the viability, migration, and proliferation of osteosarcoma cell lines and it also increased cell apoptosis, with an IC50 15\u201330 \u03bcM. The highest effects were on the Saso\u20102 osteosarcoma cells, with an IC50 of 15 \u03bcM. On normal hFOB 1.19 osteoblasts, this compound showed minor cytotoxic effects (IC50 > 100 \u03bcM). Ludartin exerted cell cycle arrest at the G2/M checkpoint [71]. This sesquiterpene lactone also showed effects on spi\u2010nal cord injury in a rat model. Treatment with this compound improved locomotion by the inhibition of inflammatory cytokine expression and prevention of cell apoptosis [72]. Ludartin has been reported to have action on estrogen biosynthesis. The STL inhib\u2010ited aromatase enzyme activity in human placental microsomes (IC50 = 55 \u03bcM), being a competitive inhibitor with a K i = 23 \u03bcM [73]. Previously, Giordano et al. [74] demonstrated that this compound showed cytoprotective effects against the development of peptic ul\u2010cers, after an oral dose of 40 mg/kg. Eupahakonenin B (70) is another guaianolide\u2010type sesquiterpene lactone that has been isolated from different Stevia species: S. alpina var. glutinosa, S. chamaedrys, S. gilliesii, S. mercedensis, S. procumbens, S. sarensis, S. satureiifolia, and S. setifera [1]. This molecule has shown activity against T. cruzi epimastigotes, trypamoastigotes, and amastigotes with IC50 values of 0.78, 33.1, and 89.4 \u03bcM, respectively [53,54]. The sesquiterpene lactone 10\u2010epi\u20108\u2010deoxycumambrin B (71) was obtained from S. grisebachiana and S. yaconensis var. subeglandulosa. This guaianolide inhibited the aroma\u2010tase enzyme activity in human placental microsomes (IC50 = 7 \u03bcM), being a competitive inhibitor with a K i = 4 \u03bcM. 10\u2010epi\u20108\u2010deoxycumambrin B acted as type II ligand to the heme iron present in the active site of aromatase cytochrome P450 [73]. Later on, Luo et al. [75] calculated the molecular geometries and electronic structure of 10\u2010epi\u20108\u2010deoxycumambrin B as an aromatase inhibitor. Taking into account the correlation analysis, ELUMO (energy of lowest unoccupied molecular orbital) would have a positive impact on the inhibition activity. Estafietin (72) is another guainolide isolated from S. alpina var. alpina, S. boliviensis, S. grisebachiana, and S. yaconensis [1]. The anti\u2010Trypanosoma cruzi and anti\u2010Leishmania activity of this STL, as well as the synthesis of derivatives, has been described [53,54,76]. Estafietin was active and selective on T. cruzi epimastigotes (IC50 = 0.24 \u03bcM, IS = 1789.25). On trypo\u2010mastigotes and amastigotes, this compound showed IC50 of 117.5 and 109.3 \u03bcM. Estafietin was also active against promastigotes of L. braziliensis (IC50 = 1.0 \u03bcg/mL). This compound selectively inhibited T cell receptor activation [77] and showed an in vitro inhibitory effect on the meiosis reinitiation of amphibian oocytes [70]. In the Stevia genus, the sesquiterpene lactone isoalantolactone (58) has been obtained from S. polyphylla and S. lucida [1,28]. This compound has many biological activities de\u2010scribed, one of them being the cytotoxic activity. Isoalantolactone has been proven to in\u2010hibit proliferation by the induction of apoptosis, autophagy, causing G1 phase arrest, or Molecules 2021, 26, 2733 12 of 45 the activation of reactive oxygen species in gynecologic cancer cells, breast cancer, leuke\u2010mia, and lung squamous cancer [78\u201384]. This compound induced apoptosis by targeting multiple cellular signaling pathways. The studies suggest that the simultaneous targeting could determine the effectiveness and selectivity in killing cancer cells [85]. In 2020, Yan et al. [86] reported the effect of isoalantolactone on pancreatic cancer cells lines, PANC\u20101 and SW\u20101990, from human pancreatic carcinoma. This STL inhibited the proliferation of PANC\u20101 and SW1990 cells at 48 h treatment. The IC50 was 3.75 and 3.15 \u03bcg/mL for isoalantolactone in PANC\u20101 and SW1990 cells, respectively. Isoalantolactone showed synergistic effects against 21 \u03b2\u2010lactamase\u2010positive S. aureus strains (including methicillin\u2010resistant S. aureus, when combining with penicillin G). The association of drugs was also effective on S. aureus\u2010infected mice, increasing the survival rate (88.24%) after 144 h treatment [87]. Isoalantolactone has been able to inhibit osteoclastogenesis, without affecting osteo\u2010genesis, which is promising for osteoporosis treatment and other metabolic bone diseases [88]. Yuan et al. [89] evaluated the effect of the sesquiterpene lactone on lung inflamma\u2010tion, using a mouse model of acute lung injury. This compound was able to diminish the injury of lung tissues induced by lipopolysaccharide (LPS) and also reduced the produc\u2010tion of inflammatory cytokines TNF\u2010\u03b1 and IL\u20101\u03b2, among other effects. The trypanocidal activity of isoalantolactone was reported by Schmidt et al. [90]. This compound showed activity against Trypanosoma cruzi and T. brucei rhodesiense with an IC50 of 22.26 and 23.62 \u03bcM, respectively. On L6 cells (rat skeletal myoblasts), the CC50 was 3.97 \u03bcM. Reynosin (73) is a sesquiterpene lactone isolated from S. chamaedrys. Turk et al. [91] evaluated the effect of this compound on the NF\u2010\u03baB transcriptional activity induced by LPS in RAW 264.7 macrophages cells. Reynosin presented an IC50 of 13.9 \u00b1 1.6 \u03bcM. Reynosin also showed mycobactericidal activity with a minimal bactericidal concen\u2010tration (MBC) of 128 \u03bcg/mL against the H37Rv, 366\u20102009, and 104\u20102010 Mtb strains and a minimal inhibitory concentration (MIC) of 64, 64, 128, 128, and 128 \u03bcg/mL against the H37Rv, 104\u20102010, 63\u20102009, 366\u20102009, and 430\u20102010 Mtb strains, respectively [92]. The hepatoprotective effect of reynosin was evaluated in vitro and in vivo by Lim et al. [93]. The compound inhibited thioacetamide\u2010induced apoptosis in primary hepato\u2010cytes and in a mouse model. The effects of reynosin on dopamine (DA)\u2010induced neuronal toxicity and the regula\u2010tion of E6\u2010associated protein and \u03b1\u2010synuclein proteins were evaluated on in vitro and in vivo models of Parkinson\u2019s disease. The compound showed a protective effect against DA\u2010induced cell death [94]. Santamarine (74) has been isolated from S. chamaedrys [1]. The anticancer activity and its mechanism of action on HepG2 cells have been evaluated by Mehmood et al. [95]. This compound inhibited proliferation and induced apoptosis with an IC50 ~70 \u03bcM. The ses\u2010quiterpene lactone promoted reactive oxygen species (ROS) generation, diminished the activity of thioredoxin reductase (TrxR), produced depletion of glutathione (GSH) and mitochondrial membrane potential (\u0394\u03a8m) dissipation, modulation of Bcl\u20102 family pro\u2010teins, cytochrome C release, caspases\u20109, \u20108, and \u20103 activation, and PARP cleavage. Santamarine showed anti\u2010inflammatory activity on lipopolysaccharide (LPS)\u2010in\u2010duced macrophages cells. This compound acted through the expression of heme oxygen\u2010ase\u20101 [96]. This sesquiterpene lactone was also assessed by measuring the effect on the NF\u2010\u03baB transcriptional activity induced by LPS. Santamarine exhibited an IC50 value of 9.2 \u00b1 0.5 \u03bcM [91]. Santamarine was active on Mycobacterium tuberculosis (Mtb) with a minimal bacteri\u2010cidal concentration (MIC) of 128 \u03bcg/mL against the H3Rv and 104\u20102010 Mtb strains and MICs of 128 \u03bcg/mL against the H37Rv, 366\u20102009, and 104\u20102010 Mtb strains [92]. Molecules 2021, 26, 2733 13 of 45 Table 2. Sesquiterpene lactones isolated from Stevia species with biological activity reported. Comp. N\u00b0 Common Name Species Reported Activity 58 Isoalantolactone S. polyphylla, S. lucida Antineoplastic. Antitumor. Antimicrobial. Anti\u2010inflammatory. Anti\u2010Trypanosoma cruzi and T. brucei. In\u2010hibits osteoclastogenesis [85\u201390]. 59 Achalensolide S. achalensis, S. polyphylla, S. satureifolia Anti\u2010inflammatory [39]. 60 Inuviscolide S. achalensis, S. isomeca, S. ovata Anti\u2010inflammatory. Cytotoxic against melanoma cells [40\u201342] 61 Costunolide S. amambayensis Anti\u2010inflammatory. Antitumor. Anti\u2010Trypanosoma. Anti\u2010Leish\u2010mania. Antioxidant. Antipyretic. Neuroprotecive. Antiallergic. Osteoporosis prevention. Antimycobacterial. Anti\u2010Helicobacter pylori. Normoglycemic. Hypolipidemic [41\u201350]. 62 Hanphyllin S. grisebachiana Antitumoral. Antioxidant [51,52]. 63 Eupatoriopicrin S. alpina var. glutinosa, S. maima\u2010rensis, S. procumbens, S. sarensis Anti\u2010Trypanosoma cruzi. Anti\u2010T. brucei. Anti\u2010Leishmania. Anti\u2010P. falciparum. Anti\u2010inflammatory. Antitumor. Antibacterial [46,53\u201359]. 64 5\u2032deoxy\u2010eupatoriopicrin S. chamaedrys Anti\u2010inflammatory [56]. 65 Eupatolide S. alpina var. glutinosa Antimetastatic. Antineoplastic [60,61]. 66 Eucannabinolide S. origanoides, S. sarensis Anti\u2010T. brucei. Anti\u2010inflammatory. Antibacterial. Antimeta\u2010static [55,62\u201365]. 67 Achillin S. alpina var. alpina Anti\u2010Trypanosoma cruzi. Antineoplastic. Antitumor. Anti\u2010in\u2010flammatory. Antiallergic [43,67,68]. 68 Leukodin o desacetoxymatricarin S. pilosa Antiallergic. Inhibitory activity on melanoma cells. Meiosis inhibition in oocytes of amphibians [67,69,70]. 69 Ludartin S. yaconensis var. subeglandulosa Antineoplastic. Anti\u2010inflammatory. Gastric cytoprotective. Aromatase inhibition [71\u201374]. 70 Eupahakonenin B S. alpina var. glutinosa, S. chamae\u2010drys, S. gilliesii, S. mercedensis, S. procumbens, S. sarensis, S. satureii\u2010folia, S. setifera Anti\u2010T. cruzi [53,54]. 71 10\u2010 epi\u20108\u2010 deoxycumam\u2010brin B S. grisebachiana, S. yaconensis var. subeglandulosa Inhibition of aromatase [73,75]. 72 Estafietin S. alpina var. alpina, S. boliviensis, S. grisebachiana, S. yaconensis Anti\u2010T. cruzi. Anti\u2010Leishmania brasiliensis. Immunomodulator [53,54,76,77]. 73 Reynosin S. chamaedrys Anti\u2010inflammatory. Antimycobacterial. Hepatoprotective. Protective effect against dopamine\u2010induced neuronal cell death [91\u201394]. 74 Santamarine S. chamaedrys Antitumor. Anti\u2010inflammatory. Antimycobacterial [91,92,95,96]. Molecules 2021, 26, 2733 14 of 45 Figure 1. Chemical structures of bioactive sesquiterpene lactones isolated from Stevia species. 4.2.2. Biological Activity of Diterpenes The information regarding biological activity of diterpenes isolated from Stevia is lower than that of sesquiterpene lactones. The structures of the compounds and the bio\u2010logical activities can be found in Figure 2 and Table 3, respectively. Labdanolic acid (46) has been isolated from S. salicifolia [1] and S. subpubescens var. subpubescens [28]. In 2007, Jayaprakasam et al. [97] assayed the compound for its anti\u2010in\u2010flammatory activity using cyclooxygenase\u20101 (COX\u20101) and cyclooxygenase\u20102 (COX\u20102) en\u2010zymes. At 100 ppm, compound 46 showed selective COX\u20102 enzyme inhibition by 43%. Austroinulin (75) was isolated from S. rebaudiana [1]. Its anti\u2010inflammatory effects were documented by Cho et al. [98]. The authors tested the effects of austroinulin on nitric oxide (NO) production and its molecular mechanism in LPS\u2010stimulated RAW264.7 mac\u2010rophages. Results showed that this terpenoid inhibits NO production and iNOS expres\u2010sion by blocking the activation of STAT1, IRF3, and NF\u2010\u043aB in LPS\u2010stimulated RAW264.7 macrophages. Another investigation also reported this activity, proving that austroinulin inhibited the enhanced production of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) expression in RAW264.7 cells (10 \u03bcg/mL = 67.9 and 45.1%, respectively) [99]. Kaurenic acid (76) has been extracted from S. monardaefolia and S. setifera [1]. Its anti\u2010protozoal activities were investigated by several authors. In 2002, Vieira et al. [100] first reported the in vitro trypanocidal activity towards Trypanosoma cruzi trypomastigote erythrocytic forms. In 2012, Brito et al. [101] developed in vitro and in vivo assays against L. braziliensis. The compound had a lethal effect on axenic amastigotes and promastigotes with DL50 of 0.25 and 0.78 \u03bcg/mL, respectively. Low toxicity was observed on J774\u2010G8 OO OOOOOHO58 59 60OOOOHOOOOOOHOH6162 64OOOOOH65OOOH63OOOOOOHOOHOOOOOOOOO66 67 68 69OOHHOOHOHOOOHHOOHHOOOOHHOOOHH70 71 72 73 74Molecules 2021, 26, 2733 15 of 45 macrophages with a DL50 of 25 \u03bcg/mL and high viability (70\u201392%), while a moderate via\u2010bility was observed for infected macrophages (37\u201381%), with concentrations of 25 \u03bcg/mL or less. Additionally, a 70% reduction was observed in the size of the skin lesions in Balb/c mice with no evident toxic effect. The antimalarial activity of compound 76 was assessed by Villasmil et al. [102]. In vitro testing measured its capacity to inhibit the formation of \u03b2\u2010hematin, with 73.5% inhi\u2010bition. The in vivo assay on mice showed an 8.5% parasitemia reduction at the 4th day post infection. To determine the antioxidant effect of compound 76, Mendoza et al. [103] conducted an in vivo experiment to test the compound on induced fatty liver mice. Gathered data suggest that kaurenic acid (76) acts as an antioxidant and reduces the genesis of lipid pe\u2010roxidation. In 2020, Sarwar et al. [104] published a review on the anticancer effects of ent\u2010kauranes in which they described that compound 76 exhibited antimelanoma effects with an IC50 value of 0.79 \u03bcM in B16F1 cells. The in vivo study showed that 76 (160 mg/kg) markedly reduced tumor sizes (49.51%) in a C57BL/6 mice model. The anti\u2010inflammatory and antipyretic biological activities of compound 76 were documented by Sosa et al. [105]; they determined anti\u2010inflammatory activity in rats using egg albumin\u2010induced paw edema (acute test) and Freund\u2019s complete adjuvant\u2010induced paw edema (subacute test), whereas the antipyretic effect was studied in rabbits by pep\u2010tone\u2010induced pyresis. A small number of biological activities has been reported for the labdane type diter\u2010pene manoyl oxide (77) isolated from Stevia berlandieri [1]. Radical scavenging activity was reported by Venditti et al. [106]. Manoyl oxide was also able to inhibit prostaglandin E2 generation in cultured mouse peritoneal macrophages stimulated by zymosan, ionophore A23187, melittin, and PMA. Results showed that the compound interacts with the eico\u2010sanoid system [107]. The diterpenoid epi\u2010manoyl oxide (78) isolated from Stevia salicifolia showed cytotox\u2010icity against different cancerous cell lines [108]. The study, using MTT assay, revealed that epi\u2010manoyl oxide was active against lung cancer cell line A549 and breast cancer cell lines MCF\u20107 and MDA\u2010MB\u2010231, with IC50s = 19.37, 15.79, and 22.24 \u03bcM, respectively. The ent\u2013kaurane type diterpene paniculoside IV (79) isolated from Stevia paniculata [1] showed \u03b1\u2010glucosidase activator activity. In vitro quantitative results on paniculoside IV against \u03b1\u2010glucosidase showed an IC50 of 406.7 \u00b1 20 mM [109]. Table 3. Diterpenes isolated from Stevia species with biological activity reported. Comp. N\u00b0 Common Name Species Reported Activity 46 Labdanolic acid S. salicifolia, S. subpubescens var. subpubescens Anti\u2010inflammatory [97]. 75 Austroinulin S. rebaudiana Anti\u2010inflammatory [98,99]. 76 Kaurenic acid/kaurenoic acid S. monardaefolia S. setifera Anti\u2010T. cruzi. Anti\u2010Leishmania. Antimalarial. Antioxidant. Antitumor. Anti\u2010inflammatory. Antipyretic [100\u2013105]. 77 Manoyl oxide S. berlandieri Radical scavenger. Inhibits PgE2 production [106,107]. 78 Epi\u2010manoyl oxide S. salicifolia Cytotoxic [108]. 79 Paniculoside IV S. paniculata Alpha\u2010glucosidase activator [109]. Molecules 2021, 26, 2733 16 of 45 Figure 2. Chemical structures of bioactive diterpenes isolated from Stevia species. 4.2.3. Biological Activity of Flavonoids Flavonoids constitute another relevant phytochemical group found in the genus Ste\u2010via. These polyphenols have shown several and diverse biological activities. Therefore, the interest in their pharmacological properties has increased significantly in the recent decades and currently, a lot of information is available. In this review, we collected the data on the biological activities of flavonoids isolated from Stevia spp. Many of these com\u2010pounds can be found in other genera of Asteraceae as well as in members belonging to other families. The information about the activity and structures of the flavonoids is sum\u2010marized in Table 4 and Figure 3. Various biological activities have been reported for the flavonoid eupatorin (28) (3\u2032,5\u2010dihydroxy\u20104\u2032,6,7\u2010trimethoxyflavone), isolated from S. satureiifolia var. satureiifolia, S. brev\u2010iaristata, S. procumbens, and S. vaga [1]. The antimycobacterial activity of eupatorin was reported by Castellar et al. [110]. The compound showed activity against Mycobacterium tuberculosis H37Rv with a MIC = 50 \u03bcg/mL. The trypanocidal and leishmanicidal activities of compound 28 were evaluated by Beer et al. [25]. Eupatorin showed IC50 values of 0.2 \u03bcg/mL and 61.8 \u03bcg/mL on T. cruzi epimastigotes and trypomastigotes, respectively. Nevertheless, this compound was not active agains the amastigote forms of the parasites. The flavone showed activity against L. braziliensis promastigotes (IC50 = 55.1 \u03bcg/mL). This compound showed no cytotoxicity on Vero cells up to a concentration of 500 \u03bcg/mL. Shafaei et al. [111] evaluated the in vitro angiotensin\u2010converting enzyme (ACE) inhi\u2010bition activity of different flavonoids. In vitro ACE inhibition activity was determined by measuring the concentration of hippuric acid (HA) formation from an ACE\u2010specific sub\u2010strate [hippuryl\u2010histidyl\u2010leucine (HHL)] by the action of ACE enzyme using a high per\u2010formance liquid chromatography method. Among the tested flavonoids, compound 28 demonstrated the highest inhibition against ACE with IC50 15.35 \u00b1 4.49 \u03bcg/mL and binding ability with Zn (II) (56.03 \u00b1 1.26%). ACE inhibition activity is directly related to com\u2010pounds\u2019 ability to bind with zinc ions in the active site of ACE enzyme. The vasorelaxant activity and the underlying mechanisms of action of eupatorin were investigated by Yam et al. [112]. The study demonstrated that eupatorin exerts a vaso\u2010relaxant effect in thoracic aortic rings isolated from Sprague Dawley rats through the NO/sGC/cGMP and PGI2 pathways, calcium and potassium channels, and muscarinic and beta\u2010adrenergic receptors. Lee et al. [113] characterized the cytotoxic effect of compound 28 in HeLa cervical carcinoma cells. They suggested that this flavone would induce G2/M cell cycle arrest Molecules 2021, 26, 2733 17 of 45 through the deregulation of cell cycle regulatory proteins and triggers apoptosis through the activation of the p53\u2010dependent and p53\u2010independent pathways. Eupatorin has also been proposed as a potent candidate for an anti\u2013breast cancer agent. Abd Razak et al. [114] evaluated the antitumor effect of 28 in 4T1\u2010challenged mice by MTT assay. The study demonstrated that eupatorin was effective for delaying the 4T1\u2010induced breast tumor growth in the animal model at the highest dosage of 20 mg/kg BW. This study showed the in vivo efficacy and the potential of eupatorin for breast cancer therapeutic purposes. The antidiabetic and antiparasitic activities of eupatorin were evaluated by Gulcin et al. [115]. Eupatorin was tested, among others, for the inhibition of \u03b1\u2010amylase and \u03b1\u2010gly\u2010cosidase enzymes to determine if they can reduce the level of glucose uptake in diabetes therapy. Eupatorin showed an effective inhibition profile with IC50 values of 175.01 nM and of 365.50 nM for the inhibitory potential of \u03b1\u2010amylase and \u03b1\u2010glycosidase, respectively. For the glutathione transferase enzyme, this phenolic compound showed an IC50 of 23.88 \u03bcM. Numerous biological activities are reported for the flavonoid santin (5,7\u2010dihydroxy\u20103,6\u2010dimethoxy\u20102\u2010(4\u2010methoxyphenyl)\u20104H\u2010chromen\u20104\u2010one) (80) isolated from S. microchaeta, S. monardifolia, and S. origanoides [116]. In vitro trypanocidal and leishmanicidal activities of santin were reported by S\u00fclsen et al. [117]. The IC50 values on Trypanosoma cruzi epi\u2010mastigotes and trypomastigotes were 47.7 and 42.1 \u03bcM, respectively. Santin was also ac\u2010tive against promastigotes of Leishmania mexicana (IC50 = 32.5 \u03bcM). Antiplasmodial activity of flavanol santin was evaluated by Melaku et al. [118]. This compound was found to be active against Plasmodium berghei\u2010infected mice when tested in vivo using Peter\u2019s four\u2010day suppressive method. Santin was found to induce inhibition of parasitemia by 85.50% and 80.95% at doses of 100 mg/kg and 50 mg/kg, respectively. Teffo et al. [119] evaluated the antioxidant potential of the compound 80 using a DPPH spectrophotometric assay and determined the antibacterial activity using a serial dilution microplate technique. Santin exhibited a weak antioxidant activity, at the highest concentration (200 \u03bcM) assayed, barely showing an antioxidant activity of 8.23%. The minimum inhibitory concentration (MIC) against Staphylococcus aureus, Enterococcus fae\u2010calis, Escherichia coli, and Pseudomonas aeruginosa varied from 63 \u03bcg/mL to 125 \u03bcg/mL. Santin showed significant inhibitory activity on tubulin polymerization. When Mai et al. [120] performed a screening test of several flavonoids, santin was the strongest in\u2010hibitor of tubulin polymerization (IC50 = 5.7 mM). Furthermore, this compound was not toxic, even at high concentrations, to human peripheral mononuclear blood cells and mice lymphoid cells, while it exhibited strong cytotoxicity against various cancer cell lines. When the antiparasitic activity was evaluated in vitro against T. brucei gambiense, good inhibition levels were observed at 50 mM. Zhong et al. [121] demonstrated that this flavo\u2010noid compound inhibits influenza A virus replication through regulating MAPKs and NF\u2010\u03baB pathways. Santin showed anti\u2010influenza activity in MDCK and THP\u20101 cells. Mechanis\u2010tic studies revealed that santin depressed the phosphorylation of p38 MAPK, JNK/SAPK, ERK, and NF\u2010\u03baB factor and subsequently attenuated the expression of inflammatory cy\u2010tokines in IAV\u2010infected cells. Stevia subpubescens var. subpubescens led to the isolation of sakuranetin (40) (5\u2010hy\u2010droxy\u20102\u2010(4\u2010hydroxyphenyl)\u20107\u2010methoxy\u20104H\u2010chromen\u20104\u2010one) [28]. Several biological activ\u2010ities have been reported for this compound. A review of sources and pharmacological aspects of sakuranetin performed by Stompor, M. [122] describes sakuranetin as having antiproliferative activity against the typical human cell lines of melanoma B16BL6, esoph\u2010ageal squamous cell carcinoma (ESCC), and the colon cancer (Colo 320). Moreover, it shows antiviral activity towards human rhinovirus 3 and influenza B virus, and is re\u2010ported to have antioxidant, antimicrobial, anti\u2010inflammatory, antiparasitic, antimuta\u2010genic, and antiallergic properties. Ugocsai et al. [123] showed that sakuranetin (40) inhibits tumor growth through the apoptosis pathway both in vitro and in vivo in colon cancer cells expressing MDR1/LRP. Molecules 2021, 26, 2733 18 of 45 Park et al. [124] observed that compound 40 inhibits the growth of human colon car\u2010cinoma (HCT\u2010116) cells with an IC50 value of 68.8 \u00b1 5.2 \u03bcg/mL. Drira and Sakamoto [125] reported that 15 \u03bcmol/L of sakuranetin had cytotoxic effects on B16BL6 melanoma cells (MTT assay, after 72 h of treatment). They proved that sakuranetin influences melanogen\u2010esis inhibiting the ERK1/2 and PI3K/AKT signaling pathways, involved in the regulation of proliferation, differentiation, and apoptosis. In this study, the upregulating effect of sakuranetin on tyrosinase, tyrosinase\u2010related protein 1, and tyrosinase\u2010related protein 2 was also proven. Hong and Ying [126] found that sakuranetin has strong effects on the inhibition of cell proliferation in esophageal squamous cell carcinoma by inducing DNA damage as well as mitochondrial membrane potential loss in esophageal cancer cells. The antifungal activity of sakuranetin was demonstrated by Grecco et al. [127]. This compound inhibited the growth of all tested Candida strains by 98% and 99% at a concen\u2010tration of 0.63 \u03bcg/\u03bcL, except C. albicans which was found to be more sensitive at 0.32 \u03bcg/\u03bcL (99% of inhibition). Cryptococcus species displayed a similar behavior: in the presence of 0.32 \u03bcg/\u03bcL of sakuranetin, C. neoformans serotype A (var. grubii) and C. gatti (R265) strains were inhibited by 99% and 97%, respectively. Strain C. neoformans serotype D (JEC21) showed 98% inhibition with a concentration of 0.08 \u03bcg/\u03bcL. Pacciaroni et al. [128] reported that sakuranetin showed activity against standardized Trichophyton rubrum (MIC = 31.2 \u03bcg/mL) as well as clinical isolates of T. rubrum and T. mentagrophytes (MIC ranges 31.2\u201362.5 \u03bcg/mL and 31.2\u2013125 \u03bcg/mL, respectively). It was demonstrated that this flavonoid not only possesses fungistatic but also fungicidal prop\u2010erties. Zhang et al. [129] described compound 40 as a competitive inhibitor of the \u03b2\u2010hydrox\u2010yacyl\u2010acyl dehydratase carrier protein from Helicobacter pylori (HpFabZ) (IC50 = 2.0 \u00b1 0.1 \u03bcM). Additionally, they showed that sakuranetin inhibited the growth of Helicobacter py\u2010lori ATCC 43,504 with a minimum inhibitory concentration (MIC) of 92.5 \u03bcM using the standard agar dilution method. Sakuranetin showed antiprotozoal activity against Leishmania amazonensis, L. braziliensis, L. major, and L. chagasi, with a range of IC50 values 43\u201352 \u03bcg/mL, as well as against T. cruzi trypomastigotes, with an IC50 value of 20.17 \u03bcg/mL [130]. Consistent with Quintanilla\u2010Licea et al. [131], compound 40 also presented antiprotozoal activity against Entamoeba histolytica (IC50 = 44.51 \u03bcg/mL). Kwon et al. [132] described the activity of sakuranetin against the influenza B/Lee/40 virus. They reported a decrease in the cytopathic effect caused by viral invasion with an IC50 of 7.21 \u03bcg/mL. Furthermore, Choi [133] reported activity against human rhinoviruses HRV3 obtained from ATCC (American Type Culture Collection, Manassas, VA, USA) and propagated in human epithelioid carcinoma cervix (HeLa) cells. The compound exhibited an antiviral activity of approximately 67% against HRV3 at 100 mg/mL and of approxi\u2010mately 41% at 10 mg/mL. Several authors investigated the anti\u2010inflammatory activity of compound 40. Bitten\u2010court\u2010Mernak et al. [134] reported that treatment with sakuranetin reduced the neutro\u2010phils in the peripheral blood and in the bronchial alveolar lavage of mice treated. It also reduced macrophage populations and keratinocyte\u2010derived chemokines (IL\u20108 homolog) and NF\u2010\u03baB levels, collagen fiber formation, MMM\u20109 and TIMP\u20101\u2010positive cells, and oxi\u2010dative stress in lung tissues compared with LPS animals treated with vehicle. Sakuranetin treatment also reduced total protein and TNF\u2010\u03b1 and IL\u20101\u03b2 levels in the lung. Sakoda et al. [135] reported that compound 40 reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflam\u2010mation. They demonstrated that in vivo sakuranetin treatment with a dose of 20 mg/kg/BALB/c in mice reduced serum IgE levels, lung inflammation (eosinophils, neutro\u2010phils, and Th2/Th17 cytokines), and respiratory epithelial mucus production in ovalbu\u2010min\u2010sensitized (for 30 days) animals in a murine experimental asthma model. Molecules 2021, 26, 2733 19 of 45 Previously, Taguchi et al. [136] investigated the anti\u2010inflammatory and antioxidant effects of sakuranetin in lung disease using an experimental model of emphysema in\u2010duced via the instillation of elastase into C57BL6 mice. Reductions in lung inflammation associated with attenuated lung parenchymal remodeling and alveolar destruction were observed in the sakuranetin\u2010treated emphysematous animals. Toledo et al. [137] observed that sakuranetin decreased IgE specific antibodies, eo\u2010sinophil inflammation, AHR, and airway remodeling by reducing oxidative stress, Th2 pro\u2010inflammatory cytokines and chemokines, and NF\u2010\u03baB activation in inflammatory cells in an experimental asthma model. Recently, Yamauchi et al. [138] observed that sa\u2010kuranetin significantly inhibited NO induction and inducible nitric oxide synthase (iNOS) expression in rat hepatocytes. Moreover, this compound decreased the expression of type 1 IL\u20101 receptor gene and phosphorylation of Akt (protein kinase B), which is regulated by phosphatidylinositol\u20104,5\u2010bisphosphate 3\u2010kinase (PI3K). In addition, sakuranetin de\u2010creased the phosphorylation of the activator of isoforms of the CCAAT/enhancer\u2010binding protein \u03b2 (C/EBP\u03b2), which synergistically activates the transcription of the iNOS gene with nuclear factor \u03baB (NF\u2010\u03baB). Consequently, sakuranetin inhibited the co\u2010activating ac\u2010tivity of C/EBP\u03b2 with NF\u2010\u03baB, leading to the suppression of iNOS gene expression in hepatocytes. Zhang et al. [139] reported that sakuranetin had potent inhibitory activity against COX\u20101 (IC50 196.1 \u03bcM). Hern\u00e1ndez et al. [140] demonstrated that sakuranetin in\u2010hibits the production of leukotrienes, the strongest inflammatory mediators. It acts as the selective inhibitor of 5\u2010lipoxygenase, the enzyme responsible for their synthesis. The role of sakuranetin in Alzheimer\u2019s disease was evaluated by Chen Li et al. [141]. The authors proposed that this flavonoid may exert protective effects on brain cells through an antioxidation mechanism. The flavone pectolinaringenin (81) was isolated from S. lucida [1]. Pectolinaringenin displayed activity against the trypomastigote forms of Trypanosoma cruzi, exhibiting 50% inhibitory concentration (IC50) values of 51.61 \u03bcg/mL, when it was evaluated in vitro by the colorimetric MTT method after 24 h incubation by Grecco et al. [142]. Muthu et al. [143] evaluated the larvicidal activity of pectolinaringenin against Culex quinquefasciatus Say and Aedes aegypti L. The compound showed LC50 and LC90 values of 0.62, 2.87 ppm and 0.79, 5.31 ppm against C. quinquefasciatus and A. aegypti, respectively. Cirsimaritin (29), isolated from S. satureiifolia var. satureiifolia and from S. maimarensis [1], has been reported to exert various activities including antiprotozoal, anti\u2010inflamma\u2010tory, antitumor, antioxidant, GABA modulator, antinociceptive, antidepressant and anxi\u2010olytic, diabetes treatment, and to alleviate heart failure, among others. The trypanocidal and leishmanicidal activities of compound 29 were evaluated by Tasdemir et al. [144]. Cirsimaritin showed IC50 values of 3.9 \u03bcg/mL, 3.3 \u03bcg/mL, and 19.7 \u03bcg/mL for L. donovani, T. brucei rhodesiense, and T. cruzi, respectively. According to Quin\u2010tanilla\u2010Licea et al. [131], compound 29 also presented antiprotozoal activity against Enta\u2010moeba histolytica (IC50 = 154.26 \u03bcg/mL). Abdelhalim et al. [145] demonstrated biphasic activity at \u03b11\u03b22\u03b32L GABA receptors by cirsimaritin. The flavonoid 29 acted as a positive modulator when applied in the pres\u2010ence of low concentrations of GABA but in the presence of high concentrations of GABA, it acted as a negative modulator (inhibiting currents due to 100 \u03bcM GABA by 23.0 \u00b1 0.5% at 100 \u03bcM and positively modulating currents due to 10 \u03bcM GABA by 89.9 \u00b1 1.5%). This activity permits cognition enhancement whilst offering protection from convulsant activ\u2010ity. Furthermore, Abdelhalim et al. [146] demonstrated antinociceptive, antidepressant, and anxiolytic activities of cirsimaritin mediated via GABA\u2010A receptors. Central antino\u2010ciceptive analgesic effects of cirsimaritin were determined in hot plate and tail immersion tests. Central analgesic effects maximum inhibition 74.71% was observed at 100 mg/kg, assessed by the tail immersion test. Compound 29 exerted significant antidepressant ef\u2010fects evidenced by the reduction of immobility time in both the tail suspension test and the forced swimming test. Cirsimaritin also exerted significant anxiolytic effects at the doses of 10\u2013100 mg/kg in both the elevated plus maze and light dark tests used. This Molecules 2021, 26, 2733 20 of 45 compound has previously been shown to have biphasic modulation of 122L GABA recep\u2010tors, and has demonstrated central nervous system activity in mouse models of antino\u2010ciception, antidepressant, and anxiolysis. Cirsimaritin also displayed activity in the antigiardial bioassay with an IC50 = 3.8 M [147]. The effect of compound 29 on melanogenesis was investigated by Kim et al. [148]. They studied the melanin\u2010inducing properties of cirsimaritin in murine B16F10 cells. Re\u2010sults indicated that cirsimaritin stimulated melanogenesis in B16F10 cells by activation of response element\u2010binding protein (CREB) in addition to upregulation of the expression of microphthalmia\u2010associated transcription factor (MITF) and tyrosinase expression, which was activated by cAMP signaling. Later, the melanogenic effect of cirsimaritin was con\u2010firmed in human epidermal melanocytes. Wu et al. [149] reported that compound 29 mitigated cardiac remodeling and left ventricular dysfunction through augmenting myocardial autophagy and decreasing ma\u2010trix metalloproteinase activities. This compound also affected the serum levels of Ang II, NE, TNF\u2010\u03b1, and BNP in rats with heart failure and attenuated the cardiac histological changes. Lee at al. [150] demonstrated the therapeutic potential of compound 29 in the pre\u2010vention and treatment of type 1 diabetes mellitus. Protein expressions related to apoptosis and the effects against streptozotocin (STZ)\u2010induced cytotoxicity in INS\u20101 cells were eval\u2010uated. Cirsimaritin demonstrated improved cell viability to near normal levels and pro\u2010tected INS\u20101 cells against STZ\u2010induced damage. Furthermore, cirsimaritin reduced the in\u2010tracellular oxidative stress induced by STZ. Later, with an IC50 value of 0.43 \u00b1 0.07 \u03bcM, cirsimaritin was found to be a potent inhibitor of dipeptidyl peptidase IV (DPP\u2010IV en\u2010zyme) for the management of type 2 diabetes [151]. Antimetastatic activity of compound 29 in breast cancer was shown by Yeon Park et al. [152]. They demonstrated cirsimaritin\u2010inhibited angiogenesis through the downregu\u2010lation of VEGF, p\u2010Akt, and p\u2010ERK in MDA\u2010MB\u2010231 cells using three in vitro cell\u2010based assays: the cell proliferation assay, tube\u2010formation assay, and Western blot analysis. Cir\u2010simaritin inhibited the viability of HUVECs in a dose\u2010dependent manner, achieving 62.04% at a level of 100. Cirsimaritin also reduced tube formation by 32.18% at the levels of 6.25 \u03bcM. The anti\u2010inflammatory effect of cirsimaritin was reported by Shin et al. [153]. This flavonoid was shown to inhibit nitric oxide (NO) production and inducible nitric oxide synthase expression in RAW264.7 cells. The compound inhibited interleukin\u20106, tumor ne\u2010crosis factor\u2010\u03b1, and NO production in a concentration\u2010dependent manner in lipopolysac\u2010charide (LPS)\u2010stimulated RAW264.7 cells. In addition, 29 suppressed activation of LPS\u2010induced transcription factors, such as c\u2010fos and signal transducer and activator of tran\u2010scription 3 (STAT3), in RAW264.7 cells. Therefore, cirsimaritin demonstrated anti\u2010inflam\u2010matory activity regulated by the inhibition of c\u2010fos and STAT3 phosphorylation in RAW264.7 cells. Yan et al. [154], investigated the anti\u2010influenza virus efficacy and antiviral mecha\u2010nism of cirsimaritin. This compound was shown to inhibit the virus replication by down\u2010regulating the NF\u2010\u03baB signal transduction pathway. Manurung et al. [155] reported that this compound exhibited very strong anticancer and antioxidant activity. Pathak et al. [156] investigated the anticancer potential of cirsimaritin in organ specific cell lines by using MTT assay. The compound showed selective anticancer activity against the NCIH\u2010520 cell line (IC50 = 23.29 \u03bcM), and also inhibited the proliferation of other cell lines up to 48% at 100 \u03bcM. Moreover, an increase in the ROS levels of 1.6 fold (10 \u03bcM) and 1.8 fold (100 \u03bcM) was observed; cirsimaritin also inhibits the activity of ODC and CATD with IC50 = 57.30 and 68.22 \u03bcM, respectively. It exhibited a good binding score with the selected targets, followed Lipinski\u2019s rule of five, and is non\u2010mutagenic. Hence, 29 inhibited the proliferation of lung squamous cell lines by inducing apoptosis. It also inhibited the ac\u2010tivity of ODC and CATD responsible for the progression phase in the cancer cells. Molecules 2021, 26, 2733 21 of 45 When an anti\u2010HIV\u20101 RT assay was performed, cirsimaritin displayed moderate activ\u2010ity with 52.50% inhibition at 200 \u03bcg/mL [157]. Hispidulin (35) (5,7\u2010dihydroxy\u20102\u2010(4\u2010hydroxyphenyl)\u20106\u2010methoxy\u20104H\u2010chromen\u20104\u2010one) isolated from S. urticifolia and S. sanguinea [1] has a wide range of reported biological ac\u2010tivities, including antiparasitic, anti\u2010inflammatory, antidiabetic, anticonvulsant, antioste\u2010oporotic, antioxidant, and anticancer properties. In vitro trypanocidal and leishmanicidal activities of the flavonoid hispidulin were reported by S\u00fclsen et al. [117]. The IC50 values on Trypanosoma cruzi epimastigotes and trypomastigotes were 46.7 \u03bcM and 62.3 \u03bcM, respectively. Hispidulin was more active on promastigotes of Leishmania mexicana (IC50 = 6.0 \u03bcM). Years later, Grecco et al. [127] re\u2010ported that hispidulin displayed moderate activity against trypomastigotes of Trypano\u2010soma cruzi (Y strain), with IC50 values of 80.61 \u03bcg/mL. Abdelhalim et al. [145] demonstrated that hispidulin acts as a positive modulator when applied at low concentrations of GABA but at high concentrations, it acts as a neg\u2010ative modulator. Moreover, hispidulin was found to act as a positive allosteric modulator at GABA\u2010A receptor subtypes (\u03b11\u20103,5,6\u03b22\u03b32), being more potent at \u03b11,2,5\u03b22\u03b32 subtypes than at \u03b13,6\u03b22\u03b32. Hispidulin was also shown to have an anticonvulsant action in seizure\u2010prone mongolian gerbils and to cross the blood\u2010brain barrier. The antidiabetic activity of hispidulin was shown by Abbas et al. [151]. With an IC50 value of 0.49 \u00b1 0.1 \u03bcM, hispidulin was found to be a potent inhibitor of dipeptidyl pepti\u2010dase\u20104 enzyme DPP\u2010IV, as an effective therapeutic target for the management of diabetes mellitus. Bourdillat et al. [158] demonstrated a correlation between the inhibition of platelet aggregation and the increase in cAMP levels induced by hispidulin. They showed that hispidulin inhibited platelet aggregation triggered by adenosine\u20105\u2019\u2010monophosphate, ara\u2010chidonic acid, paf\u2010acether, and collagen. Hispidulin (100 pM) increased the control cAMP level in platelets 4\u2010fold. Prolyl oligopeptidase\u2019s inhibitory activity of hispidulin was reported by Marques et al. [159]. Inhibitory assays indicated that at a concentration of hispidulin 100 \u03bcM inhibited 43% of total prolyl oligopeptidase (POP) activity. Mercader and Pomilio [160] performed a predictive analysis based on the quantita\u2010tive structure\u2013activity relationships (QSAR) of a property of hispidulin, which is the inhi\u2010bition (IC50) of influenza H1N1 virus neuraminidase (IC50 = 13.90 \u03bcg/mL). Yu et al. [161] evaluated the therapeutic role of hispidulin in gastric cancer through the induction of apoptosis via NAG\u20101 signaling. Results demonstrated that hispidulin in\u2010hibits the growth of AGS gastric cancer cells. They found that after hispidulin treatment, NAG\u20101 remained highly expressed, whereas COX\u20102 expression was downregulated. Flow cytometric analysis showed that hispidulin induces G1/S phase arrest and apoptosis in time\u2010 and concentration\u2010dependent manners. G1/S arrest correlated with upregulated p21/WAF1 and p16 and downregulated cyclin D1 and cyclin E, independent of p53 path\u2010way. Furthermore, hispidulin could elevate Egr\u20101 expression and ERK1/2 activity, whereas ERK1/2 inhibitor markedly attenuated NAG\u20101 mediated apoptosis. It was reported that hispidulin showed potent in vitro cytotoxicity against human carcinoma A549, MCF\u20107, and HeLa cell lines [162]. Previously, it was also reported that hispidulin could inhibit the proliferation of human esophageal squamous carcinoma Eca\u2010109, human nasopharyngeal carcinoma KB, and human colon carcinoma CL\u2010187 cells in vitro. The in vivo inhibitory effect on sarcoma 180 (S\u2010180) and hepatoma H22 cells in mice was evaluated by Xie et al. [163]. In addition, Reutrakul et al. [164] demonstrated in vitro cytotoxicity of hispidulin against murine lymphocytic leukemia P388, human colon carci\u2010noma Col\u20102, human breast carcinoma 359 BCA\u20101, and human lung carcinoma Lu\u20101. Hispidulin antiosteoporotic activity was investigated by Nepal et al. [165]. The au\u2010thors demonstrated that hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL\u2010induced NF\u2010\u03baB and NFATc1 pathways. Hispidulin was found to inhibit RANKL\u2010induced activation of Jun N\u2010terminal kinase (JNK) and p38, in addition to the Molecules 2021, 26, 2733 22 of 45 NF\u2010\u03baB in vitro experiment. Hispidulin also decreased NFATc1 transcriptional activity in RANKL\u2010induced osteoclastogenesis. Hispidulin could inhibit epithelial\u2010mesenchymal transition (EMT), an important ini\u2010tiaton step in the process of metastasis, in breast cancer cells (MCF\u20107 and HCC38). This flavonoid also may inhibit cell migration by repressing the Smad2/3 signaling pathway [166]. Liu et al. [167] demonstrated that hispidulin affects cell proliferation, apoptosis, cell cycle, angiogenesis, and metastasis. In addition, hispidulin exhibited synergistic anti\u2010tumor effects when combined with some common clinical anticancer drugs. It reduced the efflux of chemotherapeutic drugs, enhanced the chemosensitivity of cancer cells, and reversed drug resistance. Several biological activities have been reported for 5\u2010hydroxy\u20103,6,7,3\u2019,4\u2019\u2010pentameth\u2010oxyflavone (artemetin) (82) isolated from S. procumbens and S. jujuyensis [1]. The anti\u2010inflammatory activity of artemetin was reported by Serti\u2019e et al. [168]. They demonstrated that artemetin showed anti\u2010inflammatory activity using various experi\u2010mental models in rats, including inhibiting carrageenan\u2010induced paw edema, reduced granuloma formation, and reduced vascular permeability to intracutaneous histamine. Artemetin can also protect endothelial function by acting as an antioxidant and antiapoptotic agent and through the activation of extracellular\u2010signal\u2010regulated kinases 1/2 (ERK1/2) and Akt. [169]. When the antioxidant activity of artemetin was determined by the DPPH (1, 1\u2010diphenyl\u20102\u2010 picrylhydrazyl) radical\u2010scavenging assay, it appeared to have no activity because its IC50 values exceeded 500 \u03bcM. On the other hand, it effectively inhibited the NO production in LPS\u2010induced RAW264.7 cells, demonstrating anti\u2010inflam\u2010matory activity [170]. This flavonoid was able to dose\u2010dependently reduce the mean arterial pressure. Hy\u2010potensive effects induced by artemetin were attributed to its ability to decrease angioten\u2010sin II generation in vivo by ACE inhibition [171]. Artemetin exhibited antimalarial activity against Plasmodium falciparum (IC50 = 26.0 \u03bcM) [172]. In vitro trypanocidal activity against bloodstream forms of Trypanosoma brucei rhodesiense STIB 900 displayed an IC50 value of 4.7 \u03bcg/mL [173]. Wee et al. [174] reported that artemetin inhibited the production of both TNF\u2010\u03b1 and IL\u20101\u03b2 cytokine production in human U937 macrophages. They observed that artemetin inhibited cell viability of U937 macrophages. Artemetin at 50 \u03bcg/mL and 100 \u03bcg/mL re\u2010duced TNF\u2010\u03b1 level to 20 and 30%, respectively, and at 50 \u03bcg/mL significantly reduced IL\u20101\u03b2 levels to 60%. Ono et al. [175] reported that artemetin showed a GI50 of 2270 ng/mL in human lung cancer PC\u201012 cells and 2200 ng/mL in human colon cancer HCT116 cells. Ar\u2010temetin also decreased the growth of human leukemia HL\u201060 cells in a dose\u2010dependent manner, with an IC50 of 39.98 \u03bcM after 96 h. The flavonoid quercetin (37) isolated from S. urticifolia, S. pilosa and S. eupatoria [1] demonstrated varied pharmacological functions including antiprotozoal, antioxidant, an\u2010tibacterial, anti\u2010inflammatory, antidiabetic, and anticancer properties. Antiprotozoal in vitro activities of quercetin against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani were tested by Tasdemir et al. [144]. Remark\u2010able leishmanicidal potential was observed, with an IC50 of 1.0 \u03bcg/mL. Furthermore, quer\u2010cetin\u2019s antimalarial and antileishmanial activity and activity against Dengue was reported by Boniface and Ferreira [176]. Quercetin revealed antimalarial activity against P. falcipa\u2010rum NF54/64, with an IC50 value of 5.5 \u03bcg/mL. It showed inhibitory effects against rCPB2.8 proteinase from L. mexicana, with an IC50 value of 18.03 \u03bcM. Quercetin also showed in vitro antileishmanial activity against promastigote (IC50 = 0.7 \u03bcM) and intracellular amastigote (IC50 = 4.3 \u03bcM) forms of L. amazonensis. In an in vivo test, quercetin (30 mg/kg) reduced the lesion size from 1.8 (vehicle) to 0.2 mm (treated) in Leishmania amazonensis\u2010infected mice. Furthermore, quercetin showed arginase inhibitory effects on L. (L.) ama\u2010zonensis with IC50 values of 3.8 \u03bcM. Quercetin also showed inhibitory effects (66% inhibi\u2010tion at 96 \u03bcM; IC50 = 31.4 \u03bcM) against L. amazonensis. Furthermore, quercetin (16 mg/kg) Molecules 2021, 26, 2733 23 of 45 reduced the parasite (L. amazonensis) load in mice infected with cutaneous leishmaniasis. When the antileishmanial activity against promastigote forms of L. (V.) braziliensis was evaluated, quercetin showed IC50 values of 30.49 \u03bcM. The antileishmanial activity of quer\u2010cetin against L. donovani AG83 showed an IC50 value of 45.5 \u03bcM for the promastigote forms and IC50 values of 10.50 \u03bcM for intracellular amastigotes. In addition, quercetin exhibited an IC50 value of 35.7 \u03bcg/mL against DENV\u20102 (after 96 h of incubation), reduced the DENV\u20102 RNA level by 67%, and proved to be active against DENV\u20102 NS2B\u2010NS3 and DENV\u20103 NS2B\u2010NS3. Quercetin demonstrated antioxidant activity and superoxide anions scavenging ac\u2010tivity. This flavonoid exhibited an IC50 value on superoxide anions generation of 207 \u03bcM and on lipid peroxidation of 5.2 \u03bcM [177]. Moreover, Mlcek et al. [178] highlighted the role of quercetin in relation to respiratory allergic diseases (in vitro, animal, and epidemi\u2010ological studies) and food allergies. Quercetin\u2019s inhibition of the Helicobacter pylori (HpFabZ) \u03b2\u2010hydroxyacyl\u2010acyl dehy\u2010dratase carrier protein carried out by enzymatic assay and crystal structure analysis showed an IC50 value of 39.3 mM [129]. Mercader and Pomilio [160] performed a predictive analysis based on the potential of the flavonoids to inhibit H1N1 virus neuraminidase. Quercetin showed an IC50 value of 17.65 \u03bcg/mL. The obtained model suggested that the activity depends on the electric charges, masses, and polarizabilities of the atoms present in the molecule as well as its conformation. Li et al. [179] carried out a review of the main effects of quercetin on inflammation and immune function. Quercetin was reported as a long\u2010lasting anti\u2010inflammatory com\u2010pound with strong anti\u2010inflammatory capacities. Quercetin was also reported to play a modulating, biphasic, and regulatory role in inflammation and immunity, and to have an immunosuppressive effect on dendritic cells function. In in vivo animal models, quercetin also exhibited anti\u2010inflammatory effects: it ameliorated the inflammatory response in\u2010duced by carrageenan and a high\u2010fat diet, reduced visceral adipose tissue TNF\u2010\u03b1 and ni\u2010tric oxide production, and downregulated nitric oxide synthase (NOS) expression in obese Zucker rats, and decreased clinical signs of arthritis in chronic rat adjuvant induced ar\u2010thritis. Quercetin\u2019s antihypertensive mechanism of action was reported by Marunaka et al. [180] and the antidiabetic potential mechanisms were reported by Eid and Haddad [181]. A comprehensive review of the anticancer potential of quercetin was carried out by Rauf et al. [182]. Since quercetin has exhibited direct proapoptotic effects on tumor cells, they present an overview of recent developments on the use of quercetin against different types of cancer and the probable mechanisms of action. The evidence revealed that quer\u2010cetin is able to inhibit various types of cancers including breast, lung, nasopharyngeal, kidney, colorectal, prostate, pancreatic, and ovarian cancer. In addition, Shafabakhsh et al. [183] investigated the chemo\u2010preventive and curative profile of quercetin for ovarian cancer. The effects of quercetin in Alzheimer\u2019s disease as a neuroprotective compound were reported by Khan et al. [184]. A large number of flavonoids have presented antiparasitic and antiviral activity and have been considered as candidates for the development of drugs for malaria, Chagas disease, leishmaniasis, and dengue [176]. Among them, the flavonoids quercetin\u20103\u2010O\u2010\u03b2\u2010D\u2010Gucopyranoside (83), isolated from Stevia rebaudiana and Stevia nepetifolia, and querce\u2010tin\u20103\u2010O\u2010 \u03b2\u2010D\u2010Galactopyranoside (84), isolated from S.nepetifolia, S. serrata, and S. soratensis, have shown antiplasmodial and leishmanicidal activity. Luteolin (85) has been identified in S. pilosa and S. eupatoria [11]. This flavonoid, to\u2010gether with quercetin (37) and glycoside flavonoids were described in S. rebaudiana [185]. Tasdemir et al. [144] demonstrated its leishmanicidal potential against L. donovani amastigotes in vitro (IC50 = 0.8 \u03bcg/mL). In 2018, Boniface and Ferreira [176] published a review on flavonoids as trending compounds to treat neglected tropical diseases (NTD), Molecules 2021, 26, 2733 24 of 45 in which the authors describe luteolin\u2019s antiprotozoal activity against L. donovani, P. falci\u2010parum, and T. cruzi, and its antiviral properties against Dengue virus type 1. Mercader et al. [160] also determined the antiviral activity of luteolin through QSAR studies on influ\u2010enza H1N1 virus neuraminidase inhibition (IC50 = 9.65 \u03bcg/mL). This compound also showed COX\u20102 (Cyclooxygenase\u20102) inhibition through software tools and in vitro assays as demonstrated by IC50 values of 36.6 \u03bcmol/L [186] and xanthine oxidase inhibitory ac\u2010tivity in vitro with IC50 = 1.24 \u03bcmol/L and Ki = 0.90 \u03bcmol/L [187]. Antidiabetic properties of this compound have also been reported by Abbas et al. [149]. The authors estimated IC50 values of luteolin and other flavonoids on different enzymes involved in glucose up\u2010take and results showed that compound 85 had the best inhibitory activity on dipeptidyl peptidase IV (DPP\u20104) enzyme (IC50 = 0.12 \u03bcmol/L). From S. rebaudiana [1], the isolation of the flavonoid apigenin\u20104\u2032\u2010O\u2010glucoside (86) has been described. In 2015, Krasteva et al. [188] tested the compound on a t\u2010BuOOH\u2010induced oxidative stress model on rat hepatocytes. Flavonoid 86 preserved cell viability by 159% as compared to the t\u2010BuOOH group, which can be translated to hepatoprotective and an\u2010tioxidant activity. The extraction of S. sorantensis resulted in apigetrin (apigenin\u20107\u2010O\u2010glucoside) (87) [1]. In order to investigate the anti\u2010inflammatory effect of this compound, an immunohisto\u2010chemical assay was conducted to evaluate the binding capability to TLR4/MD2 and nu\u2010clear translocation of NF\u2010\u03baB p65. Molecular docking data showed that apigetrin power\u2010fully bound to MD2 and TLR4 via hydrogen bonding and could be used as immunomod\u2010ulator for the effective treatment of LPS\u2010mediated inflammatory diseases [189]. The in vitro modulation of the complement system was determined on 87 by the assay based on the hemolysis of erythrocytes membrane generated after complement activation, both for the classical way and for the alternative one. Apigenin\u20107\u2010O\u2010glucoside showed an IC50 of 52.5 mM, indicating remarkable anticomplementary activity. Minda et al. [190] studied compound 87\u2032s anticancer properties, for which anti pro\u2010liferative activity was assessed by standard MTT dye uptake assay on a HeLa human cer\u2010vical cancer cell line, presenting an IC50 = 18.28 \u03bcM. In addition, the proapoptotic activity was tested on a HeLa human cervical cancer cell line; DAPI (4\u2032,6\u2010diamidino\u20102\u2010phenylin\u2010dole) nucleic acid staining and double Annexin V\u2010FITC staining were performed, result\u2010ing in the phenomena of early apoptosis, late apoptosis, and a low percentage necrosis. In 2019, Villa\u2010Rodriguez et al. [191] demonstrated that compound 87 induces acute inhibition of glucose absorption, which ultimately translates to the attenuation of cholesterol uptake. On the same subject, Jia et al. [192] conducted an in vitro experiment to determine the \u03b1\u2010glucosidase inhibition effect of apigetrin, which presented an IC50 = 22.80 \u00b1 0.24 \u03bcM. The authors also developed an in vivo assay that proved that this compound effectively im\u2010proved insulin resistance and glucose uptake increased by approximately 73.06% relative to the model group of insulin\u2010resistant HepG2 cells, concluding that this apigenin guco\u2010side might serve as an insulin sensitizer. The methoxylated flavonoid casticin (88) was obtained from S. breviaristata and S. vaga [1]. Recently, in 2020, a review on the potential antineoplastic effects of casticin was published [193]. This paper describes that the compound has been studied against cancers, including breast, bladder, oral, lung, leukemia, and hepatocellular carcinomas, and that casticin inhibits the invasion, migration, and proliferation of cancer cells and induces apoptosis (casticin\u2010induced, ROS\u2010mediated, and mitochondrial\u2010dependent) and cell cycle arrest (G0/G1, G2/M, etc.) through different signaling pathways, namely the PI3K/Akt, NF\u2010\u03baB, STAT3, and FOXO3a/FoxM1 pathways. Koh et al. [194] tested the anti\u2010inflammatory and antiallergic potential of compound 88. Casticin significantly suppressed eotaxin production in cytokine\u2010activated A549 lung epithelial cells and also suppressed the mRNA expression levels of eotaxin, RANTES, VCAM\u20101, and ICAM\u20101, which subsequently contributed to the inhibition of eosinophil migration. Furthermore, compound 88 inhibited IkB\u2010phosphorylation and nuclear trans\u2010location of p65 in A549 cells. These results suggest that casticin has the potential for use Molecules 2021, 26, 2733 25 of 45 in the treatment of allergic asthma. The analgesic and spasmolytic potential of casticin has been studied through the years. In 1995, Bergendorff et al. [195] explored the spasmolytic activity of the compound, which showed a 53\u201363% relaxation of carbacholine induced contractions of guinea pig trachea. In 2007, Hu et al. studied compound 88 for its antino\u2010ciceptive properties in vivo, exhibiting a significant dose\u2010dependent reduction of analge\u2010sia in acetic acid\u2010induced writhing in mice. This paper also proved the antihyperprolac\u2010tinemia activity of casticin in treated mice [196]. Most recently, in 2011, Webster et al. [197] published their investigation in which they associated an opioidergic mechanism with the analgesic effect of casticin. Receptor bind\u2010ing assays and GTPgS binding assays were performed in order to elucidate if casticin acts as an agonist. Casticin was found to have the highest affinity to \u03bc\u2010opioid receptors with an IC50 of 2.84 \u00b1 0.707 \u03bcM (Ki = 1.14 \u00b1 0.167 \u03bcM). Casticin also stimulated [35S]GTP\u03b3S [Gua\u2010nosine\u20105\u2032\u2010O\u2010(3\u2010thiotriphosphate)] binding (10 and 50 mM) and was inhibited by the opioid receptor selective antagonist ICI 174,864 (N,N\u2010diallyl\u2010Tyr\u2010Aib\u2010Aib\u2010Phe\u2010Leu\u2010OH: Aib = al\u2010pha\u2010aminoisobutyric acid) (10 mM), concluding that casticin acted as an opioid receptor agonist. The latest biological activity reported for this flavonoid is the attenuation of oste\u2010oarthritis\u2010related cartilage degeneration [198]. An in vivo experiment in male BALB/c mice was conducted. Results indicated that the casticin treatments markedly reduced the destruction of cartilage and the levels of matrix metalloproteinase\u201013 (MMP13) in carti\u2010lage. Oxidative stress and inflammation of the cartilage were also decreased and proin\u2010flammatory cytokine production was suppressed. According to Hernandez et al. [1] eupatilin (89) has been reported from S. gilliesii, S. maimarensis, and S. lucida. In 2018, [199] Nageen et al. published a review about the wide range of pharmacological properties of this compound. Anticancer activity has been ex\u2010tensively studied in compound 89, including proapoptotic and cell cycle arrest activities, NF\u2010\u03baB/STAT3 signaling pathways suppression, and inhibition of PI3K/AKT and MAPK pathways. All of these mechanisms result in its reported activity against gastric cancer, leukemia cancer cells, renal carcinoma, hepatocellular cancerous cells, osteosarcoma can\u2010cer cells, glioma cancerous cells, and melanoma cancer cells, among others. The review also presents the anti\u2010inflammatory properties of eupatilin against various disease models and its molecular targets, antioxidant activity through different molecular mechanisms, and neuroprotective activity both in vitro and in vivo. In 2020, Li et al. [200] conducted an in vitro experiment that showed that compound 89 suppressed the proliferation and mi\u2010gration of airway smooth muscle cells (ASMCs). Exposure of ASMCs to eupatilin in\u2010creased the expression of contractile markers smooth muscle, whereas the expression of extracellular matrix (ECM) proteins, type I collagen (Coll I), and fibronectin were reduced; the activation of nuclear factor \u03baB (NF\u2010\u03baB), signal transducer and activator of transcrip\u2010tion 3 (STAT3), and AKT pathways caused by TGF\u2010\u03b21 in ASMCs was present. These find\u2010ings suggest that eupatilin might attenuate airway remodeling, with great potential as an antiasthmatic. Jeong et al. [201] investigated the in vivo effects of eupatilin on pain severity and cartilage degradation in an experimental rat model of osteoarthritis. Their results suggest that eupatilin suppresses oxidative damage and reciprocally enhances extracellular ma\u2010trix production in articular chondrocytes, making the flavonoid 89 a promising therapeu\u2010tic option for the treatment of osteoarthritis. Given the lipophilic nature of eupatilin and its antioxidant and anti\u2010inflammatory activities, authors Zhang et al. [202] proposed to investigate the effects of eupatilin on a mouse model of Parkinson\u2019s disease induced by 1\u2010methyl\u20104\u2010phenyl\u2010 1,2,3,6\u2010tetrahydropyridine (MPTP). The data obtained demonstrated that compound 89 alleviates behavioral impairment and dopaminergic neuron loss in\u2010duced by MPTP through the inhibition of neuroinflammation and apoptosis. Potential as an antidiabetic agent has also been reported for eupatilin. In vitro \u03b1\u2010glycosidase and \u03b1\u2010amylase inhibition assays were carried out, affording IC50 values of 324.28 nM and 244.35 nM, respectively, in the presence of eupatilin [115]. On the other hand, in vivo studies were performed to investigate the dose\u2013response effects on blood glucose regulation and Molecules 2021, 26, 2733 26 of 45 pancreatic \u03b2\u2010cell function in type 2 diabetic mice treated with eupatilin. This flavonoid significantly lowered blood glucose concentration while it increased hepatic glycogen content, and reduced hemoglobin A1c and plasma glucagon levels, along with a simulta\u2010neous increase in plasma insulin and adiponectin levels and increased pancreatic insulin concentrations [203]. In 2013, Son et al. [204] demonstrated compound 89 antiatherogenic properties in human aortic smooth muscle cells, showing that aortic sprouting as well as PDGF BB\u2010induced proliferation and the migration of human aortic smooth muscle cells were signif\u2010icantly inhibited by eupatilin, which is likely mediated through the attenuation of PI3K, MKK3/6, and MKK4 factors activation. Lastly, Metoui et al. [205] assessed in vitro the antixanthine oxidase activity of 89, showing an IC50 value of 3.3 \u03bcM vs. the result of allo\u2010purinol\u2019s IC50 of 8.2 \u03bcM, constituting a promising compound for gout treatment. The flavonoid chrysosplenetin (3, 6, 7, 3\u2032\u2010tetramethoxy quercetin) (90) has been found in S. jujuyensis [1]. \u015e\u00f6hreto\u011flu et al. tested its cytotoxic effect on the MCF\u20107 breast cancer cell line and determined its effect on DNA intercalation and on the activity of topoisomer\u2010ases I and II. The compound inhibited the proliferation of the MCF\u20107 cell line with an IC50 value of 0.29 \u03bcM. Furthermore, it possessed dual topoisomerase I and II inhibitory prop\u2010erties. Especially, it inhibited topoisomerase II by 83\u201396% in the range 12.5\u2013100 \u03bcM. Anti\u2010inflammatory properties of this compound have been described by Chougouo et al. [206]. The authors tested its capacity to modulate the activity of anticholinesterase (AchE) and the production of nitric oxide (NO) in LPS\u2010activated RAW264.7 macrophages. Compound 90 presented a high inhibitory capacity of NO production, with more than 100% inhibition relative to the control, with the respective cell viability values of 15.89%. Chrysosplenetin also exhibited 80% AchE inhibition (at 0.1 mg/mL) and afforded IC50 values of 27.14 \u03bcg/mL. Given the previously reported anti\u2010inflammatory activity of compound 90, Ebada et al. [207], in the context of the coronavirus pandemic, proposed to study anti\u2010inflamma\u2010tory, antiallergic, and COVID\u201019 protease inhibitory in vitro activities of chrysosplenetin, which revealed a potent inhibitory effect on neutrophil elastase release and superoxide anion generation by human neutrophils with IC50 values of 6.66 \u03bcM and 4.32 \u03bcM, respec\u2010tively. It also displayed potent inhibitory activity against antigen\u2010induced degranulation with IC50 values of 5.8 \u03bcM. Molecular modeling was performed and chrysosplenetin was among the top compounds that showed the best docking in the active site of human elas\u2010tase (1H1B), and has shown comparable binding affinity to the co\u2010crystalized ligand in the active site of SARS\u2010CoV\u20102 main protease (6LU7). Antiviral activity against enterovirus 71 (EV71) was also explored by Zhu et al. [208]. Results showed that chrysosplenetin pre\u2010sented strong in vitro activity against EV71 with low cytotoxicity. In the cytopathic effect (CPE) inhibition assays, both plaque reduction assay and virus yield inhibition assay, the compound showed an IC50 value of about 0.20 \u03bcM. On the other hand, antiprotozoal in vitro activity was studied against T. brucei brucei (IC50 = 95.5 \u03bcM) and P. falciparum (IC50 = 85.5 \u03bcM) and T. congolense (IC50 = 2.9 \u03bcM), by Ortiz et al. [209] and Nurbek et al. [210], respectively. Evidence of the capacity of compound 90 to inhibit key molecular targets with phar\u2010macological applications has been reported. Arroo et al. [211] proved that the compound inhibited tyrosinase in vitro (IC50 = 99.87 \u03bcM) and in silico as a competitive inhibitor, with potential applications in cosmetics, medicine, and agriculture. In 2019, Cao et al. [212] evaluated the neuraminidase inhibitory activity of several compounds, using a fluores\u2010cence\u2010based assay. Flavonoid 90 showed comparable activity to oseltamivir acid on the neuraminidase inhibition. Through P\u2010gp\u2010over\u2010expressing Caco\u20102 cells and a bidirectional transport experiment, Ma et al. [213] demonstrated that chrysosplenetin inhibits artemis\u2010inin efflux in mouse small intestine cells with upregulated expression of this membrane carrier, induced by the artemisinin treatment, proving that 90 can be useful to potentiate artemisinin and in multidrug resistance cases. The last activity reported about this com\u2010pound involved its capacity to promote osteogenesis and inhibit estrogen defiency\u2010Molecules 2021, 26, 2733 27 of 45 induced osteoporosis [214]. Human\u2010derived bone marrow stromal cells were cultured and treated with chrysosplenetin in the absence or presence of Wnt inhibitor dickkopf\u2010related protein 1 (DKK1) or bone morphogenetic protein 2 (BMP2) antagonist. Results were con\u2010sistent on the ability of chrysosplenetin to regulate the Wnt/\u03b2\u2010catenin pathway. Centaureidin (91) is another flavonoid isolated from Stevia spp. including S. rebaudi\u2010ana, S. nepetifolia, S. cuzcoensis, and S. galeopsidifolia [1]. The antiproliferative effects of com\u2010pound 91 were measured in vitro on three human cell lines (HeLa, MCF\u20107, and A431) with the MTT (3\u2010 (4,5\u2010dimethylthiazol\u20102\u2010yl)\u20102,5\u2010diphenyltetrazolium bromide) assay. The high\u2010est activity was demonstrated by compound 91, with IC50 values of 0.08 \u03bcM (HeLa), 0.13 \u03bcM (MCF\u20107), and 0.35 \u03bcM (A431) [215]. In other report, centaureidin has shown IC50 val\u2010ues of 0.11, 0.14 and 0.25 \u03bcM against HeLa, MCF\u20107 and HepG2 cell lines [216]. The anti\u2010inflammatory and inmunomodulatory activities of this compound have been demonstrated through the years and by different mechanisms. In 2011, Li et al. [186] reported COX\u20102 inhibition in vitro with an IC50 = 45 \u03bcM. That same year, Jachak et al. [217] published their work proving both COX\u20101 (61.28%) inhibition and COX\u20102 (29.83%) inhi\u2010bition in vitro, as well as antioxidant activity with DPPH radical scavenging and ABTS radical scavenging assays (IC50 of 7.07 and 10.88 \u03bcg/mL, respectively). Chang et al. [218] used IFN\u2010\u03b3 promoter and T cells to characterize immunomodulatory compounds. Results showed that centaureidin (EC50 = 0.9 \u03bcg/mL), augmented IFN\u2010\u03b3 promoter activity and that it induced the activity of NFAT and NF\u043aB enhancers, which are located within the IFN\u2010\u03b3 promoter. The antiviral action of centaureidin against Dengue virus 4 has been docu\u2010mented. Qaddir et al. [219] developed an in silico investigation on phytochemicals from two local medicinal plants of Pakistan (compound 91 among them) against the non\u2010structural protein 1 of Dengue Virus 4 (DENV4\u2010NS1). Possible binding sites to this protein were estimated with great binding affinity (\u22126.4 kcal/mol) and inhibition activity was deter\u2010mined (Ki = 20.117 \u03bcM). Lastly, centaureidin could be used as a melanin reductor and depigmenting agent, since Ito et al. [220] demonstrated that it induces significant morphological changes in normal human epidermal melanocytes and inhibits melanocyte dendrite elongation, re\u2010sulting in a reduction of melanosome transfer in an in vitro melanocyte\u2010keratinocyte co\u2010culture system. Furthermore, in vitro binding assays were performed resulting in its ca\u2010pacity to activate the Rho pathway. From the extraction of S. jujuyensis, the partially methoxylated flavonoid jaceosidin (92) was isolated [1]. Its anticancer potential was first reported in 2016 by Zater et al. [221]. Cytotoxic effects were investigated on three human cancer cell lines: A549 non\u2010small\u2010cell lung carcinoma (NSCLC), MCF7 breast adenocarcinoma, and U373 glioblastoma using a MTT colorimetric assay. The compound afforded IC50 of 32 and 40 \u03bcM on PC3 and B16\u2010F10, respectively, not being active against MCF7. Most recently, in 2020, \u015eekerler [222] studied the effect of compound 92 in hepatocellular carcinoma cell lines, HepG2 and Hep3B, as well as in a normal cell line, NIH3T3. The in vitro antihepatocellular carcinoma activity of the compound was assessed by the MTT method. Jaseosidin had the highest anticancer activity among other compounds tested, with IC50 values of 137.66 \u03bcg/mL and 147.66 \u03bcg/mL on the HepG2 and Hep3B cell lines, respectively, indicating antiprolifera\u2010tive activity. In 2005, Lee et al. [223] reported that flavonoid 92 inhibited the binding be\u2010tween oncoprotein E6 of the human papillomavirus (HPV\u201016) and the p53 tumor suppres\u2010sor protein, in addition to suppressing the binding between the E7 oncoprotein and the Rb tumor suppressor protein, performed in vitro. Furthermore, the compound inhibited the function of HPV\u201016 harboring cultured cervical cancer cells, suggesting that this com\u2010pound might be used as a potential drug for the treatment of cervical cancers associated with human papillomavirus. Compound 92 has been reported as an antioxidant agent. In vitro assays were con\u2010ducted, resulting in the inhibition of the Cu2+\u2010mediated LDL oxidation with IC50 values of 10.2 nM in the thiobarbituric acid\u2010reactive substances (TBARS) assay, as well as the Molecules 2021, 26, 2733 28 of 45 macrophage\u2010mediated LDL oxidation. It also inhibited nuclear factor \u043aB (NF\u2010 \u043aB) activity and nitric oxide (NO) production, and it suppressed the expression of inducible nitric ox\u2010ide synthase (iNOS) in LPS\u2010induced RAW264.7 macrophages [224]. An in vivo experiment performed in 2020 by Park et al. [225] demonstrated that dietary supplementation of mice with 92 increased the expression and activity of Cu and Zn\u2010SOD (copper and zinc\u2010super\u2010oxide dismutase), confirming its antioxidant properties. In this paper, the authors used diabetic mice, demonstrating reduced fasting blood glucose levels and insulin resistance through the upregulation of the insulin receptor downstream pathways in the liver and skeletal muscles, as evidence for the antidiabetic activity of jaceosidin. Lee et al. [226] investigated the antiallergic activity of compound 92 that potently inhibited the release of \u03b2\u2010hexosaminidase from RBL\u20132H3 cells induced by the IgE\u2013antigen complex, with IC50 values of 4.5 \u03bcM. At the same time, orally administered jaceosidin in\u2010hibited the passive cutaneous anaphylaxis (PCA) reaction in mice. Moreover, it sup\u2010pressed the gene expressions of TNF\u2010\u03b1 and IL\u20104 in RBL\u20132H3 cells stimulated by IgE\u2013an\u2010tigen complex. In 2009, Min et al. [227] determined the anti\u2010inflammatory effects of eu\u2010patilin and jaceosidin using carrageenan\u2010induced inflammation in an air pouch on the back of mice and carrageenan\u2010induced hind paw edema in rats. Inflammatory markers were measured. Flavonoid 92 blocked the carrageenan\u2010induced increase in leukocyte numbers and protein levels in air pouch exudates, inhibited COX\u20102 expression and NF\u2010\u043aB activation, and markedly reduced TNF\u2010\u03b1, IL\u20101 \u03b2, and prostaglandin E2 (PGE2) levels. Paw edema induced by carrageenan was reduced. Jaceosidin has been shown to attenuate osteoarthritic cartilage destruction by decreasing MMP3, MMP13, ADAMTS4, and ADAMTS5 expression levels in cultured chondrocytes and by suppressing the nuclear factor \u03baB (NF\u2010\u03baB) signalling pathway, supporting its potential application as natural ther\u2010apeutics for osteoarthritis [228]. The antibacterial activity of jaceosidin was first documented by Kumar et al. in 2016 [229]. This compound displayed mild antibacterial activities against glycopeptide\u2010inter\u2010mediate and vancomycin resistant S. aureus strains (GISA and VRSA, respectively) with a MIC = 128 \u03bcg/mL in both cultures. On the same subject, Allison et al. [230] demonstrated that 92 exhibited antibacterial activity against E. coli in liquid cultures with a MIC of 10 \u03bcM. Furthermore, the in vitro activity against the enoyl reductase enzyme (FabI) was measured using a spectrophotometric assay and completely inhibited FabI activity at a concentration of 100 \u03bcM. Lee et al. [231] reported that jaseocidin may be useful in devel\u2010oping angiogenic agents to promote the growth of collateral blood vessels in ischemic tissues. The compound stimulated the proliferation, migration, and tubulogenesis of en\u2010dothelial cells as well as ex vivo sprouting from aorta rings, which are phenomena typi\u2010cally seen in angiogenesis. Studies were conducted to conclude that the compound acti\u2010vated vascular endothelial growth factor receptor 2 (VEGFR2, FLk\u20101/KDR) and different angiogenic signaling molecules. Human umbilical vascular endothelial cells cultures were used to determine that jaceosidin stimulates angiogenesis by activating the VEGFR2/FAK/PI3K/AKT/NF\u2010kB signaling pathway. According to Hernandez et al. [1], the flavonoid jaceidin (93) can be found in S. cuz\u2010coensis. Allison et al. [230] demonstrated the antibacterial activity of jaceidin against E. coli (MIC = 50 \u03bcM). The antiprotozoal activity of cimpound 93 was evaluated by Elso et al. [62]. Jaceidin showed moderate activity against T. cruzi epimastigotes and L. infantum pro\u2010mastigotes (IC50 > 25 \u03bcM). Qaddir et al. [219] also determined potential inhibition against non\u2010structural protein 1 from dengue virus 4 properties for jaceidin (Ki = 7.299 \u03bcM), as has been described for other compounds in this update. This is also the case in Nguyen et al. [187], who proved jaceidin to be a competitive inhibitor of xanthine oxidase (IC50 = 1.15 \u03bcM; Ki = 0.79 \u03bcM). The antiplatelet activity of jaceidin was evaluated by Afifi and Aburjai [232]. This flavonoid showed weak activity when platelet aggregation was induced by collagen (IC50 = 254.7 \u00b1 13.1 \u03bcg/mL). Molecules 2021, 26, 2733 29 of 45 In 2010, Aljan\u010di\u0107 et al. [233] applied the DPPH scavenging assay on compound 93 and found an EC50 value of 1.13 mM, showing its antioxidant potential. Recently, Elhady et al. [234] published a paper concerning jaceidin antitumor activity. Jaceidin showed in vitro cytotoxic effect in different cell lines and was evaluated on an in vivo experiment on mice, against Ehrlich\u2019s ascites carcinoma. Compared to the control group, compound 93 de\u2010creased tumor weight 94.6%, improved the histological picture of tumor cells, lowered the levels of VEGF, and ameliorated the oxidative stress. Molecular docking and in silico stud\u2010ies suggested that jaceidin was a selective inhibitor of VEGF\u2010mediated angiogenesis with excellent membrane permeability and oral bioavailability. The flavonoid heteroside quercitrin (quercetin\u20103\u2010O\u2010ramnoside) (94) was isolated from S. rebaudiana as documented in the Stevia genus [1]. The biological activity of this compound has been extensively studied through the years, involving anti\u2010inflammatory activity determined by Camuesco et al. [235], antiproliferative and proapoptotic effects by Cincin et al. [236], anti\u2010Dengue virus 2 [237], osteoporosis attenuation [238], hair growth stimulation [239], improvement of hyperlipidemia and hepatic steatosis in ovariecto\u2010mized mice [240], and inhibition of \u03b1\u2010glicosidase [241]. Like other flavonoids discussed in this update, quercitrin was reviewed by Boniface and Ferreira et al. [176], showing anti\u2010protozoal activity against P. falciparum (43.4% inhibition after 48 h), inhibitory effects on L. amazonensis arginase (IC50 = 10.0 \u03bcM), and activity against Dengue virus 2 (DENV\u20102 NS2B) (IC50 = 43.6 \u03bcM) and Dengue virus 3 (DENV\u20103 NS2B) (IC50 = 32.0 \u03bcM). Like other flavonoids, antiallergic properties have been attributed to quercitrin. Jegal et al. [242] de\u2010scribed that quercitrin exhibited the most antiallergic activity against antigen\u2010induced \u03b2\u2010hexosaminidase release and IL\u20104 mRNA expression, which are markers of degranulation in RBL\u20102H3 cells. Antioxidant and anti\u2010inflammatory activities were documented for quercitrin by Ra\u2010zafin\u2010drabazo et al. [243]. The authors assessed the antioxidant capacity using the DPPH free radical scavenging method and the ferric reducing antioxidant power (FRAP) assay with an IC50 of 20.35 \u03bcg/mL. In vivo carrageenan\u2010induced mice paw edema was used to evaluate the anti\u2010inflammatory activity, while the evaluation of the antalgic activity was carried out by the in vivo acetic acid\u2010induced writhing test in mice, in which quercitrin was the most effective compound to decrease the number of writhes. In the same year, Oh et al. [244] published their investigation on the antithrombotic activity of quercitrin. Plate\u2010let aggregation, granule secretion, calcium mobilization, and integrin activation were used to assess the antiplatelet activity of quercitrin. An antithrombotic effect was deter\u2010mined in mice using ferric chloride (FeCl3)\u2010induced arterial thrombus formation in vivo and thrombus formation on collagen\u2010coated surfaces under arteriolar shear in vitro. Tran\u2010section tail bleeding time was used to evaluate whether quercitrin inhibited primary he\u2010mostasis. Results were consistent with the antithrombotic activity of compound 94. Most recently, in 2021, Guo et al. [245] explored the effect of quercitrin in ostheoar\u2010thritis (OA). Molecular mechanisms of quercitrin on OA were studied in vitro in primary chondrocytes and SW1353 cells. In order to evaluate the in vivo effect, an anterior cruciate ligament transection (ACLT) rat model of OA was used. The damage degree of tibial sub\u2010chondral bone and the protein level of MMP13, collagen II, and p110\u03b1 in articular carti\u2010lage, was determined. The flavonoid encouraged cell proliferation and retarded extracel\u2010lular matrix degradation by regulating MMP13 and the collagen II gene and protein ex\u2010pressions. An increase of the bone volume/tissue volume of tibial subchondral bone was observed. Quercitrin also enhanced the cartilage thickness and diminished Osteoarthritis Research Society International scores in osteoarthritic rats. Nepetin (36), also known as eupafolin, can be found in S. urticifolia [27]. Several bio\u2010logical activities were described for this compound including antitumor activity [246,247], antiviral activity [248], tyrosinase inhibition [211], and \u03b1\u2010glucosidase inhibition [249]. Re\u2010garding anti\u2010inflammatory activity, Lee et al. [250] conducted an experiment involving human keratinocyte HaCaT cells that were treated with particulate matter (PM) in the presence or absence of eupafolin. Cyclooxygenase\u20102 (COX\u20102) levels were determined by Molecules 2021, 26, 2733 30 of 45 Western blotting. Prostaglandin E2 (PGE2) production was evaluated by the enzyme im\u2010munoassay method. The generation of intracellular reactive oxygen species (ROS) was measured by the dichlorofluorescin (DCFH) oxidation assay, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity was determined by a chemilumines\u2010cence assay. For in vivo studies, COX\u20102 expression in the skin of BALB/c nude mice was analyzed by immunohistochemistry. Evidence showed that compound 36 inhibited PM\u2010induced COX\u20102 protein and gene expression and PGE2 production in HaCaT cells. In ad\u2010dition, eupafolin suppressed PM\u2010induced intracellular ROS generation, NADPH oxidase activity, MAPK (ERK, JNK, and p38) activation, and NK\u2010\u03baB activation. In vivo studies showed that topical treatment with eupafolin inhibited COX\u20102 expression in the epider\u2010mal keratinocytes of PM\u2010treated mice. On the same line of investigation, Chen et al. [251] demonstrated that 36 suppresses IL\u20101\u03b2\u2010induced IL\u20106, IL\u20108, and MCP\u20101 secretion and mRNA expression by repressing the activation of NF\u2010\u03baB and MAPKs, and can be ex\u2010ploited for its anti\u2010inflammatory properties. Since eupafolin was proven to have anti\u2010in\u2010flammatory and antiproliferative properties, some authors such as Chu et al. [198] studied this compound and demonstrated that it potently inhibited RANKL\u2010induced osteoclast differentiation, formation, and bone resorption in vitro, and protected mice against the deleterious effects of titanium particle\u2010induced calvarial osteolysis in vivo. Mechanisti\u2010cally, the inhibition of RANKL activated signaling pathways necessary for the induction of autophagy. This study demonstrated the potential therapeutic application of nepetin against osteoclast\u2010mediated osteolytic diseases. From S. urticifolia, Machado et al. [27] also isolated the flavonoid heteroside avicu\u2010larin (38). Like other flavonoids, this compound has shown anti\u2010inflammatory activity as was reported by Vo et al. [252], who tested avicularin in LPS\u2010stimulated RAW264.7 mac\u2010rophage cells. Compound 38 significantly inhibited LPS\u2010induced excessive production of pro\u2010inflammatory mediators such as nitric oxide (NO) and PGE2, and the protein levels of iNOS, COX\u20102 and pro\u2010inflammatory cytokine IL\u20101\u03b2. Furthermore, avicularin signifi\u2010cantly suppressed the LPS\u2010induced degradation of I\u03baB, which retains NF\u2010\u03baB in the cyto\u2010plasm, consequently inhibiting the transcription of pro\u2010inflammatory genes. Antitumor activity against hepatocellular carcinoma was investigated by Wang et al. [253]. Huh7 cells were treated with avicularin in a concentration\u2010dependent manner, and the cell prolifer\u2010ation was examined along with cell migration and invasion abilities, the activity of nuclear factor NF\u2010\u03baB (p65), cyclooxygenase\u20102 (COX\u20102), and peroxisome proliferator\u2010activated re\u2010ceptor \u03b3 (PPar\u2010\u03b3) levels. The results indicated that avicularin treatment markedly de\u2010creased cell proliferation concentration\u2010dependently in hepatocellular carcinoma, and in\u2010hibited cell migration and invasion in Huh7 cells. In addition, it was confirmed that the anticancer efficacy of avicularin in HCC was dependent on the regulation of NF\u2010\u03baB (p65), COX\u20102 and PPar\u2010\u03b3 activities. In 2018, Wang et al. [254] investigated the effect of avicularin on rheumatoid arthritis (RA) in vitro. Results demonstrated that avicularin may inhibit the inflammatory re\u2010sponse, prevent cell viability and induce apoptosis in human rheumatoid arthritis syno\u2010vial cells through preventing the activation of the MEK/NF\u2010\u03baB pathway. Shen et al. [255] reported the antidepressant activity of compound 38 in an in vivo mouse model induced by chronic unpredictable mild stress (CUM). Behavioral tests\u2014sucrose preference test (SPT), forced swimming test (FST), and the tail suspension test (TST)\u2014were performed. The levels of proinflammatory cytokines\u2014interleukin\u20101\u03b2 (IL\u20101\u03b2), IL\u20106, and tumor necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) in the hippocampi of mice were detected by enzyme\u2010linked immuno\u2010sorbent assay (ELISA). The apoptosis of hippocampal neuronal cells was determined us\u2010ing flow cytometry. The results showed that avicularin significantly relieved CUMS\u2010in\u2010duced depressive\u2010like behaviors, significantly increased the sucrose preference of the mice, and shortened the immobility time in the FST and TST. They also found that 38 decreased CUMS\u2010induced increases in the levels of IL\u20101\u03b1, IL\u20106, and TNF\u2010\u03b1 in the hippo\u2010campi of mice, and that it significantly decreased the apoptosis rate of hippocampal neu\u2010ronal cells in mice, which was increased by CUMS. In 2013, Fujimori et al. [256] Molecules 2021, 26, 2733 31 of 45 demonstrated that compound 38 suppressed intracellular lipid accumulation by repress\u2010ing glucose uptake mediated by glucose transporter 4 (GLUT4) in mouse adipocytic 3T3\u2010L1 cells. Ayanin (42) was isolated from S. subpubescens var. subpubescens [28]. This compound has been reported to have antiasthmatic activity [257], protective cardiovascular effects [258], vasorelaxant activity [259], anti\u2010inflammatory activity [260], and anticancer proper\u2010ties [261]. In order to evaluate the use of different natural compounds on the treatment of NTDs, Mahmoud et al. [262] tested ayanin for antiprotozoal activity. Results showed that ayanin had an IC50 of 8.2 \u03bcM on L. donovani amastigotes, IC50 = 11.2 \u03bcM on T. b. rhodesiense, and IC50 = 7.8 \u03bcM on P. falciparum. Ermanin (43) was also isolated from S. subpubescens var. subpubescens by Perez Cas\u2010torena et al. [26]. In 2006, Guerra et al. [263] demonstrated that this compound inhibited inducible nitric oxide synthase and cyclooxygenase\u20102 expression, indicating anti\u2010inflam\u2010matory activity. In 2015, Castillo et al. [264] isolated ermanin and proved its antiprolifer\u2010ative activity on the human cancer cell lines A549 (lung), HBL\u2010100 (breast), HeLa (cervix), SW1573 (lung), and T\u201047D (breast). Antiviral properties of this compound were reported in 2010 [265], displaying a 46.8% of inhibition on HIV\u20101 reverse transcriptase. Lastly, Filho et al. [266] evaluated compound 43 for its antiprotozoal activity, obtaining IC50 values of 40 \u03bcg/mL against L. donovani and 2.6 \u03bcg/mL against P. falciparum. Table 4. Flavonoids isolated from Stevia species with biological activity reported. Comp. N\u00b0 Common Name Species Reported Activity 28 Eupatorin S. satureiifolia var. satureiifolia, S. breviaristata, S. procumbens, S. vaga Anti\u2010T. cruzi and Anti\u2010L. braziliensis. Antibreast cancer. Antidiabetic. Angiotensin\u2010converting enzyme inhibition. Antitumor. Vasorelax\u2010ant. Anti\u2010M. tuberculosis [25,110\u2013115]. 29 Cirsimaritin S. satureiifolia var. satureiifolia, S. maimarensis Trypanocidal and leishmanicidal. Antioxidant activity. Anti\u2010E. hys\u2010tolica. Antiproliferative and antimetastatic. Anti\u2010HIV. Antidiabetic. Anti\u2010influenza A virus. Anti\u2010inflammatory. Cardiac remodeling and ventricular dysfunction improvement. Anti\u2010depressant. Anxiolytic. Antinociceptive. Antiepileptic. Antigiardial activity. Melanogenesis\u2010inducing effect [131,144\u2013157]. 35 Hispidulin S. urticifolia, S. sanguinea Anticancer. Anti\u2010T. cruzi. Antidiabetic. Antiepileptic. Antihypnotic. Anti\u2010influenza. Antiosteoporotic. Plate\u2010let aggregation inhibition. Antimetastatic (breast cancer cells) [117,127,151,158\u2013167]. 36 Nepetin S. urticifolia Alpha\u2010glucosidase inhibition. Osteoclastogenesis inhibition. Tyrosi\u2010nase inhibition. Anti\u2010inflammatory. Antiangiogenic and antitumor. Antiviral [198,211,246\u2013251]. 37 Quercetin S. urticifolia, S. pilosa, S. aupatoria S. rebaudiana Leishmanicidal. Antimalarial. Antioxidant. Anti\u2010influenza: neuram\u2010inidase inhibitor. Anti\u2010H. pylori. Anti\u2010inflammatory. Antiallergic. An\u2010tihypertensive. Antidiabetic. Neuroprotective. Antitumor [129,144,160,176\u2013184]. 38 Avicularin S. urticifolia Anti\u2010inflammatory. Anticancer. Rheumatoid arthritis protector. Anti\u2010depressive. Adipogenic genes expression inhibitor [252\u2013256]. 40 Sakuranetin S. subpubescens var. subpu\u2010bescens Anti\u2010T. cruzi and anti\u2010L. braziliensis. Anti\u2010E. hystolitica. Antiprolifera\u2010tive. Antifungal. Anti\u2010 H. pylori. Anti\u2010influenza B. Antiviral. Anti\u2010in\u2010flammatory. Antioxidant. Antiasthmatic. Alzheimer\u2019s disease treat\u2010ment. Cytotoxic against melanoma cells [13,122\u2013141]. 42 Ayanin S. subpubescens var. subpu\u2010bescens Antiasthmatic. Cardiovascular protector. Vasorelaxant. Antiallergic. Anti\u2010inflammatory. Anticancer. Anti\u2010L. donovani, \u2010P. falciparum, and \u2010T. b. rhodesiense [257\u2013262]. 43 Ermanin S. subpubescens var. subpu\u2010bescens Anti\u2010inflammatory. Antitumor. Antiviral. Anti\u2010L. donovani and \u2010P. falciparum [263\u2013266] Molecules 2021, 26, 2733 32 of 45 80 Santin Stevia microchaeta, S. monardifolia, S. origanoides Anti\u2010T. cruzi. Anti\u2010 L. braziliensis. Antiplasmodial. Antibacterial. Anti\u2010influenza A. Anti\u2010T. brucei gambiense [116\u2013121]. 81 Pectolinaringenin S. lucida Anti\u2010T. cruzi. Larvicidal against A. aegypti and Culex quinquefasciatus [142,143]. 82 Artemetin S. procumbens S. jujuyensis Anti\u2010inflammatory activity. Antimalarial. Antioxidant. Antiapop\u2010totic. Endothelial function protection. Anti T. brucei rhodisiense. Hy\u2010potensive. Antitumor [168\u2013175]. 83 Quercetin\u20103\u2010O\u2010B\u2010D\u2010Glc S. rebaudiana S. nepetifolia Anti\u2010plasmodium and anti\u2010L. donovani [176]. 84 Quercetin\u20103\u2010O\u2010B\u2010D\u2010Gal S. nepetifolia, S. serrata, S. soratensis Anti\u2010L. donovani [176]. 85 Luteolin S. pilosa S. eupatoria S. rebaudiana Antiprotozoal against P. falciparum, L. donovani, and T. cruzi. Antivi\u2010ral against Dengue virus type 1. Anti\u2010influenza. Antidiabetic. Anti\u2010inflammatory. Xanthine oxidase inhibition [144,149,160,176,186,187]. 86 Apigenin\u20104\u2032\u2010O\u2010gluco\u2010side S. rebaudiana Antioxidant [188]. 87 Apigetrin S. soratensis Anti\u2010inflammatory. Anticomplementary. Antiproliferative and proapoptotic. Alpha\u2010glucosidase inhibitor. Reduction of intestinal cholesterol uptake [189\u2013192]. 88 Casticin S. breviaristata S. vaga Anticancer. Antiasthmatic. Antihyperprolactinemia and antinocicep\u2010tive. Analgesic. Spasmolytic. Osteoarthritis\u2010related cartilage degener\u2010ation attenuation [193\u2013198]. 89 Eupatilin S. gilliesii S. maimarensis S. lucida Anticancer. Anti\u2010inflammatory. Antiasthmatic. Antinociceptive. Chondroprotective properties. Antioxidant. Neuroprotective. Antidi\u2010abetic. Antiatherogenic. Antixanthine oxidase activity [115,199\u2013205]. 90 Chrysosplenetin S. jujuyensis Cytotoxic activity. Anti\u2010inflammatory. Antiacetylcholinesterase. An\u2010tiallergic. Antiviral against SARS\u2010CoV\u20102 (COVID\u201019) and enterovirus 71. Antiprotozoal against T. brucei brucei, P. falciparum, and T. congo\u2010lense. Tyrosinase inhibition. Neuraminidase inhibition. Pg\u2010P inhibi\u2010tion. Osteogenesis activation [206\u2013214]. 91 Centaureidin S. rebaudiana S. nepetifolia S. cuzcoensis S. galeopsidifolia Cytotoxic. Tumor cell growth inhibition. Anti\u2010inflammatory. Antiox\u2010idant. Immunomodulatory. Anti\u2010Dengue virus 4. Melanin pigmentation reduction [186,215\u2013220]. 92 Jaceosidin S. jujuyensis Anticancer. Antioxidant. Antidiabetic. Antiallergic. Anti\u2010inflammatory. Osteoarthritic cartilage damage at\u2010tenuation. Antibacterial. Angiogenesis stimulation [221\u2013231]. 93 Jaceidin S. cuzcoensis Anti\u2010T. cruzi. Anti\u2010L. infantum. Anti\u2010E. Coli activity. Anti\u2010Dengue vi\u2010rus 4. Antitumor. Antiplatelet. Antioxidant activity. Xanthine oxi\u2010dase inhibition [187,230,232\u2013234]. 94 Quercitrin S. rebaudiana Oteoarthritis alleviation. Platelet activation inhibition. Antioxidant and anti\u2010inflammatory. Hyperlipidemia. Hepatic steatosis ameliora\u2010tion. Hair growth stimulation. Alpha\u2010glycosidase inhibition. Antial\u2010lergic. Antimalarial. Antileishmanial. Anti\u2010Dengue virus. Osteoporo\u2010sis attenuation. Anticancer [176,235\u2013245]. Molecules 2021, 26, 2733 33 of 45 Figure 3. Chemical structures of bioactive flavonoids isolated from Stevia species. 5. Final Remarks and Conclusions In this review, the ethnobotanical aspects and the phytochemistry of the genus Stevia, as well as the biological activities reported for extracts and isolated compounds, have been summarized. So far, data of the Stevia genus have shown how promising these species are as sources of natural and bioactive compounds. Ethnobotanical uses of many Stevia species have been part of folk medicine and popular knowledge for centuries. Of the 29 Stevia species that have been used in traditional medicine, only seven appear to have undergone biological evaluation of the extracts or the isolated compounds that could be related to their medicinal use. In this sense, it was described how decoctions from S. lucida were used to relieve pains, treat rheumatism, and heal wounds. Isoalantolactone, a guaianolide\u2010type ses\u2010quitepene lactone with demonstrated anti\u2010inflammatory and antimicrobial activity has been isolated from this species. Additionally, the flavonoid eupatilin has been tested and associated with anti\u2010inflammatory, antioxidant, antinociceptive, and chondroprotecive mechanisms. Stevia salicifolia was used for rheumatism and the labdanolic acid obtained from this species has been proven to have anti\u2010inflammatory properties. Similarly, Molecules 2021, 26, 2733 34 of 45 poultices prepared using S. pilosa were traditionally used to heal open wounds. The fla\u2010vonoids quercetin and luteolin, which have shown anti\u2010inflammatory activity, have also been reported in this species. It was reported that S. subpubescens has been popularly used to treat joint pains, among other uses. Extracts of this species, diterpenoid labdanolic acid and the flavonoids sakuranetin, ayanin, and ermanin have shown anti\u2010inflamatory activ\u2010ity. Stevia eupatoria has been employed for treating paludism and as a hypoglycemiant and anti\u2010inflammatory. These medicinal uses are consistent with the isolation of the flavonoid luteolin from this species, which has been active against P. falciparum and has demon\u2010strated antidiabetic and anti\u2010inflammatory effects. Stevia extracts have shown biological activities consistent with ethnobothanical uses. For example, S. serrata poultices were shown to treat open wounds, snake bites, and cuts on feet. The essential oil extracted from this species has shown in vivo antinociceptive activity. The pharmacological properties of S. rebaudiana extracts, as well as of its glycosylated diterpenoids, are related to the traditional uses of this species, employed as a sweetener and to decrease blood glucose levels. In the last 22 years, only 14 Stevia species were studied regarding chemical composi\u2010tion. From these 14 species, 58 compounds have been isolated, sesquiterpene lactones, flavonoids, and longipinanes being the most frequently reported. Many pharmacological properties have been described and documented for Stevia extracts and compounds isolated from them. The antiparasitic, anti\u2010inflammatory, and antitumor potential for many of the active compounds has been reported. Sesquiterpene lactones and flavonoids stand out for their broad range of activities reported. Although a great number of active compounds have been reported, many of them have been tested only in vitro assays. In vivo experiments, toxicological research, and studies to find out the mechanism of action of the active molecules should be con\u2010ducted. In addition, further Stevia species should be investigated in order to contribute to the knowledge of the chemistry of the genus, as well as to discover other pharmacological properties and bioactive molecules. This review gives the scientific background of popular and ancient knowledge about the genus Stevia, as well as its chemical composition and the pharmacological potential of extracts and isolated compounds. The extensive information collected highlights the di\u2010versity and richness of the Stevia genus and how useful its exploitation can be for the de\u2010tection of new bioactive compounds. Supplementary Materials: The following are available online, Table S1: Compounds isolated from Stevia species since 1998. Author Contributions: Conceptualization, V.P.S., J.B., L.C.L., F.M., and C.A.N.C.; methodology, J.B., L.C.L., and V.P.S.; formal analysis, V.P.S. and C.A.N.C.; funding acquisition, V.P.S.; data cura\u2010tion, V.P.S., J.B., L.C.L., F.M., and C.A.N.C.; writing\u2014original draft preparation, V.P.S., J.B., and L.C.L.; writing\u2014review and editing, V.P.S. and C.A.N.C.; supervision, V.P.S., F.M., and C.A.N.C. All authors have read and agreed to the published version of the manuscript. Funding: This research was funded by Universidad de Buenos Aires, grant number 20020170100316BA, Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, grant number 11220150100158CO, and Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica, grant number PICT 2015\u20103531. Institutional Review Board Statement: Not applicable. Informed Consent Statement: Not applicable. Acknowledgments: We kindly acknowledge the scientific support given by Virginia Martino. Conflicts of Interest: The author declares no conflict of interest. Molecules 2021, 26, 2733 35 of 45 References 1. Hern\u00e1ndez, L.R.; Catal\u00e1n, C.A.N.; Joseph\u2010Natan, P. The chemistry of the genus Stevia (Asteraceae). Rev. Acad. Colomb. Ciencias 1998, 22, 229\u2013279. 2. Rodr\u00edguez\u2010Cravero, J.F.; Guti\u00e9rrez, D.G.; Katinas, L.; Grossi, M.A.; Bonifacino, J.M.; Marchesi, E. A revision and morphological analysis of the Uruguayan species of Stevia (Compositae, Eupatorieae). Rodrigu\u00e9sia 2019, 70, e01532018. 3. Soejarto, D.D. Botany of Stevia and Stevia rebaudiana. In Stevia. The Genus Stevia; Kinghorn, A.D., Ed.; Taylor and Francis: London, UK, 2002; Chapter 2, pp. 18\u201339. 4. King, R.M.; Robinson, H. The Genera of the Eupatorieae (Asteraceae); Monographs in Systematic Botany vol 22; King, R.M., Robin\u2010son, H., Eds.; Allen Press, Inc.: Lawrence, KS, USA, 1987. 5. Ruiz\u2010Ruiz, J.C.; Moguel\u2010Ordo\u00f1ez, Y.B.; Segura\u2010Campos, M.R. Biological activity of Stevia rebaudiana Bertoni and their relation\u2010ship to health. Crit. Rev. Food Sci. Nutr. 2017, 57, 2680\u20132690. 6. Soejarto, D.D. Ethnobotany of Stevia and Stevia rebaudiana. In Stevia. The Genus Stevia; Kinghorn, A.D., Ed.; Taylor and Francis: London, UK, 2002; Chapter 3, pp. 40\u201367. 7. Cerda\u2010Garc\u00eda\u2010Rojas, C.M.; Pereda\u2010Miranda, R. The phytochemistry of Stevia: A general survey. In Stevia. The Genus Stevia; King\u2010horn, A.D., Ed.; Taylor and Francis: London, UK, 2002; Chapter 5, pp. 86\u2013118. 8. Rodr\u00edguez\u2010Cravero, J.; Guti\u00e9rrez, D. Stevia Cav. In Plantas cultivadas de la Argentina: Aster\u00e1ceas\u2010Compuestas, 1st ed.; Hurrell, J.A., Bay\u00f3n, N.D., Delucchi, G., Eds.; Hemisferio Sur: Buenos Aires, Argentina, 2017; pp. 273\u2013278. 9. Cantero, J.J.; N\u00fa\u00f1ez, C.O.; Bernardello, G.; Amuchastegui, A.; Mulko, J.; Brandolin, P.; Palchetti, M.V.; Iparraguirre, J.; Virginil, N.; y Ariza Espinar, L. Las Plantas de Importancia Econ\u00f3mica en Argentina, 1st ed.; UniR\u00edo Editora: Rio Cuarto, Argentina, 2019. 10. Soejarto, D.D.; Compadre, C.M.; Kinghorn, A.D. Ethnobotanical notes on Stevia. Bot. Mus. Leafl. Harv. Univ. 1983, 29, 1\u201325. 11. Cari\u00f1o\u2010Cort\u00e9s, R.; Hern\u00e1ndez\u2010Ceruelos, A.; Torres\u2010Valencia, J.M.; Gonz\u00e1lez\u2010Avila, M.; Arriaga\u2010Alba, M.; Madrigal\u2010Bujaidar, E. Antimutagenicity of Stevia pilosa and Stevia eupatoria evaluated with the Ames test. Toxicol. Vitro 2007, 21, 691\u2013697, doi:10.1016/j.tiv.2006.12.001. 12. Perez\u2010Perez, I.; Valencia, J.M.T. Metabolitos secundarios aislados de las ra\u00edces y las hojas de Stevia jorullensis H.B.K. Bachelor\u2019s Thesis, Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca de Soto, Mexico, 2016. 13. Brown, A.E.; Morit\u00e1n, M.G.; Ventura, B.; Hilgert, N.I.; Malizia, L.R. Plantas silvestres, \u00e1mbito dom\u00e9stico y subsistencia. In Finca San Andr\u00e9s. Un Espacio de Cambios Ambientales y Sociales en el Alto Bermejo; Brown, A.E., Morit\u00e1n, M.G., Ventura, B., Hilgert, N.I., Malizia, L.R., Eds.; Subtr\u00f3pico: Tucum\u00e1n, Argentina, 2007; Chapter 7, p. 210. 14. Cordeiro, M.S.; Simas, D.L.R.; P\u00e9rez\u2010Sabino, J.F.; M\u00e9rida\u2010Reyes, M.S.; Mu\u00f1oz\u2010Wug, M.A.; Oliva\u2010Hern\u00e1ndez, B.E.; Da Silva, A.J.R.; Fernandes, P.D.; Giorno, T.B.S. Characterization of the antinociceptive activity from Stevia serrata Cav. Biomedicines 2020, 8, 79, doi:10.3390/biomedicines8040079. 15. S\u00fclsen, V.; Martino, V. Overview. In Sesquiterpene Lactones. Advances in Their Chemistry and Biological Aspects; S\u00fclsen, V., Martino, V., Eds.; Springer: Cham, Switzerland, 2018; pp. 3\u201317. 16. S\u00fclsen, V.; Elso, O.; Borgo, J.; Laurella, L.C.; Catalan, C.A.N. Recent patents involving sesquiterpene lactones with therapeutic application. In Studies in Natural Product Chemistry (Bioactive Natural Products); Atta\u2010ur\u2010Rahman, Ed.; Elseiver Science Publisher: Amsterdam, The Netherlands, 2021. 17. Rom\u00e1n, L.U.; Morales, N.R.; Hernandez, J.D.; Cerda\u2010Garcia\u2010Rojas, C.M.; Zepeda, L.G.; Flores Sandoval, C.A.; Joseph\u2010Nathan, P. Generation of the new quirogane skeleton by a vinylogous retro\u2010Michael type rearrangement of longipinene derivatives. Tetrahedron 2001, 57, 7269\u20137275. 18. S\u00e1nchez\u2010Arreola, E.; Cerda\u2010Garc\u00eda\u2010Rojas, C.M.; Rom\u00e1n, L.U.; Hern\u00e1ndez, J.D.; Joseph\u2010Nathan, P. Longipinane Derivatives from Stevia connata. J. Nat. Prod. 2000, 63, 12\u201315, doi:10.1021/np990210t. 19. Rom\u00e1n, L.U.; Cambr\u00f3n, J.I.; Del R\u00edo, R.E.; Hern\u00e1ndez, J.D.; Cerda\u2010Garc\u00eda\u2010Rojas, C.M.; Joseph\u2010Nathan, P. Grindelane diterpe\u2010noids from Stevia subpubescens. J. Nat. Prod. 2000, 63, 226\u2013229, doi:10.1021/np990216i. 20. Rom\u00e1n, L.U.; Guerra\u2010Ram\u00edrez, D.; Mor\u00e1n, G.; Mart\u00ednez, I.; Hern\u00e1ndez, J.D.; Cerda\u2010Garc\u00eda\u2010Rojas, C.M.; Torres\u2010Valencia, J.M.; Joseph\u2010Nathan, P. First seco\u2010C Oleananes from Nature. Org. Lett. 2004, 6, 173\u2013176, doi:10.1021/ol036107j. 21. \u00c1lvarez\u2010Garc\u00eda, R.; Torres\u2010Valencia, J.M.; Rom\u00e1n, L.U.; Hern\u00e1ndez, J.D.; Cerda\u2010Garci\u00eda\u2010Rojas, C.M.; Joseph\u2010Nathan, P. Absolute configuration of the \u03b1\u2010methylbutyryl residue in longipinene derivatives from Stevia pilosa. Phytochemistry 2005, 66, 639\u2013642, doi:10.1016/j.phytochem.2004.12.001. 22. Rojas\u2010P\u00e9rez, R.E.; Cedillo\u2010Portugal, E.; Joseph\u2010Nathan, P.; Burgue\u00f1o\u2010Tapia, E. A New Longipinene Diester from Stevia monardi\u2010folia Kunth. Nat. Prod. Commun. 2009, 4, 757\u2013762, doi:10.1177/1934578x0900400603. 23. Valdez\u2010Calder\u00f3n, A.; Torres\u2010Valencia, J.M.; Manr\u00edquez\u2010Torres, J.J.; Vel\u00e1zquez\u2010Jim\u00e9nez, R.; Rom\u00e1n\u2010Mar\u00edn, L.U.; Hern\u00e1ndez\u2010Hern\u00e1ndez, J.D.; Cerda\u2010Garc\u00eda\u2010Rojas, C.M.; Joseph\u2010Nathan, P. An unusual diepoxyguaianolide from Stevia tomentosa. Tetrahe\u2010dron Lett. 2013, 54, 3286\u20133289, doi:10.1016/j.tetlet.2013.04.056. 24. Ceunen, S.; Wim, D.B.; Compernolle, F.; Mai, A.H.; Geuns, J.M.C. Diterpene glycosides from Stevia phlebophylla A. Gray. Carbo\u2010hydr. Res. 2013, 379, 1\u20136, doi:10.1016/j.carres.2013.06.003. 25. Beer, M.F.; Frank, F.M.; Elso, O.G.; Ernesto Bivona, A.; Cerny, N.; Giberti, G.; Malchiodi, E.L.; Martino, V.S.; Alonso, M.R.; S\u00fclsen, V.P.; et al. Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia satureiifolia var. satureiifolia. Pharm. Biol. 2016, 54, 2188\u20132195, doi:10.3109/13880209.2016.1150304. Molecules 2021, 26, 2733 36 of 45 26. Simas, D.L.R.; M\u00e9rida\u2010Reyes, M.S.; Mu\u00f1oz\u2010Wug, M.A.; Cordeiro, M.S.; Giorno, T.B.S.; Taracena, E.A.; Oliva\u2010Hern\u00e1ndez, B.E.; Mart\u00ednez\u2010Ar\u00e9valo, J.V.; Fernandes, P.D.; P\u00e9rez\u2010Sabino, J.F.; et al. Chemical composition and evaluation of antinociceptive activ\u2010ity of the essential oil of Stevia serrata Cav. from Guatemala. Nat. Prod. Res. 2019, 33, 577\u2013579, doi:10.1080/14786419.2017.1399376. 27. Machado, K.N.; Tasco, A.J.H.; Salvador, M.J.; Rodrigues, I.V.; Pessoa, C.; Sousa, I.J.O.; Ferreira, P.M.P.; do Nascimento, A.M. Flavonoids, Antioxidant, and Antiproliferative Activities of Stevia urticifolia. Chem. Nat. Compd. 2017, 53, 1167\u20131169, doi:10.1007/s10600\u2010017\u20102228\u20104. 28. Perez\u2010Castorena, A.L.; Arciniegas, A.; Nieto\u2010Camacho, A.; Villasenor, J.L.; de Vivar, A.R. Chemical Constituents of Stevia sub\u2010pubescens var. subpubescens and Evaluation of the Anti\u2010Inflammatory Activity. Chem. Nat. Compd. 2019, 55, 538\u2013539, doi:10.1007/s10600\u2010019\u201002734\u20103. 29. P\u00e9rez\u2010Castorena, A.L.; Nieto\u2010Camacho, A.; Maldonado, E. Sesquiterpene lactones and other constituents from Stevia jorullensis. Biochem. Syst. Ecol. 2020, 89, doi:10.1016/j.bse.2020.104003. 30. Chac\u00f3n\u2010Morales, P.A.; Dugarte, C.S.; Amaro\u2010Luis, J.M. Helenin from Stevia lucida. The first report of this natural eudesmanolide mixture in Eupatorieae tribe. Nat. Prod. Res. 2020, 1\u20134, doi:10.1080/14786419.2020.1739677. 31. Fournet, A.; Barrios, A.A.; Mu\u00f1oz, V. Leishmanicidal and trypanocidal activities of Bolivian medicinal plants. J. Ethnopharmacol. 1994, 41, 19\u201337, doi:10.1016/0378\u20108741(94)90054\u2010X. 32. Kedik, S.A.; Yartsev, E.I.; Stanishevskaya, I.E. Antiviral activity of dried extract of Stevia. Pharm. Chem. J. 2009, 43, 198\u2013199, doi:10.1007/s11094\u2010009\u20100270\u20107. 33. Shukla, S.; Mehta, A.; Mehta, P.; Bajpai, V.K. Antioxidant ability and total phenolic content of aqueous leaf extract of Stevia rebaudiana Bert. Exp. Toxicol. Pathol. 2012, 64, 807\u2013811, doi:10.1016/j.etp.2011.02.002. 34. Moselhy, S.S.; Ghonieim, M.A.; Khan, J.A. In vitro and in vivo evaluation of antimicrobial and antioxidant potential of stevia extract. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 18\u201321, doi:10.21010/ajtcam.v13i6.4. 35. Medina\u2010Medrano, J.R.; Torres\u2010Contreras, J.E.; Valiente\u2010Banuet, J.I.; Mares\u2010Qui\u00f1ones, M.D.; V\u00e1zquez\u2010S\u00e1nchez, M.; \u00c1lvarez\u2010Ber\u2010nal, D. Effect of the solid\u2013liquid extraction solvent on the phenolic content and antioxidant activity of three species of Stevia leaves. Sep. Sci. Technol. 2019, 54, 2283\u20132293, doi:10.1080/01496395.2018.1546741. 36. Farhat, G.; Berset, V.; Moore, L. Effects of stevia extract on postprandial glucose response, satiety and energy intake: A three\u2010arm crossover trial. Nutrients 2019, 11, 3036, doi:10.3390/nu11123036. 37. Mart\u00ednez\u2010Rojo, E.; Cari\u00f1o\u2010Cort\u00e9s, R.; Berumen, L.C.; Garc\u00eda\u2010Alcocer, G.; Escobar\u2010Cabrera, J. Stevia eupatoria and Stevia pilosa extracts inhibit the proliferation and migration of prostate cancer cells. Medicina 2020, 56, 90, doi:10.3390/medicina56020090. 38. Gonzales, M.; Villena, G.K.; Kitazono, A.A. Evaluation of the antioxidant activities of aqueous extracts from seven wild plants from the Andes using an in vivo yeast assay. Results Chem. 2021, 3, 100098, doi:10.1016/j.rechem.2021.100098. 39. R\u00edos, V.E.; Le\u00f3n, A.; Ch\u00e1vez, M.I.; Torres, Y.; Ram\u00edrez\u2010Apan, M.T.; Toscano, R.A.; Bravo\u2010Monz\u00f3n, \u00c1.E.; Espinosa\u2010Garc\u00eda, F.J.; Delgado, G. Sesquiterpene lactones from Mikania micrantha and Mikania cordifolia and their cytotoxic and anti\u2010inflammatory evaluation. Fitoterapia 2014, 94, 155\u2013163, doi:10.1016/j.fitote.2014.02.006. 40. M\u00e1\u00f1ez, S.; Hern\u00e1ndez, V.; Giner, R.M.; R\u00edos, J.L.; del Carmen Recio, M. Inhibition of pro\u2010inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa. Fitoterapia 2007, 78, 329\u2013331, doi:10.1016/j.fitote.2007.03.005. 41. Moujir, L.; Callies, O.; Sousa, P.M.C.; Sharopov, F.; Seca, A.M.L. Applications of sesquiterpene lactones: A review of some po\u2010tential success cases. Appl. Sci. 2020, 10, 3001, doi:10.3390/app10093001. 42. Rozenblat, S.; Grossman, S.; Bergman, M.; Gottlieb, H.; Cohen, Y.; Dovrat, S. Induction of G2/M arrest and apoptosis by sesquit\u2010erpene lactones in human melanoma cell lines. Biochem. Pharmacol. 2008, 75, 369\u2013382, doi:10.1016/j.bcp.2007.08.024. 43. Luna\u2010Herrera, J.; Costa, M.C.; Gonz\u00e1lez, H.G.; Rodrigues, A.I.; Castilho, P.C. Synergistic antimycobacterial activities of sesquit\u2010erpene lactones from Laurus Spp. J. Antimicrob. Chemother. 2007, 59, 548\u2013552, doi:10.1093/jac/dkl523. 44. Asaruddin, M.R.; Honda, G.; Tsubouchi, A.; Nakajima\u2010Shimada, J.; Aoki, T.; Kiuchi, F. Trypanocidal constituents from Michelia alba. J. Nat. Med. 2003, 57, 61\u201363. 45. S\u00e1nchez, L.A.; Capitan, Z.; Romero, L.I.; Ortega\u2010Barr\u00eda, E.; Gerwick, W.H.; Cubilla\u2010Rios, L. Bio\u2010Assay Guided Isolation of Ger\u2010macranes with Anti\u2010Protozoan Activity from Magnolia sororum. Nat. Prod. Commun. 2007, 2, 1065\u20131069, doi:10.1177/1934578x0700201101. 46. Julianti, T.; Hata, Y.; Zimmermann, S.; Kaiser, M.; Hamburger, M.; Adams, M. Antitrypanosomal sesquiterpene lactones from Saussurea costus. Fitoterapia 2011, 82, 955\u2013959, doi:10.1016/j.fitote.2011.05.010. 47. Lee, B.K.; Park, S.J.; Nam, S.Y.; Kang, S.; Hwang, J.; Lee, S.J.; Im, D.S. Anti\u2010allergic effects of sesquiterpene lactones from Saus\u2010surea costus (Falc.) Lipsch. determined using in vivo and in vitro experiments. J. Ethnopharmacol. 2018, 213, 256\u2013261, doi:10.1016/j.jep.2017.11.018. 48. Eliza, J.; Daisy, P.; Ignacimuthu, S. Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm. Chem. Biol. Interact. 2010, 188, 467\u2013472, doi:10.1016/j.cbi.2010.08.002. 49. Lee, Y.S.; Choi, E.M. Costunolide stimulates the function of osteoblastic MC3T3\u2010E1 cells. Int. Immunopharmacol. 2011, 11, 712\u2013718, doi:10.1016/j.intimp.2011.01.018. 50. Ham, A.; Lee, S.J.; Shin, J.; Kim, K.H.; Mar, W. Regulatory effects of costunolide on dopamine metabolism\u2010associated genes inhibit dopamine\u2010induced apoptosis in human dopaminergic SH\u2010SY5Y cells. Neurosci. Lett. 2012, 507, 101\u2013105, doi:10.1016/j.neulet.2011.10.037. 51. Hajd\u00fa, Z.; Zupk\u00f3, I.; R\u00e9thy, B.; Forgo, P.; Hohmann, J. Bioactivity\u2010guided isolation of cytotoxic sesquiterpenes and flavonoids from anthemis ruthenica. Planta Med. 2010, 76, 94\u201396, doi:10.1055/s\u20100029\u20101185942. Molecules 2021, 26, 2733 37 of 45 52. Fischedick, J.T.; Standiford, M.; Johnson, D.A.; De Vos, R.H.; Todorovi\u0107, S.; Banjanac, T.; Verpoorte, R.; Johnson, J.A. Activation of antioxidant response element in mouse primary cortical cultures with sesquiterpene lactones isolated from Tanacetum parthe\u2010nium. Planta Med. 2012, 78, 1725\u20131730, doi:10.1055/s\u20100032\u20101315241. 53. Fabian, L.; S\u00fclsen, V.; Frank, F.; Cazorla, S.; Malchiodi, E.; Martino, V. In silico study of structural and geometrical requirements of natural sesquiterpene lactones with trypanocidal activity. Mini Rev. Med. Chem. 2013, 13, 407\u20131414. 54. Elso, O.G.; Bivona, A.E.; Alberti, A.S.; Cerny, N.; Fabian, L.; Morales, C.; Catal\u00e1n, C.A.N.; Malchiodi, E.L.; Cazorla, S.I.; S\u00fclsen, V.P. Trypanocidal activity of four sesquiterpene lactones isolated from Asteraceae species. Molecules 2020, 25, 2014, doi:10.3390/molecules25092014. 55. Kimani, N.M.; Matasyoh, J.C.; Kaiser, M.; Brun, R.; Schmidt, T.J. Antiprotozoal Sesquiterpene Lactones and Other Constituents from Tarchonanthus camphoratus and Schkuhria pinnata. J. Nat. Prod. 2018, 81, 124\u2013130, doi:10.1021/acs.jnatprod.7b00747. 56. Michalak, B.; Piwowarski, J.P.; Granica, S.; Waltenberger, B.; Atanasov, A.G.; Khan, S.Y.; Breuss, J.M.; Uhrin, P.; Zyzynska\u2010Granica, B.; Stojakowska, A.; et al. Eupatoriopicrin inhibits pro\u2010inflammatory functions of neutrophils via suppression of il\u20108 and tnf\u2010Alpha production and p38 and erk 1/2 map kinases. J. Nat. Prod. 2019, 82, 375\u2013385, doi:10.1021/acs.jnatprod.8b00939. 57. Bachelier, A.; Mayer, R.; Klein, C.D. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. Bioorganic Med. Chem. Lett. 2006, 16, 5605\u20135609. 58. Rucker, G.; Heiden, K.; Schenkel, E. Antitumor\u2010active lactones from Kaunia rufescens and Eupatorium cannabinum. J. Indian Inst. Sci. 2001, 81, 333\u2013334. 59. Beekman, A.C.; Woerdenbag, H.J.; Harm, H.; Kampinga, H.H.; Antonius, W.T.; Konings, A.W.T. Cytotoxicity of Artemisinin, a Dimer of Dihydroartemisinin, Artemisitene and Eupatoriopicrin as Evaluated by the MTT and Clonogenic Assay. Phytother. Res. 1996, 10, 140\u2013144. 60. Wu, X. De.; Ding, L.F.; Tu, W.C.; Yang, H.; Su, J.; Peng, L.Y.; Li, Y.; Zhao, Q.S. Bioactive sesquiterpenoids from the flowers of Inula japonica. Phytochem. 2016, 129, 68\u201376, doi:10.1016/j.phytochem.2016.07.008. 61. Boldbaatar, A.; Lee, S.; Han, S.; Jeong, A.L.; Ka, H.I.; Buyanravjikh, S.; Lee, J.H.; Lim, J.S.; Lee, M.S.; Yang, Y. Eupatolide inhibits the TGF\u2010\u03b21\u2010induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional re\u2010pression of ALK5. Oncol. Lett. 2017, 14, 6031\u20136039, doi:10.3892/ol.2017.6957. 62. Elso, O.G.; Clavin, M.; Hernandez, N.; Sgarlata, T.; Bach, H.; Catalan, C.A.N.; Aguilera, E.; Alvarez, G.; S\u00fclsen, V.P. Antiproto\u2010zoal Compounds from Urolepis hecatantha (Asteraceae). Evid. Based Complement Alternat. Med. 2021, 2021, 6622894, doi:10.1155/2021/6622894. 63. Kimani, S.; Backhaus, J.; Matasyoh, J.C.; Kaiser, M.; Herrmann, F.C.; Schmidt, T.J.; Langer, K. Preparation of sesquiterpene lactone\u2010loaded PLA nanoparticles and evaluation of their antitrypanosomal activity. Molecules 2019, 24, 2110. 64. Woerdenbag, H.; Hendriks, H.J.; Malingr\u2019e, T.M.; Van Stralen, R.; Van den Berg, K.J.; Konings, A.W.T. In vitro cytotoxicity of sesquiterpene lactones from Eupatorium cannabinum L. and semi\u2010synthetic derivatives from eupatoriopicrin. Phytother. Res. 1988, 2, 109\u2013114. 65. Kudumela, R.G.; Mazimba, O.; Masoko, P. Isolation and characterisation of sesquiterpene lactones from Schkuhria pinnata and their antibacterial and anti\u2010inflammatory activities. S. Afr. J. Bot. 2019, 126, 340\u2013344. 66. Zhu, Z.; Yuan, J.; Xu, X.; Wei, Y.; Yang, B.; Zhao, H. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS\u2010like traits of TNBC via inactivation of STAT3. Neoplasia 2021, 23, 36\u201348, doi:10.1016/j.neo.2020.10.012. 67. Liu, S.J.; Liao, Z.X.; Tang, Z.S.; Cui, C.L.; Liu, H.B.; Liang, Y.N.; Zhang, Y.; Shi, H.X.; Liu, Y.R. Phytochemicals and biological activities of Artemisia sieversiana.Phytochem. Rev. 2017, 16, 441\u2013460, doi:10.1007/s11101\u2010016\u20109475\u2010z. 68. Sanchez\u2010Carranza, J.N.; Gonz\u00e1lez\u2010Maya, L.; Razo\u2010Hern\u00e1ndez, R.S.; Salas\u2010Vidal, E.; Nolasco\u2010Quintana, N.Y.; Clemente\u2010Soto, A.F.; Garc\u00eda\u2010Arizmendi, L.; S\u00e1nchez\u2010Ramos, M.; Marquina, S.; Alvarez, L. Achillin increases chemosensitivity to paclitaxel, overcoming resistance and enhancing apoptosis in human hepatocellular carcinoma cell line resistant to paclitaxel (Hep3B/PTX). Pharmaceutics 2019, 11, 512, doi:10.3390/pharmaceutics11100512. 69. Woo, S.M.; Choi, W.R.; Lee, D.R.; Kim, H.S.; Yi, C.; Kim, K.H.; Kim, H.L.; Cheng, J.; Le, B.; Yang, S.H.; et al. Leukodin isolated from Artemisia capillaris inhibits alpha\u2010melanocyte stimulating hormone induced melanogenesis in B16F10 melanoma cells. Eur. J. Integr. Med. 2019, 25, 85\u201391, doi:10.1016/j.eujim.2018.10.013. 70. Zapata\u2010Mart\u00ednez, J.; S\u00e1nchez\u2010Toranzo, G.; Cha\u00edn, F.; Catal\u00e1n, C.A.N.; B\u00fchler, M.I. Effect of guaianolides in the meiosis reinitia\u2010tion of amphibian oocytes. Zygote 2016, 25, 10\u201316, doi:10.1017/s0967199416000265. 71. Zhang, S.L.; Li, B.L.; Li, W.; Lu, M.; Ni, L.Y.; Ma, H.L.; Meng, Q.G. The effects of ludartin on cell proliferation, cell migration, cell cycle arrest and apoptosis are associated with upregulation of p21WAF1 in Saos\u20102 osteosarcoma cells in vitro. Med. Sci. Monit. 2018, 24, 4926\u20134933, doi:10.12659/MSM.909193. 72. Xu, W.; Miao, S.; Feng, Y. Ludartin exhibits therapeutic effect on spinal cord injury through inhibition of apoptosis and inflam\u2010mation. Bangladesh J. Pharmacol. 2019, 14, 54\u201360, doi:10.3329/bjp.v14i1.38725. 73. Blanco, J.G.; Gil, R.R.; Alvarez, C.I.; Patrito, L.C.; Genti\u2010Raimondi, S.; Flury, A. A novel activity for a group of sesquiterpene lactones: Inhibition of aromatase. FEBS Lett. 1997, 409, 396\u2013400, doi:10.1016/S0014\u20105793(97)00560. 74. Giordano, O.S.; Guerreiro, E.; Pestchanker, M.J.; Guzman, J.; Pastor, D.; Guardia, T. The gastric cytoprotective effect of Several sesquiterpene lactones. J. Nat. Prod. 1990, 53, 803\u2013809, doi:10.1021/np50070a004. 75. Luo, H.J.; Wang, J.Z.; Deng, W.Q.; Zou, K. DFT calculations and docking study on sesquiterpene lactones: Inhibition of aroma\u2010tase. Procedia Environ. Sci. 2011, 8, 446\u2013450, doi:10.1016/j.proenv.2011.10.070. Molecules 2021, 26, 2733 38 of 45 76. S\u00fclsen, V.P.; Lizarraga, E.F.; Elso, O.G.; Cerny, N.; Alberti, A.S.; Bivona, A.E.; Malchiodi, E.L.; Cazorla, S.I.; Catal\u00e1n, C.A.N. Activity of estafietin and analogues on Trypanosoma cruzi and Leishmania braziliensis. Molecules 2019, 24, 1209, doi:10.3390/mole\u2010cules24071209. 77. Schepetkin, I.A.; Kirpotina, L.N.; Mitchell, P.T.; Kishkentaeva, A.S.; Shaimerdenova, Z.R.; Atazhanova, G.A.; Adekenov, S.M.; Quinn, M.T. The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation. Phytochemistry 2018, 146, 36\u201346, doi:10.1016/j.phytochem.2017.11.010. 78. Liu, Y.; Meng, Q.; Jing, L.; Feng, L.; Zhou, Z.; Ni, Z. 11, 13\u2010Dehydro Lactone Moiety in Gynecologic Cancer Cells. Iran J Public Health. 2020, 49, 2103\u20132110, doi:10.18502/ijph.v49i11.4726. 79. Cai, H.; Meng, X.; Li, Y.; Yang, C.; Liu, Y. Growth inhibition effects of isoalantolactone on K562/A02 cells: Caspase\u2010dependent apoptotic pathways, S phase arrest, and downregulation of Bcr/Abl. Phytother. Res. 2014, 28, 1679\u20131686, doi:10.1002/ptr.5182. 80. Fan, Y.; Weng, Z.; Gao, H.; Hu, J.; Wang, H.; Li, L. Isoalantolactone Enhances the Radiosensitivity of UMSCC\u201010A Cells via Specific Inhibition of Erk1/2 Phosphorylation. PLoS ONE 2015, 10, doi:10.1371/journal.pone.0145790. 81. Wang, J.; Cui, L.; Feng, L.; Zhang, Z.; Song, J.; Liu, D.; Jia, X. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA\u2010MB\u2010231 cells via suppression of the p38 MAPK/NF\u2010\u03baB signaling pathway. Oncol. Rep. 2016, 36, 1269\u20131376, doi:10.3892/or.2016.4954. 82. Weng, Z.; Gao, H.; Hu, J.; Fan, Y.; Wang, H.; Li, L. Isoalantolactone induces autophagic cell death in SKOV\u2083 human ovarian carcinoma cells via upregulation of PEA\u201015. Oncol. Rep. 2016, 35, 833\u2013840, doi:10.3892/or.2015.4461. 83. Jin, C.; Zhang, G.; Zhang, Y.; Hua, P.; Song, G.; Sun, M.; Li, X.; Tong, T.; Li, B.; Zhang, X. Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells. PLoS ONE 2017, 12, doi:10.1371/jour\u2010nal.pone.0181731. 84. Khan, M.; Ding, C.; Rasul, A.; Yi, F.; Li, T.; Gao, H.; Gao, R.; Zhong, L.; Zhang, K.; Fang, X.; et al. Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC\u20101 cells. Int. J. Biol. Sci. 2012, 8, 533\u2013647. 85. Rasul, A.; Khan, M.; Ali, M.; Li, J.; Li, X. Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. Sci. World J. 2013, 2013, 248532, doi:10.1155/2013/248532. 86. Yan, Y.Y.; Zhang, Q.; Zhang, B.; Yang, B.; Lin, N.M. Active ingredients of Inula helenium L. exhibits similar anti\u2010cancer effects as isoalantolactone in pancreatic cancer cells. Nat. Prod. Res. 2020, 34, 2539\u20132544, doi:10.1080/14786419.2018.1543676. 87. Zhou, Y.; Guo, Y.; Wen, Z.; Ci, X.; Xia, L.; Wang, Y.; Deng, X.; Wang, J. Isoalantolactone enhances the antimicrobial activity of penicillin g against Staphylococcus aureus by inactivating \u03b2\u2010lactamase during protein translation. Pathogens 2020, 9, 161, doi:10.3390/pathogens9030161. 88. Lu, J.; Kuang, Z.; Chen, T.; Ye, C.; Hou, W.; Tang, L.; Chen, Y.; He, R. Isoalantolactone inhibits RANKL\u2010induced osteoclast formation via multiple signaling pathways. Int. Immunopharmacol. 2020, 84, 106550, doi:10.1016/j.intimp.2020.106550. 89. Yuan, C.\u2010B.; Tian, L.; Yang, B.; Zhou, H.\u2010Y. Isoalantolactone protects LPS\u2010induced acute lung injury through Nrf2 activation. Microb. Pathog. 2018, 123, 213\u2013218, doi:10.1016/j.micpath.2018.07.010. 90. Schmidt, T.J.; Brun, R.; Willuhn, G.; Khalid, S.A. Anti\u2010trypanosomal Activity of Helenalin and Some Structurally Related Ses\u2010quiterpene Lactones. Planta Med. 2002, 68, 750\u2013751. 91. Turk, A.; Ahn, J.H.; Jo, Y.H.; Song, J.Y.; Khalife, H.K.; Gali\u2010Muhtasib, H.; Kim, Y.; Hwang, B.Y.; Lee, M.K. NF\u2010\u03baB inhibitory sesquiterpene lactones from Lebanese Laurus nobilis. Phytochem. Lett. 2019, 30, 120\u2013123, doi:10.1016/j.phytol.2019.02.003. 92. Coronado\u2010Aceves, E.W.; Vel\u00e1zquez, C.; Robles\u2010Zepeda, R.E.; Jim\u00e9nez\u2010Estrada, M.; Hern\u00e1ndez\u2010Mart\u00ednez, J.; G\u00e1lvez\u2010Ruiz, J.C.; Garibay\u2010Escobar, A. Reynosin and santamarine: Two sesquiterpene lactones from Ambrosia confertiflora with bactericidal activity against clinical strains of Mycobacterium tuberculosis. Pharm. Biol. 2016, 54, 2623\u20132628, doi:10.3109/13880209.2016.1173067. 93. Lim, S.; Lee, S.J.; Nam, K.W.; Kim, K.H.; Mar, W. Hepatoprotective effects of reynosin against thioacetamide\u2010induced apoptosis in primary hepatocytes and mouse liver. Arch. Pharm. Res. 2013, 36, 485\u2013494, doi:10.1007/s12272\u2010013\u20100039\u20100. 94. Ham, A.; Kim, D.W.; Kim, K.H.; Lee, S.J.; Oh, K.B.; Shin, J.; Mar, W. Reynosin protects against neuronal toxicity in dopamine\u2010induced SH\u2010SY5Y cells and 6\u2010hydroxydopamine\u2010lesioned rats as models of Parkinson\u2019s disease: Reciprocal up\u2010regulation of E6\u2010AP and down\u2010regulation of \u03b1\u2010synuclein. Brain Res. 2013, 1524, 54\u201361, doi:10.1016/j.brainres.2013.05.036. 95. Mehmood, T.; Maryam, A.; Tian, X.; Khan, M.; Ma, T. Santamarine inhibits NF\u2010\u03baB and STAT3 activation and induces apoptosis in HepG2 liver cancer cells via oxidative stress. J. Cancer 2017, 8, 3707\u20133717, doi:10.7150/jca.20239. 96. Choi, H.G.; Lee, D.S.; Li, B.; Choi, Y.H.; Lee, S.H.; Kim, Y.C. Santamarin, a sesquiterpene lactone isolated from Saussurea lappa, represses LPS\u2010induced inflammatory responses via expression of heme oxygenase\u20101 in murine macrophage cells. Int. Im\u2010munopharmacol. 2012, 13, 271\u2013279, doi:10.1016/j.intimp.2012.04.016. 97. Jayaprakasam, B.; Alexander\u2010Lindo, R.L.; DeWitt, D.L.; Nair, M.G. Terpenoids from Stinking toe (Hymneae courbaril) fruits with cyclooxygenase and lipid peroxidation inhibitory activities. Food Chem. 2007, 105, 485\u2013490, doi:10.1016/j.foodchem.2007.04.004. 98. Cho, B.O.; Ryu, H.W.; So, Y.; Cho, J.K.; Woo, H.S.; Jin, C.H.; Seo, K.I.; Park, J.C.; Jeong, I.Y. Anti\u2010inflammatory effect of austroin\u2010ulin and 6\u2010O\u2010acetyl\u2010austroinulin from Stevia rebaudiana in lipopolysaccharide\u2010stimulated RAW264.7 macrophages. Food Chem. Toxicol. 2013, 62, 638\u2013644, doi:10.1016/j.fct.2013.09.011. 99. Byun, M. Anti\u2010Inflammatory Activity of Austroinulin from Stevia rebaudiana in LPS\u2010induced RAW264.7 Cells. J. Korean Soc. Food Sci. Nutr. 2012, 41, 456\u2013461, doi:10.3746/jkfn.2012.41.4.456. 100. Vieira, H.S.; Takahashi, J.A.; De Oliveira, A.B.; Chiari, E.; Boaventura, M.A.D. Novel derivatives of kaurenoic acid: Preparation and evaluation of their trypanocidal activity. J. Braz. Chem. Soc. 2002, 13, 151\u2013157, doi:10.1590/S0103\u201050532002000200004. Molecules 2021, 26, 2733 39 of 45 101. Brito, S.; Crescente, O.; Fern\u00e1ndez, A.; Coronado, A.; Rodriguez, N. Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis. Biom\u00e9dica 2006, 26, 180\u2013187, doi:10.7705/bio\u2010medica.v26i1.1511. 102. Villasmil, T.; Rojas, J.; Aparicio, R.; Gamboa, N.; Acosta, M.E.; Rodrigues, J.; Usubillaga, A. Antimalarial activity of some kau\u2010renes. Nat. Prod. Commun. 2017, 12, 217\u2013220, doi:10.1177/1934578x1701200219. 103. Mendoza, C.; M\u00e1rquez, A.; Matheus, N.; Sosa, S.M.; L\u00f3pez\u2010Ortega, A. Acci\u00f3n protectora del \u00e1cido kaur\u00e9nico en el estr\u00e9s oxida\u2010tivo hep\u00e1tico. Rev. Vet. 2017, 28, 27, doi:10.30972/vet.2811293. 104. Sarwar, M.S.; Xia, Y.X.; Liang, Z.M.; Tsang, S.W.; Zhang, H.J. Mechanistic pathways and molecular targets of plant\u2010derived anticancer ent\u2010kaurane diterpenes. Biomolecules 2020, 10, 144, doi:10.3390/biom10010144. 105. Sosa\u2010Sequera, M.C.; Su\u00e1rez, O.; Dal\u00f3, N.L. Kaurenic acid: An in vivo experimental study of its anti\u2010inflammatory and antipyretic effects. Indian J. Pharmacol. 2010, 42, 293\u2013296, doi:10.4103/0253\u20107613.70205. 106. Venditti, A.; Maggi, F.; Quassinti, L.; Bramucci, M.; Lupidi, G.; Ornano, L.; Ballero, M.; Sanna, C.; Bruno, M.; Rosselli, S.; et al. Bioactive Constituents of Juniperus turbinata Guss. from La Maddalena Archipelago. Chem. Biodivers. 2018, 15, doi:10.1002/cbdv.201800148. 107. De Las Heras, B.; Hoult, J.R.S. Non\u2010cytotoxic inhibition of macrophage eicosanoid biosynthesis and effects on leukocyte func\u2010tions and reactive oxygen species of two novel anti\u2010inflammatory plant diterpenoids. Planta Med. 1994, 60, 501\u2013506, doi:10.1055/s\u20102006\u2010959559. 108. Balaei\u2010Kahnamoei, M.; Eftekhari, M.; Ardekani, M.R.S.; Akbarzadeh, T.; Saeedi, M.; Jamalifar, H.; Safavi, M.; Sam, S.; Zhalehjoo, N.; Khanavi, M. Phytochemical constituents and biological activities of Salvia macrosiphon Boiss. BMC Chem. 2021, 15, 1\u20137, doi:10.1186/s13065\u2010020\u201000728\u20109. 109. Rasool, N.; Rashid, M.A.; Khan, S.S.; Ali, Z.; Zubair, M.; Ahmad, V.U.; Khan, S.N.; Choudhary, M.I.; Tareen, R.B. Novel \u03b1\u2010glucosidase activator from Pulicaria undulata. Nat. Prod. Commun. 2013, 8, 757\u2013759, doi:10.1177/1934578x1300800618. 110. Castellar, A.; Coelho, T.S.; Silva, P.E.A.; Ramos, D.F.; Louren\u00e7o, M.C.S.; Lage, C.L.S.; Juli\u00e3o, L.S.; Barbosa, Y.G.; Leit\u00e3o, S.G. The activity of flavones and oleanolic acid from Lippia lacunosa against susceptible and resistant Mycobacterium tuberculosis strains. Rev. Bras. Farm. 2011, 21, 835\u2013840, doi:10.1590/S0102\u2010695x2011005000076. 111. Shafaei, A.; Khan, M.S.S.; Aisha, A.F.A.; Majid, A.M.S.A.; Hamdan, M.R.; Mordi, M.N.; Ismail, Z. Flavonoids\u2010rich Orthosiphon stamineus extract as new candidate for angiotensin I\u2010converting enzyme inhibition: A molecular docking study. Molecules 2016, 21, 1500, doi:10.3390/molecules21111500. 112. Yam, M.F.; Tan, C.S.; Ahmad, M.; Shibao, R. Mechanism of vasorelaxation induced by eupatorin in the rats aortic ring. Eur. J. Pharmacol. 2016, 789, 27\u201336, doi:10.1016/j.ejphar.2016.06.047. 113. Lee, K.; Lee, D.H.; Jung, Y.J.; Shin, S.Y.; Lee, Y.H. The natural flavone eupatorin induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells. Appl. Biol. Chem. 2016, 59, 193\u2013199 doi:10.1007/s13765\u2010016\u20100160\u20100. 114. Razak, N.A.; Yeap, S.K.; Alitheen, N.B.; Ho, W.Y.; Yong, C.Y.; Tan, S.W.; Tan, W.S.; Long, K. Eupatorin Suppressed Tumor Progression and Enhanced Immunity in a 4T1 Murine Breast Cancer Model. Integr. Cancer Ther. 2020, 19, doi:10.1177/1534735420935625. 115. Gul\u00e7in, \u0130.; Taslimi, P.; Ayg\u00fcn, A.; Sadeghian, N.; Bastem, E.; Kufrevioglu, O.I.; Turkan, F.; \u015een, F. Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on \u03b1\u2010glycosidase, \u03b1\u2010amylase and human glutathione S\u2010transferase enzymes. Int. J. Biol. Macromol. 2018, 119, 741\u2013746, doi:10.1016/j.ijbiomac.2018.08.001. 116. Rajbhandari, A.; Roberts, M.F. The Flavonoids of Stevia microchaeta, Stevia monardifolia, and Stevia origanoides. J. Nat. Prod. 1985, 48, 502\u2013503, doi:10.1021/np50039a036. 117. S\u00fclsen, V.P.; Cazorla, S.I.; Frank, F.M.; Redko, F.C.; Anesini, C.A.; Coussio, J.D.; Malchiodi, E.L.; Martino, V.S.; Muschietti, L.V. Trypanocidal and leishmanicidal activities of flavonoids from Argentine medicinal plants. Am. J. Trop. Med. Hyg. 2007, 77, 654\u2013659, doi:10.4269/ajtmh.2007.77.654. 118. Melaku, Y.; Worku, T.; Tadesse, Y.; Mekonnen, Y.; Schmidt, J.; Arnold, N.; Dagne, E. Antiplasmodial Compounds from Leaves of Dodonaea angustifolia. Curr. Bioact. Compd. 2017, 13, 268\u2013273, doi:10.2174/1573407213666170403121222. 119. Teffo, L.S.; Aderogba, M.A.; Eloff, J.N. Antibacterial and antioxidant activities of four kaempferol methyl ethers isolated from Dodonaea viscosa Jacq. var. angustifolia leaf extracts. S. Afr. J. Bot. 2010, 76, 25\u201329, doi:10.1016/j.sajb.2009.06.010. 120. Mai, L.H.; Chabot, G.G.; Grellier, P.; Quentin, L.; Dumontet, V.; Poulain, C.; Espindola, L.S.; Michel, S.; Vo, H.T.B.; Deguin, B.; et al. Antivascular and anti\u2010parasite activities of natural and hemisynthetic flavonoids from New Caledonian Gardenia species (Rubiaceae). Eur. J. Med. Chem. 2015, 93, 93\u2013100, doi:10.1016/j.ejmech.2015.01.012. 121. Zhong, M.; Wang, H.Q.; Yan, H.Y.; Wu, S.; Gu, Z.Y.; Li, Y.H. Santin inhibits influenza A virus replication through regulating MAPKs and NF\u2010\u03baB pathways. J. Asian Nat. Prod. Res. 2019, 21, 1205\u20131214, doi:10.1080/10286020.2018.1520221. 122. Stompor, M. A review on sources and pharmacological aspects of sakuranetin. Nutrients 2020, 12, 513, doi:10.3390/nu12020513. 123. Ugocsai, K.; Varga, A.; Molnar, P.; Antus, S.; Molnar, J. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug\u2010resistant colon cancer cells expressing MDR1/LRP. Vivo 2005, 19, 433\u2013438. 124. Park, J.H.; Fu, Y.Y.; Chung, I.S.; Hahn, T.R.; Cho, M.H. Cytotoxic property of ultraviolet\u2010induced rice phytoalexins to human colon carcinoma HCT\u2010116 cell. J. Korean Soc. Appl. Biol. Chem. 2013, 56, 237\u2013241. 125. Drira, R.; Sakamoto, K. Sakuranetin induces melanogenesis in B16BL6 melanoma cells through inhibition of ERK and PI3K/AKT signaling pathways. Phytother. Res. 2016, 30, 997\u20131002. Molecules 2021, 26, 2733 40 of 45 126. Hong, L.; Ying, S.H. Ethanol extract and isolated constituents from Artemisia dracunculus inhibit esophageal squamous cell car\u2010cinoma and induce apoptotic cell death. Drug Res. 2015, 65, 101\u2013106. 127. Grecco, D.S.; Dorigueto, A.C.; Landre, I.M.; Soares, M.G.; Martho, K.; Lima, R.; Pascon, R.C.; Vallim, M.A.; Capello, T.M.; Romoff, P. Structural crystalline characterization of sakuranetin\u2014An antimicrobial flavanone from twigs of Baccharis retusa (Asteraceae). Molecules 2014, 19, 7528\u20137542. 128. Pacciaroni, A.V.; Gette, M.A.; Derita, M.; Luis Ariza\u2010Espinar, L.; Gil, R.R.; Zacchino, S.A.; Silva, G.L. Antifungal Activity of Heterothalamus alienus Metabolites. Phytother. Res. 2008, 22, 524\u2013528, doi:10.1002/ptr.2380. 129. Zhang, L.; Kong, Y.; Wu, D.; Zhang, H.; Wu, J.; Chen, J.; Ding, J.; Hu, L.; Jiang, H.; Shen, X. Three flavonoids targeting the \u03b2\u2010hydroxyacyl\u2010acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibi\u2010tion assay. Protein Sci. 2008, 17, 1971\u20131978, doi:10.1110/ps.036186.108. 130. Grecco, S.D.S.; Reim\u00e3o, J.Q.; Tempone, A.G.; Sartorelli, P.; Cunha, R.L.O.R.; Romoff, P.; Ferreira, M.J.P.; F\u00e1vero, O.A.; Lago, J.H.G. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae). Exp. Para\u2010sitol. 2012, 130, 141\u2013145, doi:10.1016/j.exppara.2011.11.002. 131. Quintanilla\u2010Licea, R.; Vargas\u2010Villarreal, J.; Verde\u2010Star, M.J.; Rivas\u2010Galindo, V.M.; Torres\u2010Hern\u00e1ndez, \u00c1.D. Antiprotozoal Activ\u2010ity against Entamoeba histolytica of Flavonoids Isolated from Lippia graveolens Kunth. Molecules 2020, 25, 2464, doi:10.3390/mol\u2010ecules25112464. 132. Kwon, D.H.; Ji, J.H.; Yim, S.H.; Kim, B.S.; Choi, H.J. Suppression of influenza B virus replication by sakuranetin and mode of its action. Phytother. Res. 2018, 32, 2475\u20132479, doi:10.1002/ptr.6186. 133. Choi, H.J. In vitro antiviral activity of sakuranetin against human rhinovirus 3. Osong Public Health Res. Perspect. 2017, 8, 415\u2013420, doi:10.24171/j.phrp.2017.8.6.09. 134. Bittencourt\u2010Mernak, M.I.; Pinheiro, N.M.; Santana, F.P.R.; Guerreiro, M.P.; Saraiva\u2010Romanholo, B.M.; Grecco, S.S.; Caperuto, L.C.; Felizardo, R.J.F.; C\u00e2mara, N.O.S.; Tib\u00e9rio, I.F.L.C.; et al. Prophylactic and therapeutic treatment with the flavonone sa\u2010kuranetin ameliorates LPS\u2010induced acute lung injury. Am. J. Physiol Lung C. 2017, 312, L217\u2013L230, doi:10.1152/aj\u2010plung.00444.2015. 135. Sakoda, C.P.P.; de Toledo, A.C.; Perini, A.; Pinheiro, N.M.; Hiyane, M.I.; Grecco, S. dos S.; de F\u00e1tima Lopes Calvo Tib\u00e9rio, I.; C\u00e2mara, N.O.S.; de Arruda Martins, M.; Lago, J.H.G.; et al. Sakuranetin reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflammation. Acta Histochem. 2016, 118, 615\u2013624, doi:10.1016/j.ac\u2010this.2016.07.001. 136. Taguchi, L.; Pinheiro, N.M.; Choqueta\u2010Toledo, A.; Grecco, S.S.; Lopes, F.D.; Caperuto, L.C.; Martins, L.C.; Tiberio, I.F.; C\u00e2mara, N.O.; Lago, J.H.; et al. A flavanone from Baccharis retusa (Asteraceae) prevents elastase\u2010induced emphysema in mice by regu\u2010lating NF\u2010\u03baB, oxidative stress and metalloproteinases. Respir. Res. 2015, 16, 79. 137. Toledo, A.C.; Sakoda, C.P.P.; Perini, A.; Pinheiro, N.M.; Magalh\u00e3es, R.M.; Grecco, S.; Tib\u00e9rio, I.F.L.C.; C\u00e3mara, N.O.; Martins, M.A.; Lago, J.H.G.; et al. Flavanone treatment reverses airway inflammation and remodeling in an asthma murine model. Br. J. Pharmacol. 2013, 168, 1736\u20131749. 138. Yamauchi, Y.; Okuyama, T.; Ishii, T.; Okumura, T.; Ikeya, Y.; Nishizawa, M. Sakuranetin downregulated inducible nitric oxide synthase expression by affecting interleukin\u20101 receptor and CCAAT/enhancer\u2010 binding protein \u03b2. J. Nat. Med. 2019, 73, 353\u2013368. 139. Zhang, X.; Hung, T.M.; Phuong, P.T.; Ngoc, T.M.; Min, B.\u2010S.; Song, K.\u2010S.; Seong, Y.H.; Bae, K. Anti\u2010inflammatory activity of flavonoids from Populus davidiana. Arch. Pharm. Res. 2006, 29, 1102\u20131108, doi:10.1007/BF02969299. 140. Hern\u00e1ndez, V.; Recio, M.C.; M\u00e1\u00f1ez, S.; Giner, R.M.; Rios, J.L. Effects of naturally occuring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism. Life Sci. 2007, 81, 480\u2013488. 141. Chen, L.; Hu, C. Protective effect of sakuranetin in brain cells of dementia model rats. Cell. Mol. Biol. 2019, 51, 1. 142. Grecco, D.S.; F\u00e9lix, M.J.P.; Lago, J.H.G.; Pinto, \u00c9.G.; Tempone, A.G.; Romoff, P.; Ferreira, M.J.P.; Sartorelli, P. Anti\u2010trypanosomal phenolic derivatives from Baccharis uncinella. Nat. Prod. Commun. 2014, 9, 171\u2013173, doi:10.1177/1934578x1400900210. 143. Muthu, C.; Reegan, A.D.; Kingsley, S.; Ignacimuthu, S. Larvicidal activity of pectolinaringenin from Clerodendrum phlomidis L. against Culex quinquefasciatus Say and Aedes aegypti L. (Diptera: Culicidae). Parasitol. Res. 2012, 111, 1059\u20131065, doi:10.1007/s00436\u2010012\u20102932\u20108. 144. Tasdemir, D.; Kaiser, M.; Brun, R.; Yardley, V.; Schmidt, T.J.; Tosun, F.; Ruedi, P. Antitrypanosomal and Antileishmanial Activ\u2010ities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure\u2010Activity Relationship, and Quantitative Structure\u2010Activity Relationship Studies. Antimicrob. Agents Chemother. 2006, 50, 1352\u20131364, doi:10.1128/aac.50.4.1352\u20101364.2006. 145. Abdelhalim, A.; Chebib, M.; Aburjai, T.; Johnston, G.A.R.; Hanrahan, J.R. GABAA Receptor Modulation by Compounds Iso\u2010lated from Salvia triloba L. Adv. Biol. Chem. 2014, 4, 148\u2013159, doi:10.4236/abc.2014.42019. 146. Abdelhalim, A.; Karim, N.; Chebib, M.; Aburjai, T.; Khan, I.; Johnston, G.A.R.; Hanrahan, J.R. Antidepressant, anxiolytic and antinociceptive activities of constituents from Rosmarinus officinalis. J. Pharm. Pharm. Sci. 2015, 18, 448\u2013459, doi:10.18433/j3pw38. 147. Hern\u00e1ndez\u2010Bolio, G.I.; Torres\u2010Tapia, L.W.; Moo\u2010Puc, R.; Peraza\u2010S\u00e1nchez, S.R. Antigiardial activity of flavonoids from leaves of Aphelandra scabra. Rev. Bras. Farmacogn. 2015, 25, 233\u2013237, doi:10.1016/j.bjp.2015.04.004. 148. Kim, H.J.; Kim, I.S.; Dong, Y.; Lee, I.S.; Kim, J.S.; Kim, J.S.; Woo, J.T.; Cha, B.Y. Melanogenesis\u2010inducing effect of cirsimaritin through increases in microphthalmia\u2010associated transcription factor and tyrosinase expression. Int. J. Mol. Sci. 2015, 16, 8772\u20138788, doi:10.3390/ijms16048772. 149. Wu, Z.K.; Wang, J.J.; Zhu, S.S.; Zhang, J.Y.; Wei, J.H.; Li, L. Cirsimaritin ameliorates cardiac remodeling and dysfunction through promoting myocardial autophagy in rats with heart failure. Int. J. Clin. Exp. Pathol. 2016, 9, 509\u2013520. Molecules 2021, 26, 2733 41 of 45 150. Lee, D.; Jung, Y.; Baek, J.Y.; Shin, M.S.; Lee, S.; Hahm, D.H.; Lee, S.C.; Shim, J.S.; Kim, S.N.; Kang, K.S. Cirsimaritin Contributes to the Estrogenic Activity of Cirsium japonicum var. maackii through the Activation of Estrogen Receptor \u03b1. Bull. Korean Chem. Soc. 2017, 38, 1486\u20131490, doi:10.1002/bkcs.11342. 151. Abbas, G.; Al Harrasi, A.; Hussain, H.; Hamaed, A.; Supuran, C.T. The management of diabetes mellitus\u2010imperative role of natural products against dipeptidyl peptidase\u20104, \u03b1\u2010glucosidase and sodium\u2010dependent glucose co\u2010transporter 2 (SGLT2). Bioor\u2010ganic Chem. 2019, 86, 305\u2013315, doi:10.1016/j.bioorg.2019.02.009. 152. Park, J.Y.; Kim, H.Y.; Shibamoto, T.; Jang, T.S.; Lee, S.C.; Shim, J.S.; Hahm, D.H.; Lee, H.J.; Lee, S.; Kang, K.S. Beneficial effects of a medicinal herb, Cirsium japonicum var. maackii, extract and its major component, cirsimaritin on breast cancer metastasis in MDA\u2010MB\u2010231 breast cancer cells. Bioorg. Med. Chem. Lett. 2017, 27, 3968\u20133973, doi:10.1016/j.bmcl.2017.07.070. 153. Shin, M.S.; Park, J.Y.; Lee, J.; Yoo, H.H.; Hahm, D.H.; Lee, S.C.; Lee, S.; Hwang, G.S.; Jung, K.; Kang, K.S. Anti\u2010inflammatory effects and corresponding mechanisms of cirsimaritin extracted from Cirsium japonicum var. maackii Maxim. Bioorganic Med. Chem. Lett. 2017, 27, 3076\u20133080, doi:10.1016/j.bmcl.2017.05.051. 154. Yan, H.; Wang, H.; Ma, L.; Ma, X.; Yin, J.; Wu, S.; Huang, H.; Li, Y. Cirsimaritin inhibits influenza A virus replication by down\u2010regulating the NF\u2010\u03baB signal transduction pathway. Virol. J. 2018, 15, 1\u20139, doi:10.1186/s12985\u2010018\u20100995\u20106. 155. Manurung, K.; Sulastri, D.; Zubir, N.; Ilyas, S. In silico anticancer activity and in vitro antioxidant of flavonoids in Plectranthus amboinicus. Pharmacogn. J. 2020, 12, 1573\u20131577, doi:10.5530/pj.2020.12.215. 156. Pathak, G.; Singh, S.; Kumari, P.; Raza, W.; Hussain, Y.; Meena, A. Cirsimaritin, a lung squamous carcinoma cells (NCIH\u2010520) proliferation inhibitor. J. Biomol. Struct. Dyn. 2020, doi:10.1080/07391102.2020.1763198. 157. Thanasansurapong, S.; Tuchinda, P.; Reutrakul, V.; Pohmakotr, M.; Piyachaturawat, P.; Chairoungdua, A.; Suksen, K.; Akkara\u2010wongsapat, R.; Limthongkul, J.; Napaswad, C.; et al. Cytotoxic and anti\u2010HIV\u20101 activities of triterpenoids and flavonoids isolated from leaves and twigs of Gardenia sessiliflora. Phytochem. Lett. 2020, 35, 46\u201352, doi:10.1016/j.phytol.2019.10.007. 158. Bourdillat, B.; Delautier, D.; Labat, C.; Benveniste, J.; Potier, P.; Brink, C. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. Eur. J. Pharmacol. 1988, 147, 1\u20136, doi:10.1016/0014\u20102999(88)90626\u20107. 159. Marques, M.R.; St\u00fcker, C.; Kichik, N.; Tarrag\u00f3, T.; Giralt, E.; Morel, A.F.; Dalcol, I.I. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. Fitoterapia 2010, 81, 552\u2013556, doi:10.1016/j.fitote.2010.01.018. 160. Mercader, A.G.; Pomilio, A.B. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. Eur. J. Med. Chem. 2010, 45, 1724\u20131730, doi:10.1016/j.ejmech.2010.01.005. 161. Yu, C.Y.; Su, K.Y.; Lee, P.L.; Jhan, J.Y.; Tsao, P.H.; Chan, D.C.; Chen, Y.L.S. Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG\u20101 signaling. Evid. Based Complementary Altern. Med. 2013, doi:10.1155/2013/518301. 162. Xu, Q.; Xie, H.; Wu, P.; Wei, X. Flavonoids from the capitula of Eriocaulon australe. Food Chem. 2013, 139, 149\u2013154, doi:10.1016/j.foodchem.2013.01.018. 163. Xie, W.; Li, H.; Zhu, J. Antitumor effect of hispidulin in vivo and in vitro. Mater. Med. 2007, 23, 21\u201322. 164. Reutrakul, V.; Krachangchaeng, C.; Tuchinda, P.; Pohmarkotr, M.; Jaipetch, T.; Yoosook, C.; Kasisit, J.; Sophasan, S.; Sujarit, K.; Santisuk, T. Cytotoxic and anti\u2010HIV\u20101 constituents from leaves and twigs of Gardenia tubifera. Tetrahedron 2004, 60, 1517\u20131523. 165. Nepal, M.; Choi, H.J.; Choi, B.Y.; Yang, M.S.; Chae, J. Il; Li, L.; Soh, Y. Hispidulin attenuates bone resorption and osteoclasto\u2010genesis via the RANKL\u2010induced NF\u2010\u03baB and NFATc1 pathways. Eur. J. Pharmacol. 2013, 715, 96\u2013104, doi:10.1016/j.ejphar.2013.06.002. 166. Kim, H.A.; Lee, J. Hispidulin modulates epithelial\u2010mesenchymal transition in breast cancer cells. Oncol. Lett. 2021, 21, 155, doi:10.3892/ol.2020.12416. 167. Liu, K.; Zhao, F.; Yan, J.; Xia, Z.; Jiang, D.; Maa, P. Hispidulin: A promising flavonoid with diverse anti\u2010cancer properties. Life Sci. 2020, 259, 118395, doi:10.1016/j.lfs.2020.118395. 168. Serti`e, J.A.A.; Basile, A.C.; Panizza, S.; Matida, A.K.; Zelnik, R. Anti\u2010inflammatory activity and sub\u2010acute toxicity of artemetin. Planta Med. 1990, 56, 36\u201340, doi:10.1055/s\u20102006\u2010960879. 169. Grossini, E.; Marotta, P.; Farruggio, S.; Sigaudo, L.; Qoqaiche, F.; Raina, G.; De Giuli, V.; Mary, D.; Vacca, G.; Pollastro, F. Effects of Artemetin on Nitric Oxide Release and Protection against Peroxidative Injuries in Porcine Coronary Artery Endothelial Cells. Phytother. Res. 2015, 29, 1339\u20131348, doi:10.1002/ptr.5386. 170. Hu, J.; Ma, W.; Li, N.; Wang, K.J. Antioxidant and anti\u2010inflammatory flavonoids from the flowers of chuju, a medical cultivar of chrysanthemum morifolim ramat. J. Mex. Chem. Soc. 2017, 61, 282\u2013289, doi:10.29356/jmcs.v61i4.458. 171. De Souza, P.; Gasparotto, A.; Crestani, S.; \u00c9lida, M.; Stefanello, A.; Consuelo, M.; Marques, A.; Eduardo, J.; Aparecida, C.; Kas\u2010suya, L. Phytomedicine Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Eur. J. Integr. Med. 2011, 18, 819\u2013825, doi:10.1016/j.phymed.2011.02.005. 172. Liu, K.C.; Yang, S.L.; Roberts, M.F.; Elford, B.C.; Phillipson, J.D. Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures. Plant. Cell Rep. 1992, 11, 637\u2013640. 173. Nwodo, N.; Okoye, F.; Lai, D.; Debbab, A.; Kaiser, M.; Brun, R.; Proksch, P. Evaluation of the in vitro trypanocidal activity of methylated flavonoid constituents of Vitex simplicifolia leaves. BMC Complement. Altern. Med. 2015, 15, 1\u20135, doi:10.1186/s12906\u2010015\u20100562\u20102. 174. Wee, H.N.; Neo, S.Y.; Singh, D.; Yew, H.C.; Qiu, Z.Y.; Tsai, X.R.C.; How, S.Y.; Yip, K.Y.C.; Tan, C.H.; Koh, H.L. Effects of Vitex trifolia L. Leaf extracts and phytoconstituents on cytokine production in human u937 macrophages. BMC Complementary Altern. Med. 2020, 20, 1\u201315, doi:10.1186/s12906\u2010020\u201002884\u2010w. Molecules 2021, 26, 2733 42 of 45 175. Ono, M.; Yanaka, T.; Yamamoto, M.; Ito, Y.; Nohara, T. New diterpenes and norditerpenes from the fruits of Vitex rotundifolia. J. Nat. Prod. 2002, 65, 537\u2013541. 176. Boniface, P.K.; Ferreira, E.I. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and den\u2010gue. Phytother. Res. 2019, 33, 2473\u20132517, doi:10.1002/ptr.6383. 177. Yuting, C.; Rongliang, Z.; Zhngjian, J.; Yong, J. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 1990, 9, 19\u201321. 178. Mlcek, J.; Jurikova, T.; Skrovankova, S.; Sochor, J. Quercetin and its anti\u2010allergic immune response. Molecules 2016, 21, 623, doi:10.3390/molecules21050623. 179. Li, Y.; Yao, J.; Han, C.; Yang, J.; Chaudhry, M.T.; Wang, S.; Liu, H.; Yin, Y. Quercetin, inflammation and immunity. Nutrients 2016, 8, 167, doi:10.3390/nu8030167. 180. Marunaka, Y.; Marunaka, R.; Sun, H.; Yamamoto, T.; Kanamura, N.; Inui, T.; Taruno, A. Actions of quercetin, a polyphenol, on blood pressure. Molecules 2017, 22, 209, doi:10.3390/molecules22020209. 181. Eid, H.M.; Haddad, P.S. The Antidiabetic Potential of Quercetin: Underlying Mechanisms. Curr. Med. Chem. 2017, 24, 355\u2013364, doi:10.2174/0929867323666160909153707. 182. Rauf, A.; Imran, M.; Khan, I.A.; ur\u2010Rehman, M.; Gilani, S.A.; Mehmood, Z.; Mubarak, M.S. Anticancer potential of quercetin: A comprehensive review. Phytother. Res. 2018, 32, 2109\u20132130, doi:10.1002/ptr.6155. 183. Shafabakhsh, R.; Asemi, Z. Quercetin: A natural compound for ovarian cancer treatment. J. Ovarian Res. 2019, 12, 1\u20139, doi:10.1186/s13048\u2010019\u20100530\u20104. 184. Khan, H.; Ullah, H.; Aschner, M.; Cheang, W.S.; Akkol, E.K. Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Bio\u2010molecules 2020, 10, 59, doi:10.3390/biom10010059. 185. Li, J.; Jiang, H.; Shi, R. A new acylated quercetin glycoside from the leaves of Stevia rebaudiana Bertoni. Nat. Prod. Res. 2009, 23, 1378\u20101383, doi:10.1080/14786410802447294. 186. Li, Y.; Di, Frenz, C.M.; Chen, M.H.; Wang, Y.R.; Li, F.J.; Luo, C.; Liang, N.; Yang, H.; Bohlin, L.; Wang, C.L. Primary Virtual and in vitro Bioassay Screening of Natural Inhibitors from Flavonoids against COX\u20102. Chin. J. Nat. Med. 2011, 9, 156\u2013160, doi:10.3724/SP.J.1009.2011.00156. 187. Nguyen, M.T.T.; Awale, S.; Tezuka, Y.; Ueda, J.Y.; Le Tran, Q.; Kadota, S. Xanthine oxidase inhibitors from the flowers of Chry\u2010santhemum sinense. Planta Med. 2006, 72, 46\u201351, doi:10.1055/s\u20102005\u2010873181. 188. Krasteva, I.; Bratkov, V.; Bucar, F.; Kunert, O.; Kollroser, M.; Kondeva\u2010Burdina, M.; Ionkova, I. Flavoalkaloids and Flavonoids from Astragalus monspessulanus. J. Nat. Prod. 2015, 78, 2565\u20132571, doi:10.1021/acs.jnatprod.5b00502. 189. Karunarathne, W.A.H.M.; Lee, K.T.; Choi, Y.H.; Jin, C.Y.; Kim, G.Y. Anthocyanins isolated from Hibiscus syriacus L. attenuate lipopolysaccharide\u2010induced inflammation and endotoxic shock by inhibiting the TLR4/MD2\u2010mediated NF\u2010\u03baB signaling path\u2010way. Phytomedicine 2020, 76, 153237, doi:10.1016/j.phymed.2020.153237. 190. Minda, D.; Avram, S.; Pavel, I.Z.; Kis, B.; Ghitu, A.; Zupko, I.; Dehelean, C.; Buda, V.; DIaconeasa, Z.; Scurtu, A.; et al. An in vitro evaluation of apigenin and apigenin\u20107\u2010o\u2010glucoside against hela human cervical cancer cell line. Rev. Chim. 2020, 71, 140\u2013144, doi:10.37358/RC.20.2.7906. 191. Villa\u2010Rodriguez, J.A.; Kerimi, A.; Tumova, S.; Williamson, G. Inhibition of intestinal glucose transport by polyphenols: A mech\u2010anism for indirect attenuation of cholesterol absorption. Food Funct. 2019, 10, 3127\u20133134, doi:10.1039/c9fo00810a. 192. Jia, Y.; Ma, Y.; Cheng, G.; Zhang, Y.; Cai, S. Comparative Study of Dietary Flavonoids with Different Structures as \u03b1\u2010Glucosidase Inhibitors and Insulin Sensitizers. J. Agric. Food Chem. 2019, 67, 10521\u201310533, doi:10.1021/acs.jafc.9b04943. 193. Ramchandani, S.; Naz, I.; Lee, J.H.; Khan, M.R.; Ahn, K.S. An overview of the potential antineoplastic effects of casticin. Mole\u2010cules 2020, 25, 1287, doi:10.3390/molecules25061287. 194. Koh, D.J.; Ahn, H.S.; Chung, H.S.; Lee, H.; Kim, Y.; Lee, J.Y.; Kim, D.G.; Hong, M.; Shin, M.; Bae, H. Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF\u2010\u03baB inac\u2010tivation. J. Ethnopharmacol. 2011, 136, 399\u2013405, doi:10.1016/j.jep.2011.01.014. 195. Bergendorff, O.; Sterner, O. Spasmolytic Flavonols from Artemisia abrotanum. Planta Med. 1995, 61, 370\u2013371. 196. Hu, Y.; Xin, H.L.; Zhang, Q.Y.; Zheng, H.C.; Rahman, K.; Qin, L.P. Anti\u2010nociceptive and anti\u2010hyperprolactinemia activities of Fructus viticis and its effective fractions and chemical constituents. Phytomedicine 2007, 14, 668\u2013674, doi:10.1016/j.phymed.2007.01.008. 197. Webster, D.E.; He, Y.; Chen, S.N.; Pauli, G.F.; Farnsworth, N.R.; Wang, Z.J. Opioidergic mechanisms underlying the actions of Vitex agnus\u2010castus L. Biochem. Pharmacol. 2011, 81, 170\u2013177, doi:10.1016/j.bcp.2010.09.013. 198. Chu, J.; Yan, B.; Zhang, J.; Peng, L.; Ao, X.; Zheng, Z.; Jiang, T.; Zhang, Z. Casticin Attenuates Osteoarthritis\u2010Related Cartilage Degeneration by Inhibiting the ROS\u2010Mediated NF\u2010\u03baB Signaling Pathway in vitro and in vivo. Inflammation 2020, 43, 810\u2013820, doi:10.1007/s10753\u2010019\u201001167\u2010y. 199. Nageen, B.; Sarfraz, I.; Rasul, A.; Hussain, G.; Rukhsar, F.; Irshad, S.; Riaz, A.; Selamoglu, Z.; Ali, M. Eupatilin: A natural phar\u2010macologically active flavone compound with its wide range applications. J. Asian Nat. Prod. Res. 2018, 22, 1\u201316, doi:10.1080/10286020.2018.1492565. 200. Li, Y.; Ren, R.; Wang, L.; Peng, K. Eupatilin alleviates airway remodeling via regulating phenotype plasticity of airway smooth muscle cells. Biosci. Rep. 2020, 40, 1\u201310, doi:10.1042/BSR20191445. Molecules 2021, 26, 2733 43 of 45 201. Jeong, J.H.; Moon, S.J.; Jhun, J.Y.; Yang, E.J.; Cho, M. La; Min, J.K. Eupatilin exerts antinociceptive and chondroprotective prop\u2010erties in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes. PLoS ONE 2015, 10, e0130882, doi:10.1371/journal.pone.0130882. 202. Zhang, Y.; Qin, L.; Xie, J.; Li, J.; Wang, C. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson\u2019s disease mouse model. Life Sci. 2020, 253, 117745, doi:10.1016/j.lfs.2020.117745. 203. Kang, Y.J.; Jung, U.J.; Lee, M.K.; Kim, H.J.; Jeon, S.M.; Park, Y.B.; Chung, H.G.; Baek, N.I.; Lee, K.T.; Jeong, T.S.; et al. Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic \u03b2\u2010cell function in type 2 diabetic mice. Diabetes Res. Clin. Pract. 2008, 82, 25\u201332, doi:10.1016/j.diabres.2008.06.012. 204. Son, J.E.; Lee, E.; Seo, S.G.; Lee, J.; Kim, J.E.; Kim, J.; Lee, K.W.; Lee, H.J. Eupatilin, a major flavonoid of artemisia, attenuates aortic smooth muscle cell proliferation and migration by inhibiting PI3K, MKK3/6, and MKK4 activities. Planta Med. 2013, 79, 1009\u20131016, doi:10.1055/s\u20100033\u2010135062. 205. Metoui, R.; Bouajila, J.; Znati, M.; Cazaux, S.; Neffati, M.; Akrout, A. Bioactive flavones isolated from Tunisian Artemisia cam\u2010pestris L. Leaves. Cell. Mol. Biol. 2017, 63, 86\u201391, doi:10.14715/cmb/2017.63.11.15. 206. Chougouo, R.D.K.; Nguekeu, Y.M.M.; Dzoyem, J.P.; Awouafack, M.D.; Kouamouo, J.; Tane, P.; McGaw, L.J.; Eloff, J.N. Anti\u2010inflammatory and acetylcholinesterase activity of extract, fractions and five compounds isolated from the leaves and twigs of Artemisia annua growing in Cameroon. SpringerPlus 2016, 5, doi:10.1186/s40064\u2010016\u20103199\u20109. 207. Ebada, S.S.; Al\u2010Jawabri, N.A.; Youssef, F.S.; El\u2010Kashef, D.H.; Knedel, T.O.; Albohy, A.; Korinek, M.; Hwang, T.L.; Chen, B.H.; Lin, G.H.; et al. Anti\u2010inflammatory, antiallergic and COVID\u201019 protease inhibitory activities of phytochemicals from the Jorda\u2010nian hawksbeard: Identification, structure\u2010Activity relationships, molecular modeling and impact on its folk medicinal uses. RSC Adv. 2020, 10, 38128\u201338141, doi:10.1039/d0ra04876c. 208. Zhu, Q.C.; Wang, Y.; Liu, Y.P.; Zhang, R.Q.; Li, X.; Su, W.H.; Long, F.; Luo, X.D.; Peng, T. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. Eur. J. Pharm. Sci. 2011, 44, 392\u2013398, doi:10.1016/j.ejps.2011.08.030. 209. Ortiz, S.; Dali\u2010Yahia, K.; Vasquez\u2010Ocmin, P.; Grougnet, R.; Grellier, P.; Michel, S.; Maciuk, A.; Boutefnouchet, S. Heme\u2010binding activity of methoxyflavones from Pentzia monodiana Maire (Asteraceae). Fitoterapia 2017, 118, 1\u20135, doi:10.1016/j.fitote.2017.01.012. 210. Nurbek, S.; Murata, T.; Suganuma, K.; Ishikawa, Y.; Buyankhishig, B.; Kikuchi, T.; Byambajav, T.; Davaapurev, B.O.; Sasaki, K.; Batkhuu, J. Isolation and evaluation of trypanocidal activity of sesquiterpenoids, flavonoids, and lignans in Artemisia sieversiana collected in Mongolia. J. Nat. Med. 2020, 74, 750\u2013757, doi:10.1007/s11418\u2010020\u201001429\u20102. 211. Arroo, R.R.J.; Sari, S.; Barut, B.; \u00d6zel, A.; Ruparelia, K.C.; \u015e\u00f6hreto\u011flu, D. Flavones as tyrosinase inhibitors: Kinetic studies in vitro and in silico. Phytochem. Anal. 2020, 31, 314\u2013321, doi:10.1002/pca.2897. 212. Cao, Y.; Zang, Y.; Huang, X.; Cheng, Z. Chemical constituents from Artemisia rupestris and their neuraminidase inhibitory ac\u2010tivity. Nat. Prod. Res. 2019, 1\u20138, doi:10.1080/14786419.2019.1639178. 213. Ma, L.; Wei, S.; Yang, B.; Ma, W.; Wu, X.; Ji, H.; Sui, H.; Chen, J. Chrysosplenetin inhibits artemisinin efflux in Pgp\u2010 over\u2010expressing Caco\u20102 cells and reverses P\u2010gp/MDR1 mRNA up\u2010regulated expression induced by artemisinin in mouse small intes\u2010tine. Pharm. Biol. 2017, 55, 374\u2013380, doi:10.1080/13880209.2016.1241810. 214. Hong, G.; He, X.; Shen, Y.; Chen, X.; Yang, F.; Yang, P.; Pang, F.; Han, X.; He, W.; Wei, Q. Chrysosplenetin promotes osteoblas\u2010togenesis of bone marrow stromal cells via Wnt/\u03b2\u2010catenin pathway and enhances osteogenesis in estrogen deficiency\u2010induced bone loss. Stem Cell Res. Ther. 2019, 10, 1\u201314, doi:10.1186/s13287\u2010019\u20101375\u2010x. 215. Forgo, P.; Zupk\u00f3, I.; Moln\u00e1r, J.; Vasas, A.; Dombi, G.; Hohmann, J. Bioactivity\u2010guided isolation of antiproliferative compounds from Centaurea jacea L. Fitoterapia 2012, 83, 921\u2013925, doi:10.1016/j.fitote.2012.04.006. 216. Ahmed, S.; Kamel, E.M. Cytotoxic activities of flavonoids from Centaurea scoparia. Sci. World J. 2014, 2014, 274207, doi:10.1155/2014/274207. 217. Jachak, S.M.; Gautam, R.; Selvam, C.; Madhan, H.; Srivastava, A.; Khan, T. Anti\u2010inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L. Fitoterapia 2011, 82, 173\u2013177, doi:10.1016/j.fitote.2010.08.016. 218. Chang, S.L.; Chiang, Y.M.; Chang, C.L.T.; Yeh, H.H.; Shyur, L.F.; Kuo, Y.H.; Wu, T.K.; Yang, W.C. Flavonoids, centaurein and centaureidin, from Bidens pilosa, stimulate IFN\u2010\u03b3 expression. J. Ethnopharmacol. 2007, 112, 232\u2013236, doi:10.1016/j.jep.2007.03.001. 219. Qaddir, I.; Majeed, A.; Hussain, W.; Mahmood, S.; Rasool, N. An in silico investigation of phytochemicals as potential inhibitors against non\u2010structural protein 1 from dengue virus 4. Braz. J. Pharm. 2020, 56, 1\u201321, doi:10.1590/s2175\u201097902020000117420. 220. Ito, Y.; Kanamaru, A.; Tada, A. Centaureidin promotes dendrite retraction of melanocytes by activating Rho. Biochim. Biophys. Acta Gen. Subj. 2006, 1760, 487\u2013494, doi:10.1016/j.bbagen.2006.01.003. 221. Zater, H.; Huet, J.; Fontaine, V.; Benayache, S.; St\u00e9vigny, C.; Duez, P.; Benayache, F. Chemical constituents, cytotoxic, antifungal and antimicrobial properties of Centaurea diluta Ait. subsp. algeriensis (Coss. Dur.) Maire. Asian Pac. J. Trop. Med. 2016, 9, 554\u2013561, doi:10.1016/j.apjtm.2016.04.016. 222. \u015eekerler, T.; \u015een, A.; Biti\u015f, L.; \u015eener, A. In vitro antihepatocellular carcinoma activity of secondary metabolites of Centaurea kilaea boiss. J. Res. Pharm. 2020, 24, 479\u2013486, doi:10.35333/jrp.2020.196. 223. Lee, H.G.; Yu, K.A.; Oh, W.K.; Baeg, T.W.; Oh, H.C.; Ahn, J.S.; Jang, W.C.; Kim, J.W.; Lim, J.S.; Choe, Y.K.; et al. Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16. J. Ethnopharmacol. 2005, 98, 339\u2013343, doi:10.1016/j.jep.2005.01.054. Molecules 2021, 26, 2733 44 of 45 224. Kim, M.J.; Han, J.M.; Jin, Y.Y.; Baek, N.I.; Bang, M.H.; Chung, H.G.; Choi, M.S.; Lee, K.T.; Sok, D.E.; Jeong, T.S. In vitro antioxi\u2010dant and anti\u2010inflammatory activities of jaceosidin from Artemisia princeps Pampanini cv. Sajabal. Arch. Pharm. Res. 2008, 31, 429\u2013437, doi:10.1007/s12272\u2010001\u20101175\u20108. 225. Park, E.; Hong, K.; Kwon, B.M.; Kim, Y.; Kim, J.H. Jaceosidin ameliorates insulin resistance and kidney dysfunction by enhanc\u2010ing insulin receptor signaling and the antioxidant defense system in type 2 diabetic mice. J. Med. Food 2020, 23, 1083\u20131092, doi:10.1089/jmf.2020.4739. 226. Lee, S.H.; Bae, E.A.; Park, E.K.; Shin, Y.W.; Baek, N.I.; Han, E.J.; Chung, H.G.; Kim, D.H. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps in IgE\u2010induced hypersensitivity. Int. Immunopharmacol. 2007, 7, 1678\u20131684, doi:10.1016/j.intimp.2007.08.028. 227. Min, S.W.; Kim, N.J.; Baek, N.I.; Kim, D.H. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps on car\u2010rageenan\u2010induced inflammation in mice. J. Ethnopharmacol. 2009, 125, 497\u2013500, doi:10.1016/j.jep.2009.06.001. 228. Lee, H.; Jang, D.; Jeon, J.; Cho, C.; Choi, S.; Han, S.J.; Oh, E.; Nam, J.; Park, C.H.; Shin, Y.S.; et al. Seomae mugwort and jaceosidin attenuate osteoarthritic cartilage damage by blocking I\u03baB degradation in mice. J. Cell. Mol. Med. 2020, 24, 8126\u20138137, doi:10.1111/jcmm.15471. 229. Kumar, R.; Lu, Y.; Elliott, A.G.; Kavanagh, A.M.; Cooper, M.A.; Davis, R.A. Semi\u2010synthesis and NMR spectral assignments of flavonoid and chalcone derivatives. Magn. Reson. Chem. 2016, 54, 880\u2013886, doi:10.1002/mrc.4482. 230. Allison, B.J.; Allenby, M.C.; Bryant, S.S.; Min, J.E.; Hieromnimon, M.; Joyner, P.M. Antibacterial activity of fractions from three Chumash medicinal plant extracts and in vitro inhibition of the enzyme enoyl reductase by the flavonoid jaceosidin. Nat. Prod. Res. 2017, 31, 707\u2013712, doi:10.1080/14786419.2016.1217201. 231. Lee, T.H.; Jung, H.; Park, K.H.; Bang, M.H.; Baek, N.I.; Kim, J. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF\u2010iB signaling pathways in endothelial cells. Exp. Biol. Med. 2014, 239, 1325\u20131334, doi:10.1177/1535370214533883. 232. Afifi, F.U.; Aburjai, T. Antiplatelet activity of Varthemia iphionoides. Fitoterapia 2004, 75, 629\u2013633, doi:10.1016/j.fitote.2004.04.014. 233. Aljan\u010di\u0107, I.; Stankovi\u0107, M.; Te\u0161evi\u0107, V.; Vujisi\u0107, L.; Vajs, V.; Milosavljevi\u0107, S. Protective effect on human lymphocytes of some flavonoids isolated from two Achillea species. Nat. Prod. Commun. 2010, 5, 729\u2013732, doi:10.1177/1934578x1000500511. 234. Elhady, S.S.; Eltamany, E.E.; Shaaban, A.E.; Bagalagel, A.A.; Muhammad, Y.A.; El\u2010Sayed, N.M.; Ayyad, S.N.; Ahmed, A.A.M.; Elgawish, M.S.; Ahmed, S.A. Jaceidin flavonoid isolated from Chiliadenus montanus attenuates tumor progression in mice via vegf inhibition: In vivo and in silico studies. Plants 2020, 9, 1031, doi:10.3390/plants9081031. 235. Camuesco, D.; Comalada, M.; Rodr\u00edguez\u2010Cabezas, M.E.; Nieto, A.; Lorente, M.D.; Concha, A.; Zarzuelo, A.; G\u00e1lvez, J. The in\u2010testinal anti\u2010inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 2004, 143, 908\u2013918, doi:10.1038/sj.bjp.0705941. 236. Cincin, Z.B.; Unlu, M.; Kiran, B.; Bireller, E.S.; Baran, Y.; Cakmakoglu, B. Molecular mechanisms of quercitrin\u2010induced apoptosis in non\u2010small cell lung cancer. Arch. Med. Res. 2014, 45, 445\u2013454, doi:10.1016/j.arcmed.2014.08.002. 237. Chiow, K.H.; Phoon, M.C.; Putti, T.; Tan, B.K.H.; Chow, V.T. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 2016, 9, 1\u20137, doi:10.1016/j.apjtm.2015.12.002. 238. Xing, L.\u2010Z.; Ni, H.\u2010J.; Wang, Y.\u2010L. Quercitrin attenuates osteoporosis in ovariectomized rats by regulating mitogen\u2010activated protein kinase (MAPK) signaling pathways. Biomed. Pharmacother. 2017, 89, 1136\u20131141, doi:10.1016/j.biopha.2017.02.073. 239. Kim, J.; Re Kim, S.; Choi, Y.H.; Shin, J.Y.; Kim, C.D.; Kang, N.G.; Park, B.C.; Lee, S. Quercitrin Stimulates Hair Growth with Enhanced Expression of Growth Factors via Activation of MAPK/CREB Signaling Pathway. Molecules 2020, 25, 4004, doi:10.3390/molecules25174004. 240. Hur, H.J.; Jeong, Y.H.; Lee, S.H.; Sung, M.J. Quercitrin ameliorates hyperlipidemia and hepatic steatosis in ovariectomized mice. Life 2020, 10, 243, doi:10.3390/life10100243. 241. Zhang, X.; Cheng, B.; Liu, X.; Li, Y.; Hou, J.; Chen, S.; Chen, J.; Li, S. Screening of \u03b1\u2010Glucosidase Inhibitors from Houttuynia cordata and Evaluation of the Binding Mechanisms. Chem. Sel. 2020, 5, 8440\u20138446, doi:10.1002/slct.202001657. 242. Jegal, J.; Park, N.J.; Lee, S.Y.; Jo, B.G.; Bong, S.K.; Kim, S.N.; Yang, M.H. Quercitrin, the Main Compound in Wikstroemia indica, Mitigates Skin Lesions in a Mouse Model of 2,4\u2010Dinitrochlorobenzene\u2010Induced Contact Hypersensitivity. Evid. Based Comple\u2010mentary Altern. Med. 2020, 2020, doi:10.1155/2020/4307161. 243. Razafin\u2010drabazo, F.; Donno, D.; Tombozara, N.; Razafindrakoto, Z.R.; Rajaonarison, J.F.; Andrianjara, C.; Ramanitrahasimbola, D.; Beccaro, G.L. Phyto\u2010compounds and pharmacological activities of Lygodium lanceolatum Desv. (Schizaeaceae). S. Afr. J. Bot. 2020, 135, 225\u2013232, doi:10.1016/j.sajb.2020.09.010. 244. Oh, T.W.; Do, H.J.; Jeon, J.H.; Kim, K. Quercitrin inhibits platelet activation in arterial thrombosis. Phytomedicine 2021, 80, 153363, doi:10.1016/j.phymed.2020.153363. 245. Guo, H.; Yin, W.; Zou, Z.; Zhang, C.; Sun, M.; Min, L.; Yang, L.; Kong, L. Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development: An in vivo and in vitro study. J. Adv. Res. 2021, 28, 255\u2013267, doi:10.1016/j.jare.2020.06.020. 246. Milit\u00e3o, G.C.G.; Albuquerque, M.R.J.R.; Pessoa, O.D.L.; Pessoa, C.; Moraes, M.E.A.; De Moraes, M.O.; Costa\u2010Lotufo, L.V. Cyto\u2010toxic activity of nepetin, a flavonoid from Eupatorium ballotaefolium HBK. Pharmazie 2004, 59, 965\u2013966, doi:10.1002/chin.200516192. Molecules 2021, 26, 2733 45 of 45 247. Jiang, H.; Wu, D.; Xu, D.; Yu, H.; Zhao, Z.; Ma, D.; Jin, J. Eupafolin exhibits potent anti\u2010angiogenic and antitumor activity in hepatocellular carcinoma. Int. J. Biol. Sci. 2017, 13, 701\u2013711, doi:10.7150/ijbs.17534. 248. Wang, C.Y.; Huang, S.C.; Lai, Z.R.; Ho, Y.L.; Jou, Y.J.; Kung, S.H.; Zhang, Y.; Chang, Y.S.; Lin, C.W. Eupafolin and ethyl acetate fraction of Kalanchoe gracilis stem extract show potent antiviral activities against enterovirus 71 and coxsackievirus A16. Evid. Based Complementary Altern. Med. 2013, doi:10.1155/2013/591354. 249. Yang, J.; Wang, X.; Zhang, C.; Ma, L.; Wei, T.; Zhao, Y.; Peng, X. Comparative study of inhibition mechanisms of structurally different flavonoid compounds on \u03b1\u2010glucosidase and synergistic effect with acarbose. Food Chem. 2021, 347, 129056, doi:10.1016/j.foodchem.2021.129056. 250. Lee, C.W.; Lin, Z.C.; Hsu, L.F.; Fang, J.Y.; Chiang, Y.C.; Tsai, M.H.; Lee, M.H.; Li, S.Y.; Hu, S.C.S.; Lee, I.T.; et al. Eupafolin ameliorates COX\u20102 expression and PGE2 production in particulate pollutants\u2010exposed human keratinocytes through ROS/MAPKs pathways. J. Ethnopharmacol. 2016, 189, 300\u2013309, doi:10.1016/j.jep.2016.05.002. 251. Chen, X.; Han, R.; Hao, P.; Wang, L.; Liu, M.; Jin, M.; Kong, D.; Li, X. Nepetin inhibits IL\u20101\u03b2 induced inflammation via NF\u2010\u03baB and MAPKs signaling pathways in ARPE\u201019 cells. Biomed. Pharmacother.2018, 101, 87\u201393, doi:10.1016/j.biopha.2018.02.054. 252. Vo, V.A.; Lee, J.W.; Chang, J.E.; Kim, J.Y.; Kim, N.H.; Lee, H.J.; Kim, S.S.; Chun, W.; Kwon, Y.S. Avicularin inhibits lipopolysac\u2010charide\u2010induced inflammatory response by suppressing ERK phosphorylation in RAW264.7 macrophages. Biomol. Ther. 2012, 20, 532\u2013537, doi:10.4062/biomolther.2012.20.6.532. 253. Wang, Z.; Li, F.; Quan, Y.; Shen, J. Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF\u2010\u03baB/COX\u20102/PPAR\u2010\u03b3 activities. Mol. Med. Rep. 2019, 19, 5417\u20135423, doi:10.3892/mmr.2019.10198. 254. Wang, W.E.I.; Zheng, H.; Zheng, M.; Liu, X.; Yu, J. Protective effect of avicularin on rheumatoid arthritis and its associated mechanisms. Exp. Ther. Med. 2018, 16, 5343\u20135349, doi:10.3892/etm.2018.6872. 255. Shen, Z.; Xu, Y.; Jiang, X.; Wang, Z.; Guo, Y.; Pan, W.; Hou, J. Avicularin relieves depressive\u2010like behaviors induced by chronic unpredictable mild stress in mice. Med. Sci. Monit. 2019, 25, 2777\u20132784, doi:10.12659/MSM.912401. 256. Fujimori, K.; Shibano, M. Avicularin, a plant flavonoid, suppresses lipid accumulation through repression of C/EBP\u03b1\u2010activated GLUT4\u2010mediated glucose uptake in 3T3\u2010L1 cells. J. Agric. Food Chem. 2013, 61, 5139\u20135147, doi:10.1021/jf401154c. 257. Ko, W.C.; Kuo, S.W.; Sheu, J.; Lin, C.; Tzeng, S.; Chen, C. Relaxant Effects of Quercetin Methyl Ether Derivatives in Isolated Guinea Pig Trachea and their Structure\u2010Activity Relationships. Planta Med. 1999, 65, 273\u2013275, doi:10.1055/s\u20102006\u2010960776. 258. Guerrero, M.F.; Puebla, P.; Mart\u00edn, M.L.; Carr\u00f3n, R.; San Rom\u00e1n, L.; Reguero, M.T.; Arteaga, L. Inhibitory effect of N(G)\u2010nitro\u2010L\u2010arginine methyl ester on the anti\u2010adrenergic response elicited by ayanin in the pithed rat. Planta Med. 2002, 68, 322\u2013325, doi:10.1055/s\u20102002\u201026755. 259. Guerrero, M.F.; Puebla, P.; Carr\u00f3n, R.; Mart\u00edn, M.L.; Rom\u00e1n, L.S. Quercetin 3,7\u2010dimethyl ether: A vasorelaxant flavonoid iso\u2010lated from Croton schiedeanus Schlecht. J. Pharm. Pharmacol. 2002, 54, 1373\u20131378, doi:10.1211/002235702760345455. 260. Kawai, M.; Hirano, T.; Higa, S.; Arimitsu, J.; Maruta, M.; Kuwahara, Y.; Ohkawara, T.; Hagihara, K.; Yamadori, T.; Shima, Y.; et al. Flavonoids and related compounds as anti\u2010allergic substances. Allergol. Int. 2007, 56, 113\u2013123, doi:10.2332/allergolint.R\u201006\u2010135. 261. Pick, A.; M\u00fcller, H.; Mayer, R.; Haenisch, B.; Pajeva, I.K.; Weigt, M.; B\u00f6nisch, H.; M\u00fcller, C.E.; Wiese, M. Structure\u2010activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorg. Med. Chem. 2011, 19, 2090\u20132102, doi:10.1016/j.bmc.2010.12.043. 262. Mahmoud, A.B.; Danton, O.; Kaiser, M.; Khalid, S.; Hamburger, M.; M\u00e4ser, P. HPLC\u2010Based Activity Profiling for Antiprotozoal Compounds in Croton gratissimus and Cuscuta hyalina. Front. Pharmacol. 2020, 11, 1\u201310, doi:10.3389/fphar.2020.01246. 263. Guerra, J.A.; Molina, M.F.; Abad, M.J.; Villar, A.M.; Paulina, B. Inhibition of inducible nitric oxide synthase and cyclooxygenase\u20102 expression by flavonoids isolated from Tanacetum microphyllum. Int. Immunopharmacol. 2006, 6, 1723\u20131728, doi:10.1016/j.in\u2010timp.2006.08.012. 264. Castillo, Q.A.; Triana, J.; Eiroa, J.L.; Padr\u00f3n, J.M.; Plata, G.B.; Abel\u2010Santos, E.V.; B\u00e1ez, L.A.; Rodr\u00edguez, D.C.; Jim\u00e9nez, M.A.; P\u00e9rez\u2010Pujols, M.F. Flavonoids from eupatorium illitum and their antiproliferative activities. Pharmacogn. J. 2015, 7, 178\u2013181, doi:10.5530/pj.2015.3.6. 265. Saepou, S.; Pohmakotr, M.; Reutrakul, V.; Yoosook, C.; Kasisit, J.; Napaswad, C.; Tuchinda, P. Anti\u2010HIV1 Diterpenoids from Leaves and Twigs of Polyalthia sclerophylla. Planta Med. 2010, 76, 721\u2013725, doi:10.1055/s\u20100029\u20101240683. 266. Filho, A.A.d.S.; Resende, D.O.; Fukui, M.J.; Santos, F.F.; Pauletti, P.M.; Cunha, W.R.; Silva, M.L.A.; Greg\u00f3rio, L.E.; Bastos, J.K.; Nanayakkara, N.P.D. In vitro antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from Bac\u2010charis dracunculifolia D. C. (Asteraceae). Fitoterapia 2009, 80, 478\u2013482, doi:10.1016/j.fitote.2009.06.007."}